towards feeder-free and serum- free growth...
TRANSCRIPT
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 1
TOWARDS FEEDER-FREE AND SERUM-
FREE GROWTH OF CELLS
By
Sean D. Richards, Bachelor of Science. (Hons)
Faculty of Science - School of Life Sciences
A thesis submitted for the degree of Doctor of Philosophy of the
Queensland University of Technology, June 2007.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 3
DISCLOSURE STATEMENT:
The research described in this thesis was funded by Tissue Therapies limited a
Biotechnology spin off company from the Queensland University of Technology
(QUT). Tissue Therapies has a license to commercialise the intellectual property
described in this thesis. I also received a PhD scholarship stipend (top up) from
Tissue Therapies and have stock in this company.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 4
ABBREVIATIONS
Abbreviation Translation
ACN Acetonitrile ALP Alkaline PhosphataseANK Activin:Keratinocyte growth factor:NicotinamidebFGF Basic fibroblast growth factorBPE Bovine pituitary extractBSE Bovine spongiform encephalopathycDNA complementary deoxyribose nucleic acidCM Conditioned MediumCG Complete Green’s CHCA Matrix for MS protein spottingCJD Creutzfeldt-Jacob diseaseDED De-cellularised dermisDKM Defined keratinocyte mediumDKMF Defined keratinocyte medium + Feeder cellsDMEM Dulbecco’s modified eagle mediaECM Extra-cellular matrixEGF Epidermal growth factorFBS Foetal bovine serumFDA Food and Drug AdministrationgDNA genomic deoxyribose nucleic acidGMP Good manufacturing practiceGTP Good tissue practiceH&E Haemotoxylin and eosinHaCaT Keratinocyte cell lineHBD Heparin binding domainsHCL Hydrochloric acid hEC Human embryonic carcinoma cellhEG Human embryonic germ cellhES Human embryonic stem cellHGF Hepatocyte growth factorHPLC High performance liquid chromatographyHSA Human serum albuminhTERT Human telomerase reverse transcriptasei3t3 Irradiated mouse embryonic fibroblastsICM Inner cell mass IGF Insulin-like growth factorIGFBP Insulin-like growth factor binding proteinIVF In-vitro fertilisationKSR Knock-out serum replacementLC/MS Liquid chromatography/mass spectrometryLC/ESI Liquid chromatography/electrospray ionisationLC/MALDI Liquid chromatography/ Matrix assisted laser desorption ionisation LIF Leukaemia inhibitory factorMALDI Matrix assisted laser desorption ionisation
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 5
MALDI-TOF Matrix assisted laser desorption ionization-Time of flight MEF Mouse embryonic fibroblastmES Mouse embryonic stem cellMTT Thiazolyl blue tetrazolium bromideNaCl Sodium ChlorideOct-4 Octamer binding protein 4PBS Phosphate buffered salineRT-PCR Reverse Transcriptase Polymerase Chain Reaction SCID Severe combined immunodeficiencySG Stripped Green’sSSEA Stage Specific Embryonic AntigensTFA Trifluro acetic acidTGA Therapeutic Goods AdministrationTGF Transforming growth factorVN VitronectinVN:GF (hES VN:IGFBP-3:IGF-I:bFGFVN:GF VN:IGFBP-3:IGF-I:EGF
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 6
ABSTRACT
The in-vitro culture of human embryonic stem and keratinocyte cells has great
potential to revolutionise the therapeutics industry. Indeed it is hoped that these cells
will provide a superior alternative to current tissue and organ transplantation.
However, both of these cell types require animal and/or donor products for their
successful maintenance in-vitro. This requirement results in a significant risk of
cross contamination from the animal or donor products to either the primary
keratinocyte or hES cells. These potentially transplantable cells therefore need to be
cultured in an environment free from animal or donor products to remove the risk of
contamination to the patient.
The ideal growth conditions must comprise of two attributes; firstly they must be
free from animal or donor products, and secondly the culture system must be fully
defined. Recently, it was discovered that an extra-cellular matrix protein, vitronectin,
could be used in conjunction with growth factors and growth factor-binding proteins
(VN:GF combination), to promote enhanced cell migration and growth through the co-
activation of integrin and growth factor receptors. Given that growth factors and serum
are clearly important in supporting the in-vitro cultivation of mammalian cells, and that
vitronectin is an abundant protein in serum, I hypothesised that these VN:GF
combinations could be translated into a serum-free medium that would support the serial
propagation and self renewal of primary keratinocytes and hES cells. As reported in this
thesis I have developed a defined, serum-free media for the culture of these cells that
incorporates the VN:GF combinations. While the two media differ slightly in their
compositions, both support the serial, undifferentiated expansion of their respective
cells types.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 7
Together, this represents a significant advance that will ultimately facilitate the
therapeutic use of these cells. However, the in-vitro expansion of these cells in these
new media still required the presence of a feeder cell layer. In view of this I aimed to
explore the in-vitro micro-environment of primary keratinocytes using a novel
proteomic approach in an attempt to find candidate factors that could be used in
conjunction with the VN:GF media to replace both serum and the feeder cells. The
proteomic approach adopted examined the secretion of proteins into the defined,
minimal protein content VN:GF media when the feeder cells were cultured alone, as
well as in co-culture with primary keratinocytes. This strategy allowed assessment of
proteins/factors that are secreted in response to both autocrine and paracrine cellular
interactions and revealed a number of candidate factors that warrant further
investigation.
Ultimately this proteomic information and the associated new insights into the
keratinocyte in-vitro culture microenvironment may lead to the development of a culture
system for these cells that is not reliant on either a feeder cell layer or serum for their
successful propagation. Moreover, it is likely that this will also be relevant to the feeder
cell-free propagation of hES cells. This has obvious advantages for the culture of
primary keratinocytes and hES cells in that it will allow a safe defined culture system for
the undifferentiated propagation of these cells. This will facilitate the generation of cells
and tissues free from xenogeneic and allogeneic contaminants, thus ensuring any
therapeutics developed from these cell types are approved for therapeutic applications
and importantly, will minimise risks to patients.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 8
TABLE OF CONTENTS
PAGE
Title 1
Disclosure Statement 3
Abbreviations 4
Abstract 6
Table of contents 8
List of Figures 13
List of Tables 14
Statement of original authorship 15
Acknowledgements 16
Chapter 1: Introduction 19
1.1 Cells and the Micro-Environment 20
1.2 Introduction to Human Embryonic Stem Cells 21
1.2.1 Development and The Human Embryonic Stem Cell 23
1.2.2 Human Embryonic Stem Cell Culture 24
1.2.3 The Potential of Human Embryonic Stem Cells 27
1.2.4 Issues Associated With Human Embryonic Stem Cells 29
1.3 Skin 34
1.3.1 Keratinocytes 36
1.3.2 Keratinocyte Culture 37
1.4 Vitronectin 39
1.4.1 (VN:GF) technology 42
1.5 Conclusion 44
Chapter 2: The serum-free culture of human keratinocytes 47
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 9
2.1 Introduction 48
2.2 Materials and Methods 52
2.2.1 Ethics and material collection 52
2.2.2 Isolation of primary kertinocytes 52
2.2.3 Standard culture 52
2.2.4 VN:GF culture 53
2.2.5 Defined keratinocyte media (DKM) culture 54
2.2.6 HaCaT culture 54
2.2.7 Proliferation assays 54
2.2.8 Immunohistochemistry 55
2.2.9 Preparation of dermal equivalent (de-epidermised
dermis)
56
2.2.10 Preparation and culture of skin equivalent 56
2.2.11 Immunohistochemistry and histology of skin
composites
57
2.2.12 Statistical analysis 58
2.3 Results 59
2.3.1 The culture of a keratinocyte cell line using VN:GF
medium
59
2.3.2 Proliferation of HaCaT cells in the presence of different
growth conditions
60
2.3.3 Establishment of primary keratinocyte cells using
VN:GF combination
62
2.3.4 Proliferation of primary keratinocyte cells in the
presence of different growth conditions
63
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 10
2.3.5 Characterisation of primary keratinocyte cells
propagated under different growth conditions
66
2.3.6 The histology and staining of the reconstituted
epidermis
68
2.4 Discussion 71
Chapter 3: Serum-free growth of human embryonic stem cells 77
3.1 Introduction 78
3.2 Materials and Methods 81
3.2.1 Ethics and training 81
3.2.2 Cell culture 81
3.2.3 VN:GF culture 82
3.2.4 ANK culture 83
3.2.5 Immunofluorescence 83
3.2.6 Reverse transcriptase polymerase chain reaction (RT-
PCR) analysis
84
3.2.7 Proliferation assay 85
3.2.8 Karyotype analysis 85
3.3 Results 87
3.3.1 VN:GF medium for the propagation of hES cells 87
3.3.2 Morphology of hES cells grown using VN:GF medium
as a serum-free medium
87
3.3.3 Identification of markers expressed by undifferentiated
hES cells
89
3.3.4 Karyotype analysis of H1 cells grown using VN:GF
medium
90
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 11
3.3.5 RT-PCR analysis of hES cells 91
3.3.6 Morphology of HUES-7 cells grown using the VN:GF
medium in conjunction with the ANK protocol
95
3.3.7 Identification of markers expressed by HUES-7 cells
grown using the VN:GF medium in conjunction with
the ANK protocol
95
3.4 Discussion 99
Chapter 4: The proteomic investigation of keratinocyte conditioned
medium
105
4.1 Introduction 106
4.2 Materials and Methods 109
4.2.1 Ethics and material collection 109
4.2.2 Isolation of primary keratinocytes 109
4.2.3 VN:GF culture 109
4.2.4 Two-dimensional proteomics 110
4.2.5 Sample Preparation and LC/MS using LC/ESI/MS and
LC- MALDI Analysis
112
4.2.6 Sample preparation and MALDI-TOF-TOF mass
spectrometry
113
4.2.7 Database analysis and interpretation 114
4.3 Results 115
4.3.1 Morphology and expression of cell surface markers on
passage-2 keratinocytes propagated using VN:GF
medium for proteomic analysis
115
4.3.2 Two dimensional separation of conditioned media 117
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 12
collected from both feeder cells alone and feeder
cell:keratinocyte cultures
4.3.3 Proteins identified in the feeder cell and the feeder-
cell:keratinocyte conditioned media
119
4.3.4 Differences in expression of protein species found in
the feeder cell and the feeder cell:keratinocyte
conditioned media
125
4.4 Discussion 127
Chapter 5: General Discussion 137
5.0 General Discussion 138
5.1 Serum-free propagation of primary keratinocytes 138
5.2 Serum-free propagation of human embryonic stem cells 140
5.3 Proteomics of keratinocyte conditioned media 143
5.4 Conclusion 147
Chapter 6: 6.0 References 149
Appendix I 173
Appendix II 176
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 13
LIST OF FIGURES PAGE
1.1 Schematic representation of the ECM proteins and their ECM
binding
21
1.2 Timeline and structures for development 24
1.3 Schematic representation of derivation and culturing methods of
hES cells
26
1.4 Schematic representation of the differentiation of hES cells 29
1.5 Anatomy of the skin 35
1.6 Strata of the epidermis 36
1.7 Schematic representation of vitronectin 42
2.1 The culture of a keratinocyte cell line using the VN:GF medium 60
2.2 Proliferation of HaCaT cells using the VN:GF medium 61
2.3 Establishment of primary keratinocyte cells using the VN:GF
medium
63
2.4 Proliferation of primary keratinocyte cells using the VN:GF
medium
65
2.5 Characterisation of primary keratinocyte cells using the VN:GF
medium
67
2.6-I The histology and P63 immuno-staining of the reconstituted
epidermis
69
2.6-II Immuno-staining for keratin 6 and 1/10/11 in the reconstituted
epidermis
70
3.1 VN:GF combinations for the propagation hES cells 88
3.2 Morphology of hES cells grown using the VN:GF medium 89
3.3 Markers expression of the hES cells grown using the VN:GF 93
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 14
medium
3.4 Karyotype analysis of h1 ES cells grown in VG conditions 94
3.5 RT-PCR analysis of hES cells grown using VN:GF medium 94
3.6 Morphology of HUES-7 cells grown using the VN:GF medium in
conjunction with the ANK protocol
97
3.7 Markers expression of HUES-7 cells grown using the VN:GF
medium in conjunction with the ANK protocol
98
4.1 Passage 2 morphology and marker expression of keratinocytes
propagated using VN:GF medium for proteomic analysis
116
4.2 Two dimensional separations of conditioned media 118
LIST OF TABLES
4.1 Proteins identified from feeder cell conditioned media using
LC/ESI/MS system and LC-MALDI
120
4.2 Proteins identified from feeder cell:keratinocyte conditioned
media using LC/ESI/MS and LC-MALDI
122
4.3 Differences in protein species abundance between the feeder cell
and the feeder cell:keratinocyte conditioned media
126
AI.1 MALDI-TOF-TOF Feeder Cell Conditioned Medium 174
AI.2 MALDI-TOF-TOF Keratinocyte Conditioned Medium 174
AII.1 Proteins identified from the MEF conditioned media using
MALDI-TOF-TOF, LC/ESI/MS and LC-MALDI
178
AII.2 Proteins identified from the MEF:hES cells conditioned media
using MALDI-TOF-TOF, LC/ESI/MS and LC-MALDI
180
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 15
STATEMENT OF ORGINIAL AUTHORSHIP
The work contained in this thesis has not been previously submitted for a degree or
diploma or any other higher degree institution. To the best of my knowledge and
belief, the thesis contains no material previously published or written by any other
person(s) except where due reference is made.
Sean D. Richards –
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 16
ACKNOWLEDGEMENTS
This PhD was by no means a smooth ride, with constant problems arising at every
step. However, I believe this experience has helped me to develop into a better
scientist and a more determined person. I have many people who have helped me
through this 3 year journey. Initially, I would like to thank my supervisor for giving
me the opportunity to work on this project. Zee Upton allowed me the freedom to
think for myself, but also cracking the whip when I would get side tracked with
ideas, not necessarily in line with my project.
Furthermore, I would like to thank, Tissue Therapies Ltd. for providing this project
with the growth factors and the Australian Red Cross Blood Service for providing
the cell irradiation service. We would like to further acknowledge the Australian Red
Cross Bali Appeal for funding, as well as Dr Anthony Kane and Dr Phillip
Richardson for supplying us with the skin for this project. I would like to further
thank Gemma Topping for her assistance with setting up the DED studies and
Rebecca Dawson for staying on my case and her assistance in learning the skin
isolation.
Additionally, I would like to express my gratitude to Martin Pera for training me in
hES cell culture at the MIRD. Their guidance and support throughout the year has
been greatly appreciated. I would also like to thank Chris Joy and Sue White, from
QML, for undertaking the karyotype analysis on the hES cells. The technical advice
from Tony Parker, Steve Myers, and Levi Carroll was also of great value. To Gillian
Beattie, Alberto Hayek, and Ana Lopez at the Whittier Institute, thank you for the
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 17
opportunity to travel and work in your lab, it was a great experience, and I believe
this collaboration holds great promise.
A special thanks to my fellow students and friends, especially, Louise Ainscough,
Brett Hollier, James Broadbant and Alun Jones (especially for their invaluable help
with the proteomics), and more recently my student Luke Cormack, for their support
in and out of the lab and their friendship.
Finally, to my friends and family their support was invaluable, their guidance and
strong work ethics set the foundation for my self-belief and discipline, this was
especially important during my first year, when most of my work was destroyed.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 20
1.0 INTRODUCTION
1.1 Cells and the Micro-Environment
A cell is the smallest functional unit within the body capable of metabolism,
replication, and respiration. The body consists of several different cell types each
carrying out unique roles that allow us to function as a living unit. In the body, cells
are provided with a favourable environment, their ‘micro-environment’, which allow
them to survive, replicate and carry out their respective functions. This micro-
environment is the immediate environment that the cell is in contact with. The
micro-environment can include other cells, nutrients, growth factors and an intricate
array of extra-cellular matrix (ECM) proteins, (refer to Figure 1.1 A). The ECM
proteins allow the cells to anchor to their immediate environment via cell surface
proteins, primarily known as integrins, (refer to Figure 1.1 B). Furthermore, ECM
proteins can influence other cellular responses, including migration, proliferation and
cellular morphology.
Indeed, it was the replication of this micro-environment that allowed researchers to
grow cells ‘outside of the body’, (in-vitro). This is accomplished by providing the
cells with an appropriate platform on which they can attach, i.e. culture-ware; the
appropriate nutrients, which can be delivered through media; and a favourable
atmosphere, generally provided by an incubator. The ability to grow cells in-vitro
allows scientists to investigate single cell or mixed cell populations which can
provide insights into the cells physiology and metabolic activity. Moreover, cell
culture can lend itself to other facets of cell biology such as, drug design and the
generation of transplantable tissues (Docherty 2001; Guan et al. 2001; Bagutti et al.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 21
1996). In fact, the promise of transplantable tissues has led to the exploration of
more primitive cell types such as, pluripotent cells, i.e. human embryonic stem cells,
which have the ability to form several different cell types.
Figure 1.1: A) A variety of proteins, involved with attachment, migration, and proliferation,
of cells, that are commonly located in the ECM, B) A schematic representation of the cells
integrin proteins binding to the ECM. Modified from, www.glycoforum.gr.jp/.../
14/images/2.gif
1.2 Introduction to Human Embryonic Stem Cells
A stem cell has the ability to renew itself as well as give rise to more specialised cell
types. There are primarily two types of stem cells; adult stem cells and embryonic
stem cells. Adult stem cells are pluripotent, thus they are able to differentiate into a
number of cell and tissue types. Human embryonic stem (hES) cells on the other
hand are totipotent, possessing the potential to differentiate into all somatic cell and
tissue types within the body (Pera et al. 2000).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 22
Human embryonic stem cell research is viewed as a relatively new field of science
which has primarily developed over the last 7 years. However, this field of research
has stemmed from scientific work that is approximately 125 years old. The first step
in this research was in 1878 with the first reported attempt of fertilising mammalian
eggs outside the body (Trounson et al. 2000b). Another 81 years passed before the
first reported case of a successful in-vitro fertilization (IVF) with rabbits in the USA
in 1959 (Chang, 1959). In 1969 Edwards and Bavister performed the first reported
human egg fertilization in-vitro (Edwards and Bavister 1969). Ten years later, the
first IVF baby was born in England, with Australia following suit two years later
(Trounson 1982). The first embryonic stem cells explored in the field of science
were mouse embryonic stem (mES) cells. These were derived and cultured from the
inner cell mass of mouse blastocysts (Evans and Kaufman 1981). This in turn led to
the first attempt at culturing hES cells in 1994, when Bongso tried to propagate the
inner cell mass from blastocysts donated from patients within the IVF program.
These hES cell cultures could only be passaged twice before differentiating and no
longer demonstrating totipotential behavior (Bongso et al. 1994). Thomson et al.
(1998) were the first group to successfully establish a system for the culture of hES
cells. They demonstrated that these cells could be propagated for long periods of
time whilst still maintaining markers that are representative of an undifferentiated
hES cell (Thomson et al. 1998). This early work has now expanded such that many
groups all around the world are developing these cells as tools for the
pharmacological industry, using their totipotency to drive them into specific cell and
tissue types, and to develop improved culture technologies.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 23
1.2.1 Development and the Human Embryonic Stem Cell
The pathway for development of the human embryonic stem cell begins with the
human egg being fertilised by a sperm cell. Following this, a series of events occur
that lead to the formation of the blastocyst. The first step that occurs is at day two
post-fertilization, and involves the first cleavage. By day three, two more divisions
have occurred to give rise to an eight cell structure called the morula. After another
two days of development a structure known as the blastocyst is formed. This
structure is formed from approximately 200-250 cells resulting in the creation of two
distinct cell layers. The outer wall of the blastocyst is known as the trophectoderm,
which accounts for the majority of cells. The blastocyst also has a single polar cell
clump known as the inner cell mass, which contains approximately 30-34 totipotent
hES cells. It is from the inner cell mass that the first hES cell line was established
(Thomson et al. 1998).
In addition to hES cells, there are two other cell types of interest that are related to
this field of research, human embryonic germ (hEG) and human embryonic
carcinoma (hEC) cells. The hEG cells are derived from the primordial germ cells,
which exist in a region of the foetus known as the gonadal ridge. The hEC cells are a
cell type derived from teratocarcinomas which are germ cell tumours consisting of
multiple cell and tissue types (Iacovitti et al. 2001) (refer to Figure 1.2). Both these
cell types demonstrate high levels of similarity to the hES cells, morphologically and
biochemically, and thus are regularly used in this field as model systems for hES cell
studies.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 24
Figure 1.2: The timeline and structures for development and derivation of hES, human
embryonic germ (hEG), human embryonic carcinoma (hEC) cells. Taken from www.stem
cellresearch.org/testimonies/ prentice3.htm
1.2.2 Human Embryonic Stem Cell Culture
Human embryonic stem (hES) cells have great potential to revolutionise the
therapeutics industry due to this totipotential ability. Indeed some scientists believe
these cells will provide a superior alternative to tissue and organ transplantation.
Nevertheless, the field of hES cell research is relatively new when compared to the
field of mouse embryonic stem (mES) cell research. Mouse embryonic stem cell
research was also the direct source of the initial culturing techniques for hES cells.
As stated previously, Thomson et al. (1998) published the first successful method for
the long term culture of hES cells in an undifferentiated state. This culture
methodology involved the removal of the inner cell mass from the blastocyst stage
embryo and the seeding of the inner cell mass into specific culture conditions.
Thomson et al. (1998) discovered that successful propagation of the hES cells was
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 25
obtained when using a culture system containing a mitotically-inactivated feeder cell
layer and foetal bovine serum (FBS). It is not yet understood what the exact function
of the MEF feeder cell layer in the culture system is, but it has been demonstrated to
supply a range of extra-cellular matrix (ECM) proteins, growth factors and
cytokines, such as the IGFs, bFGF and leukaemia inhibitory factor (LIF), all of
which may be vital for maintaining the hES cells in an undifferentiated state
(Barreca et al. 1992). Furthermore, it has been demonstrated that mES cells express
many of the receptors for the above growth factors, including the IGF-I receptor and
αv integrins, thus suggesting that the same situation is likely to exist for hES cells
(Newman-Smith and Werb 1995). Nevertheless, further studies are required to
determine what receptors are present on hES cells, and to further identify the role
that the feeder cell layer and serum has in the maintenance of the hES cells.
Once hES cells have been grown in these culture conditions for approximately seven
days they reach a morphological state classed as confluent. At this stage the colonies
also begin to differentiate. Thus, the hES cell colonies are passaged into fresh culture
conditions. There are currently two methods for the passaging of hES cells, namely
mechanical dissection and chemical dissection. Mechanical dissection is the process
of cutting the undifferentiated portions of the confluent hES cell colonies into
smaller pieces for transfer to fresh culture. The second method, known as chemical
dissection, involves the use of enzymes such as trypsin/EDTA or collagenase to
disaggregate the hES cell colonies into smaller pieces for the transfer into fresh
culture conditions (refer to Figure 1.3).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 26
Figure 1.3: Schematic representation of derivation and culturing methods of hES cells. hES
cells are mechanically or chemically dissected on ~ day7 and transferred ~1:3 to new culture
plates.
Furthermore, the fragile nature of the hES cell requires particular freezing methods
for the long term storage of these cells. It has been demonstrated that the standard
methods of liquid nitrogen storage in FBS + dimethyl sulfoxide result in cell survival
rates of about 1 to 10 percent. However, Reubinoff et al. (2001) derived “the pulled
straw method of cryo-preservation”, which allowed for significantly enhanced cell
survival rates. This cryo-preservation technique involves a series of solutions in
which the hES cell colony pieces are incubated. The pieces are then transferred to a
cryo-straw and stored at -196 degrees celsius in liquid nitrogen. This technique has
allowed for the both the long term storage and upscaled provision/generation of
several of the hES cell lines available in the market. Nevertheless, it is clear that the
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 27
methods used to culture and store hES cells to date are not optimal and there is a
need to develop novel culturing methods if hES cells are to prove useful for
therapeutic applications.
1.2.3 The Potential of Human Embryonic Stem Cells.
Scientists currently have the ability to culture hES cell colonies in relatively large
amounts whilst still maintaining them in an undifferentiated state. This has led to
studies which exploit the totipotential ability of hES cells including: generating new
tissues for donation (Docherty 2001; Guan et al. 2001; Bagutti et al. 1996);
investigating the complex events that occur during the early developmental stages
(Dinsmore et al. 1998); and the use of these cells to examine the toxicity or efficacy
of a new drug/treatment (Rohwedel et al. 2001). Dinsmore et al. (1998) discovered
components that trigger the hES cells to differentiate into dopamine neurons. It is
from these developmental discoveries that scientists will be able to understand and
map out the sequence of events that occur during the evolution of the embryonic
stem cell to the somatic cell. Another emerging use for human embryonic stem cells
is in the testing of new drugs and chemicals. Due to the potentially hazardous side
effects it is often hard to test experimental drugs and chemicals on humans.
Therefore, human embryonic stem cells can be manipulated to form specific tissue
types for testing these drugs and chemicals. This not only removes the risk of
adverse effects and/or injury to the patient but also provides scientists with a readily
available and relevant cell line to test their drugs (Rohwedel et al. 2001). It is hoped
that the hES cell developmental studies will reveal appropriate environmental, and
culture conditions, for each of the specific cell types within the body, thus providing
society with a viable alternative to current transplantation therapies.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 28
The totipotential behaviour of the hES cells provides a means of generating new
cells and tissue for therapeutics. These cells originate from a structure known as the
blastocyst. As the blastocyst progresses through it’s developmental stages, the inner
cell mass continues to differentiate resulting in gastrulation and the formation of the
three embryonic germ layers. These layers are commonly known as the ectoderm,
mesoderm, and endoderm. It is from these three germ layers that all the somatic cells
and tissues within the body are formed, thus demonstrating the potential value of
these cells for use as a therapeutic tool. Interestingly, these cells have recently been
shown to also differentiate into haploid cell types such as sperm and egg cells
(Geijsen et al. 2003). As development progresses the three embryonic germ layers
start to differentiate into their prospective tissues. For example, ectoderm derives
into the nervous tissue; the endoderm derives into the gut endothelium and the
mesoderm derives into the connective tissue such as striated muscle (refer to Figure
1.4).
As eluded to earlier, investigators have discovered that they can supply a range of
conditions and growth factors to the hES cells to drive them towards specific cell
lineages, thus creating a source of tissue that could potentially be used for
therapeutic applications. Lumelsky et al. (2001) have discovered a method for
driving embryonic stem cells into insulin-secreting structures similar to that of the
pancreatic islets. Furthermore, Boheler et al. (2002) have discovered ways to drive
embryonic stem cells into cardiomyocytes. Interestingly, these cardiomyocytes were
demonstrated to have the ability to spontaneously beat, thus representing beating
heart tissue. The applications for generating transplantable tissue from embryonic
stem cells are enormous, with scientists now able to create both haploid and diploid
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 29
cells. However if these cells are to prove useful there are a number of hurdles to
overcome, i.e. specifically, the safe culture of these cells.
Figure 1.4: Schematic representation of the differentiation of hES cells into the three germ
layers. Adapted from en.wikipedia.org/wiki/User:Lexor/Temp/Cell_(NCBI)
1.2.4 Issues Associated With Human Embryonic Stem Cells.
There are several problems associated within the field of hES cell research. The
major disadvantages being: the moral implications of the scientific technologies and
procedures (McLaren 2002); the second disadvantage is that hES cells are
allogeneic; the third disadvantage is the lack of definitive assays for determining
whether the hES cells are differentiated; and the fourth being concerns with cross
contamination from the feeder cell layers and / or the serum during the culture
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 30
process. Additionally, there are concerns with safety and resource allocation. The
harvesting of hES cells is carried out by culturing cells from the inner cell mass
(ICM) of a blastocyst, which are donated with consent, from people involved with
an IVF program. This process requires dissolving the blastocyst, which has led to
controversial debates focusing on the moral and legal status of the human embryo.
The Catholic and Anglican churches have taken the position that from the moment
of conception the human embryo/foetus constitutes an individualised human entity.
The question is, does life begin at conception or does it in fact start with the
development of consciousness? This question will be the main restriction for some
time as society tries to weigh the moral issues against the promise of a healthier
tomorrow that the human embryonic stem cells can give.
While ethical and moral considerations will always exist, other biological problems
affecting this area of science are the lack of definitive assays for recognising a hES
cell and the rejection of non-self tissue. For hES cells to be therapeutically
beneficial, immune rejection needs to be overcome. One way to combat this
problem is through therapeutic cloning, which is accomplished by removing the
nucleus of either a donor or self oocyte, and inserting the nucleus of a self somatic
cell into this oocyte. The cell is then stimulated to divide to produce a blastocyst for
the harvesting of embryonic stem cells, which can later be used for therapeutic
applications free from the risk of immune rejection. Furthermore, novel molecular
engineering approaches have also started to address potential problems such as the
adverse immunological responses elicited by allogeneic hES cell antigens (Rideout
et al. 2002). It has also been reported that cells from embryonic origins present
fewer immunological response stimuli, than for example, allogeneic adult
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 31
stem/progenitor cells (McLaren 2002). Moreover, there are many problems
associated with the lack of knowledge on what a human embryonic stem cell is.
Due to the infancy of this field of research there are currently no definitive testing
methods to prove that the cultured hES cells are healthy and have retained their
undifferentiated state. Nevertheless, certain tests are commonly applied in this field,
albeit with some limitations, to identify that the cells have maintained their
embryonic-like nature. For example, karyotyping is routinely used to determine if
abnormalities such as chromosome exchange have occurred in cultured hES cells
(Amit et al. 2000). Furthermore, other tests can be applied to hES cells to identify
whether they express several genes/markers such as stage specific embryonic
antigens (SSEAs) (Draper et al. 2002). Most of the testing revolves around the use of
PCR and biochemical methods for the detection of undifferentiated hES cells (zur
Nieden et al. 2001). In addition to marker detection, alkaline phosphatase and
telomerase are two enzymes commonly expressed by hES cells and thus are used to
categorise these cells. The presence of these two enzymes indicates the degree of
differentiation within these cells (Lanzendorf et al. 2001). Currently, the most
definitive test for truly totipotent hES cells is the formation of teratomas (a complex
tumor containing several different tissue types) following the injection of hES cells
into severe combined immunodeficiency (SCID) mice (Richards et al. 2002).
The previously mentioned methods for propagating the hES cells have proved to be
effective. However, a significant problem exists in that they require xenogeneic or
allogeneic products such as human or animal serum, and require the presence of
allogeneic feeder cells such as mouse embryonic fibroblasts (MEF) (Henderson et al.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 32
2002; Schick et al. 2003). The presence of these components presents a significant
risk to patients that may ultimately be treated with these cells. For example, it is
possible that patients may inadvertently be infected with diseases such as “new
variant CJD”, which may be present in these poorly-defined animal products. More
recently, Dr. Ajit Varki demonstrated that hES cell lines were starting to express a
non-human sialic acid (Neu5Gc), which was thought to have come from either the
serum or the mouse embryonic fibroblast feeder-layer (Martin et al. 2005). This
finding demonstrates that the hES cells are vulnerable to what is present in their in-
vitro micro-environment.
In view of this, several investigators have attempted to address the problems
associated with the use of animal products in the culture of these cells by replacing
these animal derived feeder cell layers with human-derived feeder cell layers (Amit
et al. 2000; Richards et al. 2002; Cheng et al. 2003). While this has proven
successful it still does not remove the risk of cross-contamination from diseases that
could be potentially carried by the human derived feeder cell layer. Alternatively,
other researchers have adopted the approach of removing the feeder cell layer totally
and replacing it with an extra-cellular matrix (ECM) protein. For example, laminin
and matrigel™ (a solubilised basement membrane preparation extracted from the
Engelbreth-Holm-Swarm (EHS) mouse sarcoma), were demonstrated to replace the
need for a feeder cell layer (Xu et al. 2001). Moreover, it was revealed that the hES
cells could survive for ~130 population doublings whilst still maintaining an
undifferentiated state. However, this system only proved functional with the addition
of MEF conditioned medium, which still carries the risk of transmitting diseases to
the hES cells. Moreover, due to the fact that matrigel™ is derived from xenogeneic
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 33
origins this also poses the risk of contaminating the hES cells. Furthermore, Richards
et al. (2002), Cheng et al. (2003), Amit et al. (2000), as well as our own group
(unpublished data), have found it difficult to duplicate the results reported by Xu et
al. (2001). These difficulties in reproducing Xu’s work could be attributed to hES
cell variability between labs.
More recently, Amit et al. (2004) discovered a method to propagate these cells using
serum replacement medium with a range of growth factors such as, transforming
growth factor β1 (TGF β1), leukaemia inhibitory factor (LIF), basic fibroblast
growth factor (bFGF), and a fibronectin matrix. In this study they demonstrated that
the hES cells could be propagated for over 20 passages by replacing both the serum
and feeder cell layer with an ECM protein and a range of growth factors.
Nevertheless, there was still a requirement for Knockout Serum Replacement (KSR)
(Invitrogen), which is a commercial serum product from Invitrogen and is still not
fully defined. Perhaps one of the more promising advances in the removal of the
feeder-layer was established by Beattie et al. (2005). They demonstrated that hES
cells could be serially propagated for greater than 20 passages by substituting the
feeder-layer with a laminin coated culture vessel and by supplementing the media
with activin A, nicotinamide and keratinocyte growth factor. While this is an
important step forward, this protocol still had a dependence on Knockout serum
replacement.
Recently, scientists discovered that they can maintain the hES cells in a pluripotent
state by triggering certain pathways in development such as the Wnt signaling
pathway (Sato et al. 2004). Thus, Sato et al. (2004) demonstrated that a protein found
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 34
in mollusks known as 6-bromoindirubin-3`-oxime (BIO) is a critical activator of the
Wnt signaling pathway. They demonstrated that BIO has the ability to stimulate
feeder-free self-renewal of the hES cells and that this reaction was reversible through
the removal of the BIO compound. However, this approach has not yet been
demonstrated to support long-term, serial, undifferentiated passage of hES cells, and
hence the use of BIO as an alternative to feeder cells is far from established. It is of
vital importance that a serum-free and feeder-free methodology, for the
establishment and bulk culture of these cells, be developed so that we can take
advantage of the human embryonic stem cell potential.
1.3 Skin
The early techniques developed for culturing hES cells were originally based on
those developed for the ex-vivo expansion of skin cells. In view of this I will also
review the literature with respect to skin and more specifically, keratinocyte cell
culture.
Skin is the largest and one of the most complex organs of the human body. This vital
sensory organ carries out many functions, which include: acting as a physical barrier
from our external environment; immune surveillance; aiding the production of
hormones/vitamins; and facilitating various homeostatic functions such as
temperature regulation and the maintenance of fluid levels. The skin is a multilayer
tissue made up of an epidermis, which is separated from the dermis by a basement
membrane composed of several extra-cellular matrix (ECM) proteins (refer to Figure
1.5).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 35
Figure 1.5: Anatomy of the skin. Taken from Wikipedia:- This file is licensed under
Creative Commons Attribution 2.5 License. Attribution: http://www.3dscience.com.
The epidermis is an epithelial cell layer primarily composed of keratinocytes. These
cells are involved in the self-renewal, maintenance and formation of the skin’s outer
layer (Leary et al. 1992). Keratinocytes are thought to arise from a more primitive
‘keratinocyte stem cell’, which exists within the basal layer of skin, the stratum
basale, (Kaur et al. 2004; Li and Kaur 2004; Li et al. 2004). As these cells divide and
mature they migrate to the outer surface of the skin forming 4 distinct layers in the
process, the stratum spinosum, stratum granulosum, stratum lucidium, and the
stratum corneum (refer to Figure 1.6). Whilst these cells are migrating through the
strata they undergo a process named keratinisation. The keratinisation process results
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 36
in a change in the keratinocyte phenotype and function resulting in the formation of
the protective outer layer of skin.
Figure 1.6: Strata of the epidermis.
1.3.1 Keratinocytes
Due to the critical role that keratinocytes have in the maintenance and formation of
skin, researchers worldwide have been exploiting these cells for use in a range of
skin defects such as the treatments of burns and skin ulcers (Green 1991; Mean et al.
1998; Wright et al. 1998). It was in 1975 that Rheinwald and Green developed the
first viable methodology for the culture of human epidermal keratinocytes in-vitro
(Rheinwald and Green 1975). In this study they demonstrated that keratinocyte cells
could be obtained from patient skin biopsies and co-cultured with irradiated murine
i3T3 cells in the presence of serum to produce a system that supported the serial
propagation of human keratinocyte cells. However, as alluded to earlier, a significant
Dermis Stratum Basale
Stratum Spinosum
Stratum Corneum
Stratum Lucidium Stratum Granulosum
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 37
problem arises with culturing keratinocyte cells in the presence of human and/or
animal products such as serum and mouse fibroblasts as “feeder” cells. The
introduction of these foreign products into the culture presents a risk in that patients
may inadvertently be infected with diseases such as “new variant Creutzfeldt-Jacob
disease (CJD)”, thought to be derived from Bovine Spongiform Encephalopathy
(BSE), which may be present in these ill-defined animal products (Rolleston 1999).
The risk of infection, albeit small, will eventually make it difficult, if not impossible,
for keratinocyte cell-based treatments to gain broad approval as therapeutics by the
Food and Drug Administration (FDA) and the Australian Therapeutic Goods
Administration (TGA). As is the case with hES cells, if these skin cells are to
maintain their usefulness in an ever changing regulatory environment, improved cell
culture technologies need to be developed to eliminate the risk of pathogens
contaminating the cultured cells, whilst at the same time providing the necessary
conditions for their in-vitro expansion.
1.3.2 Keratinocyte Culture
Due to the need to remove both the serum and the feeder cell layer from skin culture,
research efforts have been trying to address the problems associated with the use of
donor and animal-derived components in this system. Thus far, the main focus has
been the removal of serum from the culture. Currently, serum-free alternatives for
the growth of keratinocytes are commercially available. Defined keratinocyte
medium (Invitrogen, Mulgrave, VIC, Australia) and MCDB 153 (Sigma, St. Louis,
MO) are examples of these products, all of which have been demonstrated to support
the propagation of keratinocytes. However, these products all require the inclusion of
human and/or animal products, such as purified human serum albumin (HSA) or
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 38
bovine pituitary extract (BPE), for the long-term survival of keratinocytes and also
generally require high cell seeding densities.
Perhaps one of the most difficult components to remove from the culture of
keratinocytes is the feeder cell layer. Indeed, Sun et al. (2006) demonstrated that the
fibroblasts could normally migrate into fibrin gels when cultured alone. However,
when co-cultured with the keratinocytes this fibroblast migration was reduced,
suggesting that the keratinocytes require the fibroblasts to be in close proximity.
Certain groups are currently focused on examining whether extra-cellular matrix
(ECM) proteins can provide the solution to serum-free and feeder-free culture
techniques. One such approach involves the use of laminin 10/11, a common ECM
protein found in adult skin (Pouliot et al. 2002). While it has been demonstrated that
laminin can provide the cells with an environment favourable for attachment,
proliferation and migration, the use of a keratinocyte growth medium containing
BPE was still required for the establishment and growth of these cells. Whilst these
novel approaches address the potential problems of pathogen transfer that exist
through the use of serum, they do not avoid the problems associated with poorly-
defined and uncharacterised compounds such as BPE and HSA found in the serum-
free media.
Our laboratory has been investigating alternative culture technologies comprising of
vitronectin (VN), Insulin-like growth factor-I (IGF-I) and Insulin-like growth factor
binding protein-3 (IGFBP-3) (VN:GF medium), suitable for adult and embryonic
stem cells and it is thought that this culture methodology may prove useful for the
establishment and in-vitro expansion of keratinocytes for skin grafting applications.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 39
The VN:GF medium, which combines the ECM protein VN, a major component of
human serum, with IGFBP-3, IGF-I, may provide a substitute for both the serum and
the feeder cell layer. In view of this, we hypothesised those in-vitro culture
technologies incorporating the VN:GF combination, may be useful for developing a
fully defined serum-free medium suitable for in-vitro expansion of human
keratinocytes for clinical applications such as cultured epithelial autografts for
patients.
1.4 Vitronectin
Vitronectin (VN) is an extra-cellular matrix ECM glycoprotein with an open reading
frame of 459 amino acids including a 19 amino acid signal peptide resulting in a 75
kDa mature protein. Proteases can cleave this 75 kDa protein to yield 65 kDa and 11
kDa disulfide-linked fragments (Kitagaki-Ogawa et al. 1990; Gibson and Peterson
2001). The VN protein exists in both monomeric and multimeric forms within the
body and possess domains and binding sites which are differentially revealed
depending on the conformation of the protein. For example, the denatured form of
VN has binding sites for collagen, glycosylaminoglycans (GAGs) and urokinase
receptor urokinase complex (Seiffert 1997; Francois et al. 1999) (refer to Figure 1.7
A). An Arginine, Glycine and Aspartate (RGD) sequence exists within the VN
protein towards the N-terminus (residues 45-47); the primary function of the RGD
sequence being to mediate cell attachment and spreading (Morris et al. 1994; Seiffert
and Smith 1997), (refer to Figure 1.7 B). The cell attachment and spreading function
of VN arises when the RGD sequence interacts with certain cell-surface receptors
called integrins (αvβ3, αvβ5 αvβ1 αIIbβ3 αvβ6 αvβ8) (Schvartz et al. 1999; Nam et al.
2002). When VN binds to its integrin receptors it activates intracellular signaling
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 40
pathways that regulate cytoskeletal reorganization, intracellular ion transport, lipid
metabolism and gene expression (Schvartz et al. 1999).
Vitronectin is predominantly synthesised in the smooth muscle cells of the liver but
is also expressed in other tissues throughout the body (Schvartz et al. 1999).
Expression has also been demonstrated at high levels by certain tumours, raising the
possibility that this protein may play a role in malignancy (Schvartz et al. 1999). The
concentrations of VN in human plasma are high, at approximately 200-400 μg/mL.
Interestingly, the plasma concentrations are up-regulated after vascular injury,
especially during the formation of new blood vessel layers (Dufourcq et al. 2002). In
addition, it has been demonstrated that VN can be deposited within the ECM of
endothelial cells and is localised at other extra-vascular sites (Zhuang et al. 1996 part
I; Schvartz et al. 1999). Taken together, this clearly demonstrates that VN has
important roles in the process of wound healing. Vitronectin’s role in the process of
wound healing has been demonstrated in studies utilizing VN knockout mice in
which the VN gene was inactivated. The knockout mice exhibited a delayed wound
healing response and an imbalance in the fibrinolytic pathway (Jang et al. 2000). In
addition, many proteases have been found to degrade VN. Thrombin, elastase, and
plasmin, which are present with VN at the wound-healing site, have all been shown
to cleave VN at its basic amino acid cluster (Gechtman et al. 1997).
Many of VN’s biological responses are mediated through specific interactions of
other proteins with the various structural domains within VN. These interactions
mediate multiple physiological functions within the ECM and the circulation
including; blood coagulation; fibrinolysis; pericellular proteolysis; complement-
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 41
dependent immune responses; cell attachment; and cell migration (Zhuang et al.
1996 part I; Zhuang et al. 1996 part II; Chavakis et al. 1998). These activities result
in VN having roles in several diseases such as cancer, atherosclerosis and
degenerative central nervous system disorders. Relevant to this project, VN has also
been suggested to play a role in cellular differentiation during embryonic
development (Pons and Marti 2000).
The biological significance of the interactions between ECM proteins such as VN
and growth factors is becoming increasingly appreciated. Of interest to this project,
VN has been demonstrated to specifically bind IGF-II (Upton et al. 1999). While
IGF-I does not directly bind to VN, it can form a trimeric complex with VN in the
presence of select IGFBPs such as IGFBP-5 (Nam et al. 2002; Kricker et al. 2003).
Other heparin-binding growth factors have also been examined and there are
suggestions that these too have the ability to bind to VN. These growth factors
include: transforming growth factor-β (TGF-β); vascular endothelial growth factor
(VEGF); epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF)
(Schoppet et al. 2002).
Thus multimeric VN, the predominant form of VN found in the ECM, has the
potential to bind several different growth factors at the one time. Taken together,
these findings suggest that this protein, in conjunction with other binding proteins,
may be a potential mechanism for the delivery and concentration of growth factors at
their cell surface receptors. Indeed, this will be the foundation from which I propose
to develop a serum-free and feeder-cell free culture technology, specifically focusing
on hES and primary keratinocyte cells.
SEAN RICHARDS
Figure 1.7: Schematic representation of the vitronectin protein and its binding domains;
for plasminogen activator inhibitor-1 (PAI-1), urokinase receptor (uPAR), integrins,
thrombin–antithrombin III complex (TAT) and collagen are located in the N-terminus of the
molecule, while the binding domains for plasminogen, heparin and PAI-1 are located in the
carboxyl terminal edge (Scharvtz et al. 1999).
1.4.1 (VN:GF) technology
The VN:GF technology being developed at QUT relies on elucidating optimal
complexes of VN, growth factors and binding proteins to support the ex-vivo
survival and growth of particular cells. Initial studies performed within the Tissue
Regeneration and Repair program have examined the ability of different
combinations and concentrations of IGF-I, IGF-II, IGFBPs, EGF, FGF and VN to
support the short-term serum-free, feeder-cell free expansion of primary adult skin
and corneal-derived keratinocytes. The initial research in our program has focused
on complexes comprised of VN and IGFs.
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 42
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 43
IGF-I and IGF-II have been demonstrated to stimulate DNA synthesis, cell cycle
progression, angiogenesis and differentiation. Although IGF-II is considered to be
less potent than IGF-I (Clemmons 1998; Marinaro et al. 1999) it is the pre-dominant
IGF expressed during embryogenesis in humans (Nonoshita et al. 1994). The IGF
proteins primarily act through the type-1 IGF receptor (IGFI-R) and their ability to
interact with this receptor is modulated by at least six IGFBPs (Marinaro et al.
1999). It has recently been demonstrated that IGFBP-3 and -5 bind to VN via the
heparin binding domain (HBD) present in many of the IGFBPs (Nam et al. 2002;
Kricker et al. 2003). Moreover, it has been found that IGFBP-5 enhances the effects
of IGF-I in the presence of VN (Rees and Clemmons 1998; Nam et al. 2002). More
recently, our laboratory has also demonstrated that IGFBP-2, -3, -4 and -5 enhance
the proliferative and migratory effects of IGF-I in the presence of VN (Upton and
Kricker 2002; Kricker et al. 2003; Noble et al. 2003). These data have stimulated us
to analyse the effects of trimeric complexes, consisting of VN, IGF-I and IGFBPs,
and dimeric complexes, consisting of IGF-II and VN, on the attachment,
proliferation and migration of a range of cell lines including short-term studies in
hES cells. Furthermore it has been demonstrated that these enhanced effects require
activation of not only the IGFI-R, but also require VN to bind its cell-surface
receptors, the αv integrins.
Interestingly, prior studies examining combinations of IGF-I and EGF have been
shown to increase growth of keratinocytes beyond the responses that either of these
mitogens elicits alone (Vardy et al. 1995). It has also been demonstrated that IGF-I
increases the levels of the EGF receptor (EGFR) in keratinocytes (Krane et al. 1991)
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 44
and that EGF can enhance the growth of keratinocytes in media and prevent
senescence (Rheinwald and Green 1977). Thus our laboratory hypothesised that EGF
can be used with IGF in VN:GF complexes to further enhance cell proliferation and
migration of cells. Furthermore, FGFs are potent inducers of cell attachment and
proliferation (Heun Rho et al. 2001; Tanghetti et al. 2002) and certain FGFs, in
particular FGF-4 and FGF-8, have been demonstrated to be important during
embryonic development (Wilder et al. 1997; Valve et al. 2000). Hence FGF-4 and
FGF-8 are candidate mitogens that are being considered for incorporation into novel
VN:GF complexes designed to support growth of cells, especially hES cells. Indeed
it has recently been demonstrated that IGF-I enhances DNA synthesis in
oligodendrocyte stem cells to a greater degree when in the presence of FGF-2
(bFGF) (Jiang et al. 2001). In addition, the incorporation of bFGF into the hES cell
culture media enhances the undifferentiated growth of these cells (Cowan et al.
2004). Of importance to this project, we have demonstrated that incorporating bFGF
into the VN:GF complexes enhances the proliferation of keratinocyte cells (Hollier
et al. 2005). In addition to exploring various VN:GF combinations as a serum
substitute for the growth of keratinocytes and hES cells, it is also of great importance
to study what critical factors the feeder cells supply to the micro-environment of
these two cell types.
1.5 Conclusion
Clearly in-vitro cell culture research is in its infancy and many questions remain to
be answered i.e. how can we propagate cells without the need for serum? Thus, I
hypothesised that the VN:GF combinations can be translated into a serum-free media
for the serial propagation of primary keratinocytes and hES cells. Additionally, I
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 45
believed that the investigation of the in-vitro micro-environment of primary
keratinocytes would reveal potential candidate proteins that will aid in the removal
of fibroblast feeder cells from the keratinocyte culture system. To this end the aim of
this PhD project was to specifically examine whether VN:GF complexes can be
developed to support serum-free and feeder-cell free culture of both primary
keratinocytes and hES cells. The specific aims were to: 1) develop a serum-free
medium for primary keratinocytes; 2) develop a serum-free medium for hES
cells; and 3) explore the in-vitro micro-environment of primary keratinocytes
using proteomic approaches to reveal novel candidate factors that may
ultimately lead to the replacement of feeder cells. The development of synthetic
culture methods, such as those potentially encompassed by the VN:GF complexes
technology, will be vital for eliminating the need for animal and semi-defined
products for the propagation of these cells. Furthermore, the cultivation of hES cells
is still in it’s infancy with many of the technologies currently used with these cells
being ‘bucket science technologies’. Thus, the third aim of my PhD project was to
help fill this gap in the knowledge by conducting proteomic studies. This approach
would provide insights into the several important pathways that are active during the
development and differentiation of cells. Hence, the information derived from
addressing these three aims may lead to developing not only an animal free culture
system for these cells, but will also be the foundation for creating viable cell types
that may provide clinicians with a readily available source of tissue for
transplantation therapies. To this end the investigations reported in this thesis
demonstrated: the serum free isolation, establishment and serial passaging of primary
human keratinocytes using a VN:GF combination specific for keratinocytes; the
establishment and serial passaging of hES cells using a second VN:GF combination
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 46
specific for hES cells; and finally the identification of factors secreted by feeder cells
alone as well as feeder cells co-cultured with keratinocytes using a novel proteomics
approach. Together this data provides an enhanced understanding of the factors
required by these cells for their successful in-vitro expansion.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 47
CHAPTER 2
The serum-free culture of human keratinocytes
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 48
2.1 INTRODUCTION
Human skin is primarily composed of keratinocytes, which are involved in the self-
renewal, maintenance, and formation of the skin’s epidermal layer (Leary et al.
1992). There are several different types keratinocytes ranging from the more
primitive, or stem cell-like keratinocytes (Kaur et al. 2004; Li and Kaur 2004; Li et
al. 2004), which are located near the basement membrane, through to the more
differentiated keratinocytes, located at the outermost layer of the skin. The cells
closer to the external environment phenotypically change via a keratinisation process
that acts as our natural barrier to external elements.
As stated in Chapter 1 the first successful propagation of keratinocytes in-vitro was
achieved in 1975 (Rheinwald and Green 1975). They discovered that an inactivated
feeder cell layer and animal serum could provide an in-vitro micro-environment
favourable for keratinocyte growth. The ability to grow large quantities of
keratinocytes in-vitro has provided clinicians and scientists with a useful research
tool to develop techniques for the repair of skin defects such as, burns and skin
ulcers (Green 1991; Meana et al. 1998; Wright et al. 1998). However, using
xenogeneic products such as serum and mouse fibroblasts can lead to the
introduction of contaminating products, such as Bovine Spongiform Encephalopathy
(BSE) (Rolleston 1999), to the keratinocytes. Clearly, improved cell culture
technologies need to be developed to eliminate the risk of pathogens contaminating
the cultured cells, whilst at the same time providing the necessary conditions for
their in-vitro expansion.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 49
Currently, serum-free alternatives for the growth of keratinocytes are commercially
available. Defined keratinocyte medium (Invitrogen, Mulgrave, VIC, Australia) and
MCDB 153 (Sigma, St. Louis, MO) are examples of these products, all of which
have been demonstrated to support the serum-free and feeder cell-free propagation of
keratinocytes. However, these products require the inclusion of undefined human
and/or animal products, such as purified human serum albumin (HSA) or bovine
pituitary extract (BPE), for the long-term survival of keratinocytes and also generally
require isolation using serum and high cell seeding densities. The problem associated
with high seeding cell densities is that this scenario may not be possible in a clinical
setting if patients are suffering from large surface area damage. Furthermore, if the
keratinocytes are originally isolated using serum, they can still be potentially
contaminated at this stage, thereby removing any advantage gained through the
subsequent expansion using serum-free or feeder cell-free technologies.
From studies reported thus far, it would appear that the most difficult component to
remove from the culture of keratinocytes is the feeder cell layer and scientists are
now looking to the extra-cellular environment for the answer. Indeed, extra-cellular
matrix (ECM) proteins, such as laminin 10/11, have been used to provided
keratinocytes with a favourable environment for their attachment, proliferation and
migration (Pouliot et al. 2002). Whilst this technology provided a serum-free and
feeder cell-free culture environment, bovine pituitary extract (BPE) was still required
for the establishment and growth of these cells. Whilst these novel approaches
address the potential problems of pathogen transfer that exist through the use of
serum, they do not avoid the problems associated with poorly defined and
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 50
uncharacterised compounds such as BPE and human serum albumin (HAS) found in
the serum-free media.
The removal of a feeder cell layer from the culture of keratinocytes may not be
possible, thus Bullock et al. (2006) demonstrated the successful propagation and re-
epithelisation using a human-derived feeder cell layer and serum free conditions.
Nevertheless, this methodology still involves the use of serum for the initial
keratinocyte isolation and trypsin neutralistion, thus, resulting in the carry over of
serum components to the keratinocytes. Furthermore, human derived pathogens
could be easily transferred from the human feeder cell layer to the primary
keratinocytes.
Therefore our laboratory has been investigating alternative culture technologies
suitable for adult stem cells and has recently discovered a technique that may lead to
a fully defined serum-replacement method for the establishment and in-vitro
expansion of keratinocytes for skin grafting applications. This new technology is
based on the finding that a synergistic effect occurs between growth factors and a
specific extra-cellular matrix (ECM) protein called vitronectin (VN) (Hollier et al
2005; Kricker et al. 2003; Upton and Kricker 2002). This has led to the development
of novel dimeric, trimeric and multimeric growth-promoting combinations
incorporating growth factors such as insulin-like growth factors (IGFs) and insulin-
like growth factor binding proteins (IGFBPs) in conjunction with VN (VN:GF).
The addition of these VN:GF combinations to defined media has been demonstrated
to stimulate short-term migration and proliferation in a range of cells, including adult
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 51
skin and corneal-derived keratinocytes (Ainscough et al. 2006; Hollier et al 2005;
Hyde et al. 2004). In view of this, I hypothesised those in-vitro culture technologies
incorporating ECM proteins and growth factors, such as those encompassed by these
VN:GF medium, may be useful for developing animal-product free media suitable
for in-vitro expansion of human keratinocytes for clinical applications such as
cultured epithelial autografts for burns patients. In the study reported here, I
examined the long-term survival and biological responses of a continuous
keratinocyte cell line (HaCaT), as well as primary keratinocyte cells derived from
adult human skin when grown in the presence of media containing the VN:GF
medium.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 52
2.2 MATERIALS AND METHODS
2.2.1 Ethics and material collection
Ethics for this project was approved by the Human Research Ethics Committee (ID:
3673H) (Queensland University of Technology) and the St. Andrews and Wesley
Hospitals, Brisbane, Australia. Skin was obtained from consenting patients
undergoing breast reductions and abdominoplasties.
2.2.2 Isolation of primary keratinocytes
Primary keratinocytes were isolated from split thickness skin biopsies obtained from
breast reductions and abdominoplasties as described by (Goberdhan et al. 1993).
Briefly, this method involved dissecting the skin biopsy into 0.5 cm2 pieces followed
by a series of antibiotic wash steps. The skin was then incubated in 0.125% trypsin
in PBS (Invitrogen, Mulgrave, VIC, Australia) overnight at 4°C. The isolation step
differed significantly from Goberdhan’s method in that all steps were conducted
serum-free. The trypsinised skin pieces were removed from the trypsin and
suspended in 50 mLs of Dulbecco’s modified eagle media (DMEM) (Invitrogen).
Epidermal and dermal layers were separated and keratinocytes removed via gentle
scraping. Keratinocyte cells were then suspended in DMEM (Invitrogen), filtered
(100 µm), and pelleted via a 500-600 g centrifugation step for 5 minutes.
2.2.3 Standard culture
The freshly isolated keratinocytes were then cultured on serum starved gamma-
irradiated (two doses of 25 Gy) (Australian Red Cross Blood Service, Brisbane,
QLD, Australia) mouse i3T3 cells (ATCC# CCL-92) using Complete Green’s (CG)
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 53
media, which incorporated, DMEM/HAMS medium (Invitrogen); 0.4 μg/mL
hydrocortisone; 10 μg/mL EGF (Sigma-Aldrich, Castle Hill, NSW, Australia); 0.1
nM cholera toxin; 1.8x10-4 M adenine; 2x10-7 M triiodo-l-thyronine; 5 µg/mL
insulin; 5 μg/mL transferrin; 2x10-3 M glutamine (Invitrogen); 1000 IU/mL penicillin
/ 1000 μg/mL streptomycin (Invitrogen); and 10% foetal bovine serum (Trace
Scientific, Noble Park, VIC, Australia). The cultures were established in 25 cm2
flasks at a density of 1x106 cells and incubated at 37°C in 5% carbon dioxide, with
media changes every third day. The cells were seeded at 2.5 x 105 cells per 25 cm2
flask for subsequent passages.
2.2.4 VN:GF Culture
The serum-free culture of the freshly isolated keratinocytes involved the use of the
previously mentioned irradiated i3T3 cells with the incorporation of Stripped
Green’s (SG) medium. This medium is the CG medium described above but without
serum, EGF, and insulin. The VN:GF culture media was created by adding, 0.6
µg/mL VN (Promega, Annandale, NSW, Australia), 0.6 µg/mL IGFBP-3 (N109D
recombinant mutant) (Auspep, Parkville, VIC, Australia), 0.2 µg/mL IGF-I (GroPep,
Adelaide, SA, Australia) and 0.2 µg/mL EGF (Invitrogen) (VN:GF) to 5 mL of SG
media in a 25 cm2 flask. The keratinocytes isolated from skin as described in section
2.2.2 were seeded at an initial density of 1 x 106 cells and incubated at 37°C in 5%
carbon dioxide, and re-fed every third day with half the amount of the VN:GF media
as described above. The cells were seeded at 2.5 x 105 cells per 25 cm2 flask for the
subsequent passages.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 54
2.2.5 Defined Keratinocyte Media (DKM) culture
Cells were also grown in a commercially available serum-free keratinocyte medium
developed for the in-vitro propagation of keratinocyte cells. The DKM media
(Invitrogen) evaluated includes animal and human products; however these were not
clearly defined by the manufacturer. The DKM cultures were set up in both the
presence and absence of the irradiated i3T3s. The “no i3T3” cultures were
established due to the fact that this product states that it is feeder and serum-free. The
keratinocyte cultures were seeded at an initial density of 1 x 106 cells in 25 cm2
flasks and incubated at 37°C in 5% carbon dioxide, using 5 mLs of DKM media,
with media changes occurring every third day. The cells were seeded at 2.5 x 105
cells per 25 cm2 flask for the subsequent passages.
2.2.6 HaCaT culture
The HaCaT cells (human keratinocyte cell line), obtained from Professor Norbet
Fusenig (DFZ, Heidelberg, Germany), were cultured using CG, VN:GF media and
DKM medium in the absence of feeder cells. These cultures were seeded at 2 x 105
cells per 25 cm2 flask serially propagated at 37°C in 5% carbon dioxide, with media
changes every third day.
2.2.7 Proliferation Assays
Proliferation was measured using two methods; the first method involved monitoring
the metabolic activity of the mitochondria with Thiazolyl blue tetrazolium bromide
(MTT) (Sigma Aldrich). MTT assays were performed in 24-well plates that were
pre-seeded with 1 x 105 HaCaTs/well and grown for 72 hours. Cultures were then
washed twice in PBS and incubated with MTT for 1 hour. The MTT was removed
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 55
from the wells, which were subsequently washed as previously described. Dimethyl
sulfoxide was then added to the wells and the absorbances of the resulting solutions
were measured at 540 nm – 630 nm (Ealey et al. 1988). The MTT assays were
conducted in triplicate and all experiments were replicated at least twice.
Keratinocytes were cultured in 25 cm2 flasks in parallel with the MTT assays to
enable cell counts to be conducted on cells grown in the various treatments. The
i3T3 cells were firstly removed as described above, followed by a 0.05%
trypsinisation step to remove the keratinocytes from the 25 cm2 flasks. Both the
HaCaT and primary keratinocyte cells were resuspended in CG and counted using a
haemocytometer. Both proliferation assays (MTT and cell count) were conducted in
triplicate and all experiments repeated through 4 passages (P0-P4). P0 cells were
keratinocytes freshly isolated from patient biopsies. Three different patient samples
were used to conduct this study.
2.2.8 Immunohistochemistry
Immunohistochemistry was performed at several different passages to ensure that the
keratinocytes had maintained their basal phenotype. Mouse antibodies to keratin 6
(present in hyper-proliferative skin), keratin 14 (present in basal cells), and keratin
1/10/11 (present in more differentiated, supra-basal cells) (Research Diagnostics
Inc., Flanders, Ca, USA) were used in this study. Cells grown in the various
treatments were incubated in their respective media treatments for 2 days following
seeding in 96-well plates. Media was aspirated from the plates, and cells washed
twice in PBS. All treatments were incubated in extraction buffer (0.5% triton X-100,
0.1 M pipes buffer, 5 mM MgCl2, and 1mM EGTA at pH 7.0) for two minutes. This
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 56
was then followed by a 10-minute incubation in a fixation buffer (2%
paraformaldehyde in extraction buffer). Treatments were then blocked for one hour
in PBS/5% normal goat serum (NGS). The primary antibodies were incubated for an
hour in PBS/1% NGS. A series of three 1 minute washing steps were carried out
followed by one hour incubation with an alexa-488 goat anti-mouse IgG antibody
(Molecular Probes, Eugene, OR, USA). The plates were then washed 5 times and
viewed with a Nikon TE-2000 fluorescence microscope. Secondary antibody
controls were also examined in these experiments to ensure that no non-specific
binding had occurred.
2.2.9 Preparation of dermal equivalent (de-epidermised dermis)
The human skin off cuts were washed in PBS and cut into pieces measuring approx
1.38 cm X 1.38 cm such that they fitted into a 24-well culture plate. Off cuts were
then incubated in 1 M NaCl at 37°C for 18 hours after which forceps were used to
remove the epidermis, leaving behind the de-cellularised dermis (DED). Subsequent
incubations were performed every 24 hours with DMEM (Dawson et al. 2006).
2.2.10 Preparation and culture of skin equivalent
DED pieces were placed in 24-well cell culture plates with the papillary side up.
Sterile stainless steel rings (Aix Scientifics, Aachen, Germany) with a 7 mm silicone
washer base were placed in the culture wells on top of the DED pieces. P5
keratinocytes, cultured in either CG or VN:GF medium, were placed into the rings at
a concentration of 1.9 x 104 cells/ring. Subsequently, the rings were removed after 3
days of culture and the dermis plus cells (composite) were then placed onto stainless
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 57
steel grids in 6 well culture plates. The composites were then cultured at the air-
liquid interface in either CG or VN:GF medium for 5 days.
2.2.11 Immunohistochemistry and histology of skin composites
The skin composites were washed in PBS three times then fixed using 4% formalin.
The composites were then subjected to a series of ethanol washes to dehydrate the
samples. The dehydrated composites were then embedded using paraffin and cut into
5 µm sections. A set of sectioned slides were stained using haemotoxylin and eosin
(H&E), (H&E staining conducted by Mr Don Geyer School of Life Sciences QUT).
Remaining composite sections were stained for keratin 1/10/11, keratin 6, Keratin
14, Collagen IV, and P63 (Research Diagnostics). Initially, sections were de-
paraffinised and rehydrated in 100% xylene for 10 minutes, 100% xylene for 5
minutes, 100% ethanol for 5 minutes, 100% ethanol for 5 minutes, 95% ethanol for 5
minutes, 70% ethanol for 5 minutes, and ddH20 for 10 minutes. This was followed
by two 5 minute washes in PBS. DAKO blocking reagent (Dakocytomation, Botany,
NSW, Australia) was added to the sections for 5 minutes and then rinsed off with
water. Sections were added to a PBS bath for 5 minutes then blocked using 2% BSA
for 30 minutes, this was followed by another 5 minute PBS bath. Primary antibodies
were then added to the sections and incubated for 2 hours. Primary antibodies were
then removed and sections were subjected to two x 10 minute PBS washes. The
labeled DAKO polymer was then added and incubated for 20 minutes. Sections were
then washed in PBS for 5 minutes and the DAB chromagen solution was added until
colour development is observed. Sections were then washed in PBS and
counterstained using haematoxylin for 35 seconds. The counterstain was washed for
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 58
10 minutes under running water and the sections dehydrated using the reverse of the
above rehydration step.
2.2.12 Statistical analysis
The Tukey’s T test was used to analyse the proliferation data. A p-value of 0.05 was
determined to be statistically significant.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 59
2.3 RESULTS
2.3.1 The culture of a keratinocyte cell line using VN:GF medium.
Previous studies have demonstrated that HaCaT cells can attach, migrate and
proliferate in short term assays using VN:GF combinations (Hollier et al 2005; Hyde
et al. 2004). Thus we wished to examine whether the SG medium containing VN:GF
combinations (VN:GF medium) could support the serial propagation of these cells
and replace the need for serum for the long term propagation of this cell line.
Initially the HaCaT cells were grown using DMEM + 10% FCS and then later
transferred to, and serially propagated in either: CG (Figure 2.1 A and B), DKM
(Figure 2.1 C and D), or VN:GF medium (Figure 2.1 E and F). This experiment
revealed that the HaCaT cells could be successfully propagated for at least 5
passages using VN:GF medium whilst still displaying the expected cobble stone-like
morphology (Figure 2.1 F refer to arrow), whereas colonies grown using DKM
started to display a larger, more spindle-like cell phenotype representative of a more
differentiated cell (Figure 2.1 D refer to arrow). Interestingly other replicate
experiments demonstrated that the VN:GF medium could support the growth of
HaCaTs for up to 10 passages (data not shown). Therefore, it appears that the
VN:GF medium is able to support a normal morphology for the HaCaT cells through
5 passages, whilst maintaining a morphology similar to cells grown in the CG
medium (Figure 2.1 B).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 60
Figure 2.1: The culture of a keratinocyte cell line using the VN:GF medium. The
HaCaT cell line was subjected to a range of growth conditions as described in the materials
and methods section. The morphology of HaCaT cells grown in: A) CG medium (passage
2); B) CG medium (passage 5); C) DKM (passage 2); D) DKM (passage 5); E) VN:GF
medium (passage 2) and F) VN:GF medium (passage 5), are depicted. (Scale bar = 100µm)
(n=3).
2.3.2 Proliferation of HaCaT cells in the presence of different growth conditions.
To further assess the efficacy of these VN:GF media, HaCaT cell proliferation was
determined by MTT assay and by total cell count. We employed the cell count
method due to the fact that MTT is only an indication of metabolic activity thus may
not reflect accurately the actual proliferative response. The MTT assay revealed that
there were no significant differences between any of the treatments (Figure 2.2 A),
however, when the cells were manually counted the CG treatment significantly
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 61
enhanced (p < 0.01 %) the proliferative response of these cells and was more
effective than either the SG + VN:GF or DKM treatments (Figure 2.2 B).
Figure 2.2: Proliferation of HaCaT cells using the VN:GF medium. Passage 1 HaCaT
cell proliferation in the presence of different media was assessed by; A) MTT and B) manual
cell counting. The following treatments were analysed: CG medium; DKM; and VN:GF
medium (SG + VN:GFs). Each treatment was replicated 3 times and in each experiment the
cells were passaged 5 times. The cells were assayed for MTT activity and cell counting at
the end of each passage. The data from these experiments was analysed using the Tukey’s
test and standard error of the mean (SEM) represented by the error bars. Significant
differences in proliferation (p < 0.05) from the Complete Green’s treatment are represented
by the asterisks (*) (n=3).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 62
2.3.3 Establishment of primary keratinocyte cells using VN:GF medium.
Having ascertained that HaCaT cells could be serially passaged with a defined
medium containing VN:GF medium, we then examined whether primary
keratinocyte cells derived from adult skin could be established and serially
propagated using this same method. This would determine whether the VN:GF
medium could provide a viable alternative for replacing the need for
xenogeneic/allogeneic serum for the culture of these cells.
Freshly isolated keratinocyte cells were cultured in CG + i3T3 feeder cells (Figure
2.3 A and B), DKM + i3T3 feeder cells (Figure 2.3 C and D), and VN:GF + i3T3
feeder cells (Figure 2.3 E and F). Similar to the results found with the HaCaT cells,
this experiment revealed that the primary keratinocyte cells could be isolated and
established using the VN:GF medium, thus in serum-free conditions (Figure 2.3 E).
Furthermore, these cells were successfully cultured to passage 4 using these serum-
free conditions (Figure 2.3 F refer to arrow), whereas cultures grown using DKM for
4 passages started to display a larger, more dysplastic phenotype representative of a
more differentiated cell (Figure 2.3 D refer to arrow). Therefore, VN:GF + i3T3
feeder cells is able to support the establishment and growth of primary keratinocyte
cells with a phenotype similar to those established and cultured using CG + i3T3
feeder cells (Figure 2.3 F and B respectively).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 63
Figure 2.3: Establishment of primary keratinocyte cells using the VN:GF medium. The
primary cells were subjected to a range of growth conditions as described in the materials
and methods section. The morphology of keratinocytes grown in: A) CG + i3T3 feeders
(passage 2); B) CG + i3T3 feeders (passage 4); C) DKM + i3T3 feeders (passage 2) and D)
DKM + i3T3 feeders (passage 4); E) VN:GF medium + i3T3 feeders (passage 2); F) VN:GF
medium + i3T3 feeders (passage 4), are depicted. (Scale bar = 100µm) (n=6).
2.3.4 Proliferation of primary keratinocyte cells in the presence of different growth
conditions.
Proliferation assays using the primary keratinocytes were undertaken to ascertain
whether the VN:GF medium was an efficient stimulator of cell proliferation. Once
again cell count was utilised, however, this time measurements were taken during all
4 passages of the cells in these treatments. For these assays we included DKM in the
presence (DKMF) and absence (DKM) of i3T3 feeder cells as shown in Figure 2.4.
Manual cell counting revealed that the DKM treatment resulted in a significantly less
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 64
(p < 0.05) proliferative response when compared to all other treatments using the
Tukey’s test (Figure 2.4 #). Additionally, the CG treatment had a significantly
higher proliferative response than P1, P2 DKM and P3 DKMF treatments (Figure 2.4
*). All remaining treatments were equivalent in stimulating cell growth.
Interestingly, the same level of proliferation was observed through the four passages
in the SG + VN:GFs treatment. This suggests that the primary keratinocyte cells
were being maintained in a state of self-renewal. The cells shown in Figure 2.3 are
from one of the patient samples that were used in the proliferation studies.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 65
Figure 2.4: Proliferation of primary keratinocyte cells using the VN:GF medium.
Keratinocyte cell proliferation in the presence of different media was assessed by cell
counts. The following treatments were analysed: complete Green’s medium + i3T3 feeders
(CG); Defined Keratinocyte Medium + i3T3 feeders (DKMF); Defined Keratinocyte
Medium (DKM); and VN:GF medium + i3T3 feeders (SG + VN:GFs). Each treatment was
replicated twice for cell counts and the experiment was repeated through 4 passages. The
data from these experiments was analysed using the Tukey’s test to compare all treatments
across all passages with significant differences in proliferation (p < 0.05) being represented
by the (#). The Student T-test was utilised to compare between treatments within the same
passage with significant differences in proliferation (p < 0.05) being represented by the
asterisks (*) (n=2).
0
0.2
0.4
0.6
0.8
1
1.2
1.4
P1 P2 P3 P4
Serum
VN:GF-KC
DKM+F
DKM
* * *
#
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 66
2.3.5 Characterisation of primary keratinocyte cells propagated under different
conditions.
At present there are no definitive assays for determining whether cultured primary
keratinocyte cells have maintained a stem cell like state. However, keratin markers
can be used to provide useful information regarding the proliferative state of the cell,
and whether or not the cell is a basal keratinocyte (Watt 1998). Therefore antibodies
that recognise keratin 6 (present in hyper-proliferative skin), keratin 14 (present in
basal cells), and keratin 1/10/11 (present in more differentiated, supra-basal cells)
were used to assess the differentiation status of the cells cultured in these media.
Once again the cells pictured in Figure 2.3 were used to conduct these immuno-
fluorescence studies. Fluorescently-labeled secondary antibodies to the keratin
primary antibodies were used to establish whether these proteins were present.
Passage 4 keratinocyte cells propagated with CG, VN:GF media demonstrated high
expression levels of keratin 6 and 14 (Figure 2.5 C, D and F, G respectively). In
addition, low levels of K1/10/11 expression were observed in the CG and VN:GF
treatments (Figure 2.5 B and E). Similar keratin expression was also observed in the
DKMF treatments, however, passage 4 DKMF treatments appeared to have reduced
levels of keratin 6 and 14 and increased expression of keratins 1/10/11 (Figure 2.5
H-J). A “no primary antibody control”, was included by incubating the keratinocyte
cells with the secondary antibody only and this indicated minimal non-specific
binding between the secondary antibodies and the cells (Figure 2.5 A). Taken
together, these immunofluorescence studies suggest that the cells grown with these
combinations can be established and serially passaged whilst maintaining markers
that are representative of an undifferentiated state.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 67
Figure 2.5: Characterisation of primary keratinocyte cells using the VN:GF medium.
The primary cells were serially passaged in a range of growth conditions as described in the
materials and methods section. The expression of keratin 1/10/11, 6, and 14 expression in
cells grown in: B-D) CG + i3T3 feeders (passage 4); E-G) VN:GF medium + i3T3 feeders
(passage 4); and H-J) DKM + i3T3 feeders (DKMF) (passage 4), are depicted. (Scale bar =
100µm) (n=3).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 68
2.3.6 The histology and staining of the reconstituted epidermis
Having ascertained that the primary keratinocytes could be propagated for 5
passages using the VN:GF medium, I then sought to examine whether these cells
could reconstitute an epidermal layer. Histological staining demonstrated that
keratinocytes grown using VN:GF long term could in fact re-constitute the epidermis
(Figure 2.6-I A-C). However, there did seem to be a slightly different epidermal
morphology between the VN:GF (Figure 2.6-I B) and the serum-grown keratinocytes
(Figure 2.6-I C). Furthermore, these reconstituted epidermal constructs were
subjected to p63 staining to determine if there was still a population of primitive
keratinocyte cells. Clearly, the VN:GF (Figure 2.6-I E) and serum-grown (Figure
2.6-I F) epidermal constructs both expressed p63. Figures 2.6-I A and D are a
negative controls and represent cells that were transferred to the DED constructs in
the absence of either VN:GF or serum.
The ability for these cells to re-constitute the epidermis was further assessed using
keratin 6, a marker present in hyper-proliferative skin and keratin 1/10/11 a marker
present in more differentiated, supra-basal cells. Keratin 6 staining looked similar
between the VN:GF (Figure 2.6-II B) and serum (Figure 2.6-II C). However, there
seemed to be a marked increase in keratin 1/10/11 in the serum-grown treatment
(Figure 2.6-II F) over that of the VN:GF (Figure 2.6-II E). Figures 2.6-II A and D are
a negative controls and represent cells that were transferred to the DED constructs in
the absence of either VN:GF or serum.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 69
Figure 6-I
Figure 2.6-I: The histology and P63 immuno-staining of the reconstituted epidermis.
Primary keratinocytes were serially passaged 5 times in CG + i3T3 feeders and VN:GF
medium + i3T3 feeders. Cells were then added to the DED pieces and grown in, SG (A&D),
VN:GF medium (B&E), and CG (C&F) as described in the Materials and Methods section.
Haemotoxylin and Eosin staining was carried out on (A-C) and P63 staining on (D-F) as
described in the Materials and Methods section. All treatments were conducted in triplicate
and 3 patient samples were assessed. (Scale bar = 100µm).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 70
Figure 6-II
Figure 2.6-II: Immuno-staining for keratin 6 and 1/10/11 in the reconstituted
epidermis. Primary keratinocytes were serially passaged 5 times in CG media + i3T3
feeders and VN:GF medium + i3T3 feeders. Cells were then added to the DED pieces and
grown in, SG (A&D), VN:GF medium (B&E), and CG (C&F) as described in the Materials
and Methods section. Cells stained for keratin 6 are observed in panels (A-C) and keratin
1/10/11 staining in panels (D-F) as described in the Materials and Methods section. All
treatments were conducted in triplicate and 3 patient samples were assessed. (Scale bar =
100µm).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 71
2.4 DISCUSSION
While in-vitro cultured keratinocytes appear to have great potential to cure a wide
variety of diseases and injuries (Green 1991; Meana et al. 1998; Wright et al. 1998),
the fact that these culture systems require xenogeneic and poorly defined
components means that these cells are unlikely to be readily approved for broad
clinical use. Thus, there is a global move towards serum-free, animal product-free,
defined media for the culture of keratinocytes, and indeed other cell types. Many
researchers have investigated ways to minimise the risk of contamination from
animal products such as serum. One such example is the replacement of foetal
bovine serum with purified bovine serum albumin (Castro-Munozledo et al. 1997).
Whilst this method did prove successful in the propagation of keratinocytes, it does
not remove the risk of contamination by the BSA from the culture system. Nor does
it result in a fully defined media as the BSA used was purified from serum rather
than made recombinantly.
As irradiated feeder cells (i3T3) are known to secrete large quantities of IGFs and
ECM proteins (Barreca et al. 1992), and given that VN is a major component of
serum (Schvartz, et al. 1999), the hypothesis underlying this project was that
combinations comprised of IGFs and VN may trigger matricellular signaling events
that support the serum-free establishment and growth of human keratinocyte cells.
Moreover, keratinocytes have also been demonstrated to express the receptors for
both these proteins (Adams and Watt 1991; Haase et al. 2003; Rodeck et al. 1997;
Stoll and Elder 1997; Watt and Jones 1993; Watt et al. 1993). Indeed, other
laboratories have investigated the use of these proteins for the culture of
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 72
keratinocytes. For example, Dawson et al. (1996) demonstrated that keratinocytes
can attach and proliferate in response to VN-coated surfaces.
Our studies here, differ, however, as they specifically exploit VN’s demonstrated
ability to bind to IGF-I through the mediation of IGFBP3 (Kricker et al. 2003). We
have previously demonstrated that this interaction can significantly enhance cell
attachment, migration and protein synthesis in short term assays in a range of tissues,
including skin, corneal and breast epithelial cell lines (Kricker at al. 2003; Noble et
al. 2003; Upton et al. 1999; Upton and Kricker 2002). Indeed, it was these results
that prompted us to investigate whether the VN:GF technology could be translated
for the undifferentiated, serial propagation of primary keratinocyte cells. Recently,
Dawson et al. (2006), demonstrated that primary keratinocytes could be serially
propagated using complexes of VN:IGFBP-3:IGF-I:EGF or VN:IGFBP-5:IGF-
I:EGF. The Dawson study revealed that the keratinocytes could be propagated
through to passage two and that the complex containing IGFBP-5 demonstrated a
morphologically better cell. However, this work still involved the use of serum in the
isolation of the primary keratinocyte cells, thus, introducing another potential source
of contamination. Therefore, I hypothesised that VN:GF combination could be
improved in two ways, firstly by incorporating the complex technology into a serum-
free medium rather than as a pre-bound substrate, and secondly using the complexes
to replace the need for serum in the isolation steps.
To examine this hypothesis we firstly examined the potential of the VN:GF medium
to support the long-term growth of the HaCaT keratinocyte cell line. We demonstrate
here, that the HaCaT cell line can be serially propagated using the VN:GF medium
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 73
(Figure 2.1). However, these experiments revealed that the culture of HaCaTs in the
CG medium resulted in a significantly higher rate of proliferation above that found
with either DKM or the SG medium containing the VN:GF (Figure 2.2).
Nevertheless, the morphology of the cells grown using SG medium containing the
VN:GF more closely reflect the morphology of those grown in the CG medium. In
contrast the cells cultured in DKM appeared larger and more differentiated.
In view of this, we then examined the same culture conditions to establish whether a
serum-free medium could be developed for the in-vitro expansion of primary human
keratinocytes derived from adult skin. Our results indicate that this is indeed the
case, as the primary cells were successfully established and propagated using SG
with the VN:GF (Figure 2.3). The findings we report here demonstrate that not only
did this medium containing VN:GF result in similar levels of cellular proliferation to
that obtained with cells grown in the CG medium (Figure2.4), but in addition we
demonstrate that these cells maintain an undifferentiated phenotype (Figure 2.5).
This is significant as cells grown using the commercially available DKM + i3T3
demonstrate decreased expression of markers relevant for the undifferentiated state
at passage 4 (Figure 2.5). Furthermore, DKM used alone was not able to support the
establishment and serial propagation of the keratinocyte cells involved in this study.
These results suggest that the SG media with VN:GFs can support the establishment
and undifferentiated propagation of keratinocyte cells, and can also support the
prolonged growth of these cells. Future studies will further investigate and quantitate
the levels of markers expressed in undifferentiated keratinocyte cells. Flow
cytometry and Western blot analysis will be employed to evaluate the expression
differences between specific treatments. Additionally, the components that make up
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 74
the VN:GF combination will be evaluated using dose response studies in order to
optimise this technology. Moreover, keratinocytes propagated using VN:GF media
were able to still form an epidermis, whilst maintaining markers similar to those
grown under normal culture conditions (Figures 2.6 I and II).
Whilst we have demonstrated that keratinocytes can be established and serially
propagated using this VN:GF technology, further investigation is required to confirm
whether these cells are therapeutically useful and whether a more optimal
concentration of VN:GF can be identified. In particular there is still a need to
investigate alternatives to using the i3T3 feeder cell layer. Recently, it was
demonstrated that pre-established normal human keratinocytes could be propagated
under xenobiotic-free conditions using a non-irradiated human skin-derived feeder
cell layer on plasma-coated surfaces (Sun et al. 2004a). While this represents an
improvement, the ideal scenario would be the development of culture conditions in
which feeder cells are not required, as the presence of feeder cells, whether of human
or animal origin, adds increased regulatory burden.
Since a paracrine relationship exists between the dermal fibroblasts and
keratinocytes (Maas-Szabowski 1999; Werner and Smola 2001), we propose that
genomic and proteomic approaches to analyse this paracrine relationship may reveal
other biological agents that could be used in conjunction with the VN:GF medium to
more closely mimic the micro-environment generated by the feeder cell layer.
Furthermore, other heparin-binding growth factors, such as transforming growth
factor-β (TGF- β), vascular endothelial growth factor (VEGF), epidermal growth
factor and bFGF (Hollier et al. 2005; Schoppet et al. 2002), also appear to be able to
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 75
bind to VN. Thus, investigations into these additional growth factors may also
improve the culture system reported here. Moreover, this technology is likely to be
applicable to not only primary keratinocyte cells, but also a range of other cell and
tissue types important to the development of medical therapies. Importantly, any
culture system developed must contain synthetic and/or recombinant components. To
this end, recombinant VN has recently been produced in our laboratory and has been
shown to be functional when incorporated into VN:GF complexes (data not shown).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 77
CHAPTER 3
Serum-free growth of human embryonic stem cells
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 78
3.1 INTRODUCTION
As stated in Chapter 1 human embryonic stem (hES) cells are a totipotent cell type
that has the therapeutic potential to generate new cells and tissues for donation.
However, methods to culture these cells rely on the use of animal-derived products
such as foetal bovine serum (FBS) and mouse embryonic fibroblasts (MEFs) for
their successful self renewal (Thomson et al. 1998; Pera et al. 2000; Henderson et al.
2002; Schick et al. 2003). While these products are successful in supporting in-vitro
hES cell growth, their non-human origin can potentially introduce pathogenic, toxic
and immunogenic agents (Martin et al. 2005; Heiskanen et al. 2007).
With this in mind, intensive research efforts worldwide are now starting to address
the problems associated with using animal-derived feeder cells in hES cell culture
systems. As discussed in Chapter 1 feeder-free growth of hES cells has been
examined in two general ways. The first approach involves the removal of feeder cell
layers. Thus, Lebkowski et al. (2001) and Xu et al. (2001) demonstrated a successful
feeder-free hES culture system that allowed undifferentiated cells to be maintained
for at least 130 population doublings. These techniques are based on the culture of
hES cells on either matrigel-coated or laminin-coated surfaces, in media conditioned
by MEF cells. However, Richards and co-workers (2002) reported an inability to
replicate this methodology and instead developed an approach utilising human foetal
and adult fibroblast feeder cells to support the prolonged undifferentiated growth of
hES cells (Richards et al. 2002). This method was also shown to be superior to
culture technologies that have been developed using cell-free matrices (collagen 1,
human extra-cellular matrix, Matrigel, and laminin) supplemented with conditioned
media from MEF feeder cells. While this novel approach addresses the potential
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 79
problem of pathogen transfer that exists through the use of xenogeneic cells, it does
not avoid the problems associated with the use of poorly defined and uncharacterised
compounds found in serum, or purified from serum. Nor does it eliminate the risk of
pathogen contamination from the use of allogeneic feeder cells and/or serum.
More recently, Beattie et al. (2005) discovered that using a combination of activin-A,
nicotinamide and keratinocyte growth factor, in conjunction with a commercially
available undefined, human serum-derived serum replacement product termed
knock-out serum replacement (KSR), could remove the need for a feeder cell layer.
However, while this technology proved effective, more research needs to be
conducted in order to remove the need for KSR in this culture system. Interestingly,
Ludwig et al. (2006) created a culture system termed TeSR1 which was independent
of both a feeder cell layer and serum. This technology involved the use of large
quantities of purified human serum albumin (HSA) and several other reagents
purified from human serum. The TeSR1 culture system also required large doses of
recombinant insulin (23 μg/mL) for the successful propagation of the hES cells.
Whilst this technology was an exciting step forward for the culture of hES cells, the
high cost and poorly defined nature of TeSR1 suggests that this may not be the
answer. Furthermore, long term propagation of hES cells using the TeSR1
technology resulted in chromosomal abnormalities. Recently, Ludwig et al. (2007)
reported that bovine serum albumin and matrigel, two purified xeno-derived
components, needed to be re-introduced into the TeSR1 culture system (mTeSR1) to
make it commercially viable (Ludwig et al. 2007). Thus, there is clearly a need to
examine alternative serum-free and feeder-cell free culture technologies.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 80
As documented in Chapter 2, I have been investigating alternative culture
technologies suitable for adult stem cells and this has led to the development of a
technique that may lead to the first defined serum-free media for the in-vitro
expansion of keratinocytes for skin grafting applications. Briefly, this technology
involves the use of vitronectin (VN), insulin-like growth factors (IGFs) and insulin-
like growth factor binding proteins (IGFBPs) (Upton and Kricker 2002; Kricker et
al. 2003). This technology has been demonstrated to support the serum-free isolation
and serial propagation of primary keratinocytes (Refer to Chapter 2). Furthermore,
earlier work I conducted as a part of my honours project, demonstrated that
complexes of VN:IGF-I or –II:IGFBP-3 could support the short term growth (9 days)
of hES cells. In addition, via these studies I proved that the incorporation of IGF-I
was more successful than IGF-II for the expansion of hES cells (unpublished data).
Taking the data I obtained during honours, combined with the fact that hES cell
culture has similar culture requirements to keratinocytes i.e. a need for feeder cells
and serum, I hypothesised that the VN:GF medium incorporating IGF-I would be
useful for developing a fully defined, serum-free medium suitable for in-vitro
expansion of hES cells. In the study reported herein, the biological responses of hES
cells to this serum-free media were examined. This involved the establishment of a
hES cell line and associated culture technologies at Queensland University of
Technology (QUT). Having established the hES cells, I subsequently examined
whether these cells could be propagated in an undifferentiated state using the VN:GF
medium in the place of serum-containing media. In this chapter I report my progress
towards the translation of this new culture media for the in-vitro expansion of hES
cells.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 81
3.2 MATERIALS AND METHODS
3.2.1 Ethics and Training
Specialist training in hES cell culture was undertaken at the Monash Institute of
Reproduction and Development (MIRD, Melbourne, Victoria) and Embryonic Stem
Cell International (ESI, Melbourne, Victoria). Ethics approval to use the human
embryonic stem cell lines was received from the QUT Human Research Ethics
Committee (ID: 2943H) with strict adherence to the state, federal and NHMRC
guidelines regarding the conduct of research using hES cells. Additionally, informed
donor consent was obtained by the investigators who initially derived the hES cell
lines utilised.
3.2.2 Cell Culture
Mouse embryonic fibroblasts (MEF) cells (ESI, Melbourne, Australia) were cultured
in 80 cm2 culture flasks in 85% Dulbecco’s Modified Eagle Medium (DMEM)
(Invitrogen, Mulgrave, VIC, Australia), 10% foetal bovine serum (FBS) (Gibco,
Mulgrave, VIC, Australia), 1 mM L-glutamine, 0.5% penicillin/streptomycin and
0.01% gentamycin. Passage 7 MEFs were used as the feeder cell layer for the hES
cells. Surfaces to be seeded with the MEFs were coated in 0.1% gelatin for a
minimum of 1 hour before addition of the cells. Mitomycin-C was subsequently
added to the flasks containing the MEFs and incubated at 37ºC, 5% CO2 for 2.5 to 3
hours to mitotically inactivate the MEF cells. The MEFs were seeded into 6-well
plates (NUNC) (10 cm2) at a density of 2 x 104 cells/cm2.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 82
The HUES-9 and H1 cells (Harvard University, Boston, Chicago, U.S.A. and
WiCell, Madison, Wisconsin, U.S.A. respectively) were cultured on passage 7
mitomycin-C inactivated MEFs in hES medium containing: Dulbecco’s Modified
Eagle Medium (DMEM) (Invitrogen); 20% Knock-out Serum Replacement (KSR)
(Invitrogen); 1000 IU/mL penicillin/1000 μg/mL streptomycin (Invitrogen); 1 mM
glutamax (Invitrogen); 1% non-essential amino acids; 0.1 mM β-mercaptoethanol;
10 ng/mL basic fibroblast growth factor (bFGF) (Chemicon); and 12 ng/mL
leukaemia inhibitory factor (LIF) (Chemicon). Following the hES cell colony
obtaining confluence, the cells were washed in 2 mL PBS-/well (Invitrogen, PBS-)
and exposed to 0.05% trypsin/EDTA (Invitrogen) for a 1-2 minute incubation (37ºC
5% CO2). The cells were then re-suspended in hES media and spun at 500-600 g for
5 minutes. The cells were then transferred to fresh inactivated MEFs and the medium
was changed daily 48 hours post transfer.
3.2.3 VN:GF Culture
The serum-free culture of the hES cells involved the use of the previously mentioned
inactivated MEF cells being pre-plated 24 hours before use and then serum starved
for four hours. Human embryonic stem cells were then plated onto the serum starved
MEFs in 2.5 mL of serum free medium containing: Dulbecco’s Modified Eagle
Medium (DMEM) (Invitrogen); 1000 IU/mL penicillin/1000 μg/mL streptomycin
(Invitrogen); 1 mM glutamax (Invitrogen); 1% non-essential amino acids; 0.1 mM
β-mercaptoethanol; 0.6 µg/mL VN (Promega, Annandale, NSW, Australia); 0.6
µg/mL IGFBP-3 (N109D recombinant mutant) (Auspep, Parkville, VIC, Australia);
0.2 µg/mL IGF-I (GroPep, Adelaide, SA, Australia); 12 ng/mL LIF; and 0.02 µg/mL
bFGF (Chemicon). The cultures were then grown at 37°C in 5% CO2 and re-fed
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 83
every day 48 hours after the initial transfer. The hES cells were then split, using
previously described methods (section 3.2.2), 1:3 to 1:4 depending on their rate of
growth and confluence.
3.2.4 ANK Culture
Briefly HUES-7 cells were cultured on plates coated with 20 µg/mL of laminin
(Chemicon) and were grown in Dulbecco’s Modified Eagle Medium (DMEM)
containing: 20 % knock-out serum replacement (Invitrogen); 1000 IU/mL
penicillin/1000 μg/mL streptomycin (Invitrogen); 1 mM glutamax (Invitrogen); 1%
non-essential amino acids; 0.1 mM β-mercaptoethanol; 50 ng/mL of activin-A
(PreproTech); 50 ng/mL keratinocyte growth factor (PreproTech), and 10 mM
nicotinamide (Sigma) (ANK culture) (Beattie et al. 2005). ANK/VN:GF culture,
both in the presence and absence of KSR, involved various combinations of 0.6
µg/mL VN (Promega, Annandale, NSW, Australia); 0.6 µg/mL IGFBP-3 (N109D
recombinant mutant) (Auspep, Parkville, VIC, Australia); 0.2 µg/mL IGF-I (GroPep,
Adelaide, SA, Australia); 0.02 µg/mL bFGF (Chemicon); 50 ng/mL of activin-A
(PreproTech); 50 ng/mL keratinocyte growth factor (PreproTech); and 10 mM
nicotinamide (Sigma).
3.2.5 Immunofluorescence
Stage specific embryonic antigen-1 (SSEA–1), stage specific embryonic antigen-4
(SSEA–4), tumour repressor antigen 1-81 (Tra 1-81) and octamer binding
transcription factor-4 Oct-4 are expressed by undifferentiated hES cells (Thomson et
al. 1998; Reubinoff et al. 2000). The presence of these proteins was monitored using
mouse monoclonal antibodies raised against the proteins. The cultures were fixed
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 84
using 4% paraformaldehyde/phosphate buffered saline (PBS) for 15 minutes, or in
100% methanol for 2 minutes. The fixing agent was removed and the cultures were
washed twice, for 15 minutes per wash in 20 mM Tris-HCl, 0.15 M NaCl, 0.05%
Tween-20, pH 7.4 (TBST). The cells were then permeabilised with 0.1% Triton X-
100/PBS for 10 minutes prior to a further washing step. The cultures were then
blocked in 4% goat serum for 30 minutes at room temperature. The blocking solution
was removed and primary antibodies against SSEA-1, SSEA-4, Tra 1-81, and Oct-4
(Chemicon, Boronia, Victoria, Australia) were diluted to 1:50 in 4% goat serum and
incubated on the cultures for 1 hour. The primary antibodies were removed and the
wash steps repeated. The anti-mouse secondary antibodies (Chemicon) were diluted
in PBS at 1:100 and incubated for 1 hour. The secondary antibodies were removed,
the wash steps were repeated and the colonies were viewed with a Nikon TE-2000
fluorescence microscope.
3.2.6 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Analysis
Oct-4, human telomerase reverse transcriptase (hTERT) and alkaline phosphatase
(AP) have been shown to be expressed in the undifferentiated human embryonic
stem cells (Xu et al. 2001). Hence, RT-PCR was applied to these markers to
determine whether the hES cell colonies maintained an undifferentiated state. RNA
was isolated from the colony pieces using tri-reagent and its accompanying protocol
(Sigma). The RNA samples were applied to oligo-dT 18mers to create cDNA. The
Oct-4 primers were: sense, 5’-CTTGCTGCAGAAGTGGGTG-GAGGAA-3’; and
antisense, 5’-CTGCAGTGTGGGTT-TCGGG-CA-3’. The hTERT primers were:
sense, 5’-CGGAAGAGTGTCTGGAGCAA-3’; and antisense, 5’-GGATGA-
AGCGGAGTCTGGA-3’. The alkaline phosphatase primers were: sense, 5’–
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 85
CGTGGCTAAGAATGTCATCATGTT-3’; and antisense, 5’-TGGTGGAGCT-
GACCCTTGA-3’. The 18sRNA internal standard primers were: sense, 5’-TT-
CGGAACTGAGGCCATGAT-3’; and antisense, 5’-CGAACCTCCGACTTTCGT-
TCT-3’. One µg of cDNA was added to each of the four primer sets and subjected to
an initial denaturation step of 94˚C for 5 minutes, followed by 30 cycles of
denaturation at 94˚C for 30 seconds, annealing at 55˚C for 30 seconds and extension
at 72˚C for 30 seconds, followed by a final extension at 72˚C for 5 minutes.
3.2.7 Proliferation Assays
Proliferation of the hES cells was measured by assessing the metabolic activity of
the mitochondria with thiazolyl blue tetrazolium bromide (MTT) (Sigma Aldrich).
MTT assays were performed in 24-well plates that were pre-seeded with 4 x 104
MEFs/well and ~ 1 x 104 hES cells (value determined by cell count of 20 colony
pieces). The cultures were grown for 4 days and then washed twice in PBS and
incubated with MTT for 1 hour. The MTT was removed from the wells and was
subsequently washed as previously described. Dimethyl sulfoxide was then added to
the wells and the absorbances of the resulting solutions were measured at 540 nm –
630 nm. The MTT assays were conducted in triplicate and all experiments were
replicated twice. Data from these experiments were statistically analysed using the
Tukey’s test and a p < 0.05 was determined to be statistically significant.
3.2.8 Karyotype Analysis
Queensland Medical Laboratories (QML, Brisbane, Queensland, Australia)
performed karyotype analysis on hES cells that had been passaged 10 times. The
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 86
Giemsa staining method was used to analyse 20 cells from 2 different cultures to
assure that the karyotype revealed was accurate.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 87
3.3 RESULTS
3.3.1 VN:GF medium for the propagation hES cells.
Having previously established that hES cell colonies could be propagated short-term
using pre-bound VN/growth factor complexes (data not shown, results from my
honours thesis), I wished to assess whether the proteins involved in these complexes
could be translated into a VN:GF medium. Due to the fact that these cells need to be
grown in colonies for their optimal growth, it was difficult to quantify exactly how
many cells were added to the treatments, however, we estimated that ~1 x 104 hES
cells per well were used. The proliferation of hES cells on the treatments and control
were assessed utilising the MTT assay. This assay revealed that whilst there were no
significant differences between treatments, the VN:GF medium, demonstrated by the
last bar Figure 3.1, showed a trend towards an increase in proliferation above both
the DMEM control and the growth factors alone (Figure 3.1). Treatments were
assessed independently in triplicate using the HUES-9 cell line and the experiment
repeated 3 times.
3.3.2 Morphology of hES cells grown using the VN:GF combinations as a serum-
free medium.
Having demonstrated that the VN:GF combination would induce the propagation of
hES cells, I then proceeded to examine whether this new VN:GF medium could be
used for the long term serial propagation of hES cells. This needed to be established
to determine whether the VN:GF medium could effectively replace the need for
serum in the culture of hES cells. Human embryonic stem cell lines, H1 (WiCell)
and HUES-9 (Harvard), were grown for 10 passages in culture medium containing
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 88
serum and a feeder cell layer, and also in VN:GF medium in the presence of a feeder
cell layer (Figure 3.2 A & C and Figure 3.2 B & D respectively). This experiment
revealed that both the VN:GF propagated H1 and HUES-9 cell lines (Figure 3.2 B &
D) looked similar in morphology to those propagated using serum containing media
(Figure 3.2 A & C). Interestingly, the hES cells grown in the serum-free medium
appeared morphologically less differentiated than those grown for extended passages
in medium containing serum. Therefore, the VN:GF medium appears to be a viable
method for the serum-free culture of hES cells.
Figure 3.1: VN:GF combinations for the propagation hES cells (HUES-9). hES cell
proliferation in the presence of DMEM, VN:GF medium and its various components were
assessed by MTT assay, as described in the materials and methods. The following treatments
were analysed: DMEM; DMEM + VN; DMEM + IGFBP3; DMEM + IGF-I; DMEM +
bFGF; DMEM + VN:IGFBP3:IGF-I:bFGF. Each of the above treatments were conducted in
wells containing 4 x 104 MEFs and 1 x 104 hES cells. Treatments were assessed in triplicate
and the experiment conducted 3 times, with the data from the 3 experiments pooled and
averaged. The bars on the graph represent the standard error of the mean. The data from
these experiments was analysed using the Tukey’s test (p < 0.05).
0
0.5
1
1.5
2
2.5
3
DMEM VNBP3
IGF
bFGF
VN+IGF+bF
GF+BP3
Treatment
(ABS
540
-630
nm)
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 89
Figure 3.2: Morphology of hES cells grown using the VN:GF medium. Colonies were
propagated using: A) H1 cells (WiCell) grown in serum with MEFs; B) H1 cells grown in
VN:GF medium with MEFs; C) HUES-9 cells (Harvard) grown in serum with MEFs; and
D) HUES-9 cells grown in VN:GF medium with MEFs. Experiments were conducted in
triplicate and repeated in two distinct hES cells lines. (Scale bar = 500 µm).
3.3.3 Identification of markers expressed by undifferentiated hES cells.
At present there are no definitive assays for determining whether cultured hES cells
have maintained an undifferentiated state. However, hES cells have been shown to
express several markers, such as, stage specific embryonic antigens (SSEAs). These
markers can be used to assess the differentiation status of hES cells (zur Nieden et al.
2001; Draper et al. 2002), therefore antibodies that recognise SSEA-1 (expressed on
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 90
differentiated cells) and SSEA-4 (expressed on undifferentiated cells) were selected
to analyse the differentiation status of the hES cell colonies grown for 10 passages
using the VN:GF medium. Fluorescently labeled, secondary antibodies to the SSEA-
1 (red) and SSEA-4 (green) primary antibodies were used to establish whether these
proteins were present on the hES cells. Interestingly, hES cells propagated using the
VN:GF serum-free medium demonstrated high levels of SSEA-4 expression and next
to no levels of SSEA-1 expression (Figures 3.3). The “no primary antibody control”
results were obtained by incubating the hES cell colonies with the secondary
antibody only and no non-specific binding of primary antibody was observed (data
not shown).
3.3.4 Karyotype analysis of H1 cells grown using VN:GF medium..
Karyotype analysis involves the identification of all the morphological
characteristics of a single cell’s chromosomes. It relies on staining the cell during the
period of metaphase with Giemsa staining reagent. The stained cell is then pressed
firmly onto a microscope slide to analyse the banding patterns of each of the
chromosomes. This analysis can reveal a variety of chromosomal aberrations such as
aneuploidy events, deletions, insertions, and translocations (Schrock et al. 1996;
Amit et al. 2000). Thus, karyotype analysis of the hES cell lines was performed to
ascertain whether the hES cells grown using the VN:GF medium for multiple
passages had retained a normal karyotype. The karyotype analysis represented in
Figure 3.4 was performed by Queensland Medical Laboratories (QML) on hES cell
colonies that have been passaged 10 times. This analysis revealed a 46XX normal
karyotype. No chromosomal aberrations were noted from the karyotype analysis
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 91
suggesting that the culture method has no adverse effect on the propagation of these
cells.
3.3.5 RT-PCR analysis of hES cells.
Due to the fact that expression of SSEA-4 alone is not definitive for identifying an
undifferentiated hES cell colony, RT-PCR analysis was also used to analyse the
expression of 3 genes present in undifferentiated hES cell colonies. The genes
analysed encode Oct4 (a transcription factor), hTERT (human telomerase reverse
transcriptase) and AP (alkaline phosphatase). Combined, the expression of these
genes is reported to result in a more accurate assessment of the differentiation status
of the hES cell colonies (Xu et al. 2001).
In order to establish that the samples were not contaminated with complementary
deoxyribose nucleic acid (cDNA) or genomic deoxyribose nucleic acid (gDNA), the
template was omitted in the series of negative controls (data not shown). The
primers were designed such that they annealed to different exons within the gene,
therefore any contaminating genomic deoxyribose nucleic acid (gDNA) present in
the PCR reaction would result in a larger molecular weight band than the cDNA.
This analysis revealed that hES cell colonies grown under normal conditions and
using the VN:GF medium expressed Oct4, AP, and 18sRNA (included as an internal
standard control) (Figure 3.5). No hTERT expression was observed in either of the
cell lines tested nor in either the normal or VN:GF medium treatments. Furthermore,
I believe that this is a result of extremely low expression levels which did not affect
the pluripotent nature of the cells, as confirmed by the presence of the other markers
for the hES cell undifferentiated state. This experiment further verifies that the
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 92
VN:GF medium is maintaining the hES cells in a similar condition to those
propagated using normal culture conditions.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 93
Figure 3.3: Expression of cell-surface markers on the hES cells grown using the VN:GF
medium. H1 hES cell colonies (A-C) and HUES-9 hES cell colonies (G-I) were grown
using KSR + feeder cells. H1 hES cell colonies (D-F) and HUES-9 hES cell colonies (J-L)
were also grown using the VN:GF medium, as described in the materials and methods
section. Cultures were subsequently incubated with mouse anti-SSEA1 (red) antibodies
(B,E,H,K) and mouse anti-SSEA-4 antibodies (green) (C,F,I,L). Colonies were also
incubated with secondary antibodies only as a control against non-specific binding (M-O).
Experiments were conducted in triplicate and repeated in two distinct hES cells lines. (Scale
bar = 250 µm).
M N O
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 94
Figure 3.4: Karyotype analysis of H1 hES cells grown in VN:GF medium. The
karyotype was performed using the Giemsa banding method of chromosome analysis. The
H1 cell line was 46XX normal (n=2, representative experiment depicted).
Figure 3.5: RT-PCR analysis of hES cells grown using VN:GF medium. Colonies were
grown in either serum (Normal) or VN:GF medium (VN:GF) in conjunction with a MEF
feeder cell layer. Two cell lines were analysed, A) H1 and B) HUES-9. 18sRNA (151 bp
band), Oct-4 (169 bp band), TERT (145 bp band) and ALP (90 bp band) transcripts were
used to analyse the differentiation status of the hES cells. Negative controls involved no
addition of the template to ensure no contamination occurred in the PCR reaction (data not
shown) and C) a TERT positive control to demonstrate that the primers were working. The
molecular weight marker used was a 100 bp DNA ladder (Roche).
C
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 95
3.3.6 Morphology of HUES-7 cells grown using the VN:GF medium in
conjunction with the ANK protocol.
Recently, Beattie et al. (2005) demonstrated that hES cells could be propagated
feeder-free using Activin-A, nicotinamide and keratinocyte growth factor (ANK).
Therefore, we used ANK in conjunction with our optimum serum-free VN:GF
medium for the propagation of hES cells. The hES cells propagated using ANK +
VG:GF combinations for 6 days (Figure 3.6 D) demonstrated a cellular morphology
similar to hES cells grown using KO-serum + feeder cells, VG:GF combinations +
feeder cells and ANK (Figures 3.6 A, B, and C respectively). However, the colonies
looked less differentiated in the first three treatments than they did in the ANK +
VG:GF combinations. Consequently, cells grown in AN + VN:GF medium, A +
VN:GF medium, ANK + VN:GF medium – bFGF, ANK + VN:GF medium – VN,
and ANK – laminin + VN:GF medium (Figures 3.6 E, F, G, and H respectively)
treatments were analysed to determine if there was a more efficient culture
combination for the hES cells. Interestingly, the A + VN:GF medium and the ANK +
VN:GF medium – VN (Figures 3.6 F, and H respectively) treatments demonstrated
both cell and colony morphologies similar to the KO-serum + feeder culture (Figure
3.6 A).
3.3.7 Identification of markers expressed by HUES-7 cells grown using the
VN:GF medium in conjunction with the ANK protocol.
The differentiation status of hES cells grown using combinations of ANK and
VN:GF medium was assessed using Oct-4 and TRA 1-81 primary antibodies. Both
of these markers are expressed on undifferentiated hES cells. Fluorescently labeled,
secondary antibodies to TRA 1-81 (red) and Oct-4 (green) primary antibodies were
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 96
used to establish whether these proteins were present on the hES cells. Interestingly,
hES cells propagated in all treatments demonstrated high levels of TRA 1-81 and
Oct-4 (Figures 3.7). High immuno-reactivity of the two markers was observed in the
feeder + KO-Serum, feeder + VN:GF medium, ANK + KO-Serum, ANK + VN:GF
medium (Figures 3.7 A, B, C, and D respectively). The treatments of ANK + VN:GF
medium – VN and ANK – laminin + VN:GF medium also demonstrated marker
expression, however, the cells and colonies appeared to be more differentiated when
compared to the feeder + serum treatment. The “no primary antibody control” results
were obtained by incubating the hES cell colonies with the secondary antibody only
and no non-specific binding between primary antibody and hES cell was observed
(data not shown).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 97
Figure 3.6: Morphology of HUES-7 cells grown using the VN:GF medium in
conjunction with the ANK protocol. Colonies were propagated using: A) Feeder + KO-
Serum; B) Feeder + VN:GF medium; C) ANK + KO-Serum; D) ANK + VN:GF; E) AN +
VN:GF; F) A + VN:GF; G) ANK + VN:GF – bFGF; H) ANK + VN:GF – VN; and I) ANK
– laminin + VN:GF, refer to Materials and Methods. (Scale bar = 250 µm) (n=2,
representative experiment depicted).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 98
Figure 3.7: Expression of cellular markers in HUES-7 cells grown using the VN:GF
medium in conjunction with the ANK protocol. Colonies were propagated using: A)
Feeder + KO-Serum; B) Feeder + VN:GF medium; C) ANK + KO-Serum; D) ANK +
VN:GF; E) AN + VN:GF; F) A + VN:GF; G) ANK + VN:GF – bFGF; H) ANK + VN:GF –
VN; and I) ANK – laminin + VN:GF. All colonies were stained with Oct-4 (Green) and
TRA 1-81 (Red), refer to Materials and Methods. (Scale bar = 250 µm) (n=2, representative
experiment depicted).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 99
3.4 DISCUSSION
While hES cells appear to have great potential to cure a wide variety of diseases and
injuries (Docherty 2001; Guan et al. 2001; Boheler et al. 2002), the fact that their
culture systems require poorly defined components and/or xenogeneic products
means that hES cells may inherently be exposed to pathogens, resulting in unsafe
material for transplantation. This has prompted investigators to attempt to develop
culture systems that are fully defined and xenogeneic-free. For example, many
researchers have focused on replacing animal-derived feeder cell layers with human-
derived feeder cell layers (Amit et al. 2000; Richards et al. 2002; Cheng et al. 2003).
While this creates a favourable micro-environment there is still a risk of cross-
contamination from the human-derived feeder cell layer, hence this method of
culture is far from ideal.
The use of extra-cellular matrix (ECM) proteins in place of a feeder cell layer has
also been demonstrated to successfully provide a self renewing culture system for
hES cells. Thus, Xu et al. (2001) used laminin and matrigel to replace the feeder cell
layer (Xu et al. 2001). However, this system only proved functional with the addition
of MEF conditioned medium, which still carries the risk, albeit small, of
transmission of pathogens to the hES cells grown in these conditions. In fact a range
of ECM proteins such as laminin (LN), fibronectin (FN), and vitronectin (VN)
(Bagutti et al. 1996; Bradshaw et al. 1995) have all been investigated as potential
factors to replace feeder cells. It is important to also note that in all cases the ECM
proteins used for these studies were purified from plasma or tissues hence are not
completely defined, nor synthetic; leading to another potential source of
contamination.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 100
Due to the demonstrated potential of ECM proteins to potentially support the growth
and self-renewal of hES cells, along with VN’s demonstrated ability to interact with
IGF-I, IGFBP-3 and bFGF (VN:GF) (Clemmons 1998; Rees and Clemmons 1998;
Nam et al. 2002; Kricker et al. 2003; Upton et al. 1999; Schoppet et al. 2002), I
hypothesised that the technology developed in Chapter 2 for the primary
keratinocytes could be translated to hES cells. Initially, the most robust VN:GF
combination was determined by assessing the proliferation of the hES cells in short
term assays and it was demonstrated that the VN:IGFBP-3:IGF-I:bFGF combination
was the most successful treatment for the propagation of hES cells (Figure 3.1).
Additionally, the components that make up the VN:GF combination will be
evaluated using dose response studies in order to optimise this technology for the
hES cells.
To examine this VN:GF medium further, I established cultures of both the H1 and
HUES-9 hES cell lines using MEF cells and KO serum. I then proceeded to transfer
the hES cells from the serum-containing medium to the VN:GF serum-free media.
Encouragingly, the hES cell lines established in the serum free conditions
demonstrated an undifferentiated morphology typical of cells grown using a MEF
feeder cell layer and serum (Figure 3.2). This was further verified by subjecting the
hES cells to a range of assays examining the presence of specific markers, such as
SSEA-4, SSEA-1 (Figure 3.3), alkaline phosphatase, Oct-4, and hTERT (Figure 3.5)
(Thomson et al. 1998; Lanzendorf et al. 2001; Lebkowski et al. 2001; Xu et al. 2001;
Richards et al. 2002). Additionally, the hES cells were examined to determine if they
had maintained a normal karyotype after being cultured over a long time frame (10
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 101
passages). The chromosomal analysis revealed that the H1 (Figure 3.4) and HUES-9
(data not shown) cells had indeed maintained their original karyotypes.
Having demonstrated that two independent hES cell lines could be established in a
fully defined serum-free culture system, I then decided to incorporate a feeder-free
technology with our VN:GF culture in an attempt to create the first synthetic, fully
defined culture system. Beattie et al. (2005) discovered that the feeder cell layer
could be removed from the culture of hES cells by replacing it with a combination of
activin-A, keratinocyte growth factor, and nicotinamide (ANK). However, KSR was
still required within this culture system. Therefore, I conducted studies at the
Whittier Institute San Diego CA, USA, in conjunction with Beattie et al. (2005) to
determine if it was feasible to combine the ANK technology with the VN:GF
medium and remove the need for both feeder cells and serum for the culture of hES
cells. Initially the cultures were established using MEF cells and KO-serum, prior to
transferring the hES cells to a variety of conditions to evaluate the possibility that the
feeder-free and serum-free technologies combined, could replace the reliance of hES
cells on feeder cells and serum. In this chapter I demonstrated that the HUES-7 cell
line could be established, and that the cells remained undifferentiated when cultured
using ANK and the VN:GF medium (Figure 3.6 D). This was further verified by
examining the expression of Tra 1-81 and Oct-4 markers present in undifferentiated
hES cells (Figure 3.7 D). However, this analysis revealed that hES cells grown in
these novel conditions were not as undifferentiated as those grown using KO serum
and feeder cells. Consequently, hES cell cultures were grown in media containing
various combinations of the ANK and VN:GF components (Figures 3.6 & 3.7).
Interestingly, combinations where keratinocyte growth factor and nicotinamide were
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 102
removed seemed more robust (Figures 3.6 F and 3.7 F). However, only short term
studies were conducted and further examination is required to explore the potential
of this system.
Recently, other serum-free and feeder-free culture systems have been developed for
hES cell growth. For example, Ludwig et al. (2006) utilised a combination of growth
factors, insulin (23µg/ml) and HSA (13 mg/ml), termed TeSR1, for the culture of
hES cells. Interestingly, the karyotype analysis conducted on the hES cells that were
serially propagated using the TeSR1 technology revealed a 47 XXY chromosomal
aberration. Perhaps the inclusion of supra-physiological concentrations of growth
factors in the TeSR1 media led to the coincidental selection of cells with
tumourigenic potential. Additionally, the large amounts of protein required in this
TeSR1 technology result in this product being excessively expensive. Similarly,
another serum-free, feeder-cell free protocol was reported by Lu et al. (2006). This
technology also included high concentrations of other factors purified from serum
such as HSA and growth factors, as well as the addition of insulin. Thus, none of
these recent “advances” in hES culture media are commercially viable from a cost
perspective, nor are they readily regulatory compliant.
The results from the experiments reported in this chapter are clearly very
encouraging. I have demonstrated that the VN:GF medium can replace the need for
serum in hES culture. Furthermore, the short term studies examining the ANK
components with the VN:GF medium warrants additional investigation. In particular,
studies examining whether hES cells can be serially passaged long term both serum-
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 103
free and feeder-free using the ANK/VN:GF medium and still retain their desired
undifferentiated state are necessary.
Given the diverse approaches reported in the literature to replace feeder cells, it
would appear that there is also a need to investigate the hES cell in-vitro micro-
environment using a more systematic approach, for example through proteomic
analysis. Such an approach may well identify molecules that could be added in
conjunction with the VN:GF medium to further develop and optimise a synthetic,
fully defined, culture system. Nevertheless, the data reported in this chapter have
demonstrated that hES cells can attach, expand long term and survive in an
undifferentiated state when using the VN:GF medium as a serum-free media; this
represents a significant advance in the field of hES cell culture. The results reported
herein also indicate that technologies developed for improved culture of primary
keratinocytes are highly applicable to hES cells.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 105
CHAPTER 4
Proteomic Analysis of Media Conditioned by Keratinocytes
Cultured In-Vitro
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 106
4.1 INTRODUCTION
As discussed in Chapter 1 human skin is made up of an epithelial cell layer which is
primarily composed of keratinocytes. These cells are involved in the self-renewal,
maintenance and formation of the skin’s outer layer (Leary et al. 1992). The natural
in-vivo micro-environment provides the keratinocytes with an array of growth
factors, extra-cellular matrix (ECM) proteins and other nutrients important for their
survival and renewal. In 1975 Rheinwald and Green discovered a way to recapitulate
this micro-environment using an irradiated feeder cell layer and animal serum. This
revolutionised research into the skin as the newly established methods for the in-
vitro culture of keratinocytes provided researchers with a tool to examine methods to
regenerate and repair skin defects (Green 1991; Meana et al. 1998; Wright et al.
1998). However, this culture method uses xenogeneic components, hence carries the
risk of contaminating keratinocytes with infectious and pathogenic agents. More
recently, the addition of these animal components has also been demonstrated to
introduce immunogenic agents (Martin et al. 2005; Heiskanen et al. 2007) suggesting
that the cells grown in these conditions can be phenotypically manipulated by their
micro-environment.
As described in Chapter 2, I have developed a fully defined serum-replacement
method for the isolation, establishment and in-vitro expansion of keratinocytes for
skin grafting applications. Whilst this technology has proved to be successful in
removing serum from the culture of keratinocytes, there is still a need for a feeder
cell layer in the culture system. Interestingly, other groups have demonstrated that
human embryonic stem cells which are cultured using a similar approach, can be
propagated by using medium that has been conditioned by feeder cells (Lebkowski et
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 107
al. 2001; Xu et al. 2001). This suggests that a soluble factor/s secreted by the feeder
cells may be critical for the propagation of hES cells.
The complexity and importance of the feeder cell layer to the hES micro-
environment is unquestionable and has led to the proteomic profiling of culture
medium conditioned by feeder cells (Wee Eng Lim and Bodnar 2002; Prowse et al.
2006). These studies analysed animal and human-derived feeder cell layers to
determine what proteins were expressed by the cells, and in turn, facilitated
identification of factors which may be important for the self renewal of hES cells.
However, while these studies examined the proteome of the conditioned media and
the feeder cells, they have left out one important aspect; namely, what do the hES
cells contribute to their micro-environment? That is, what proteins important to the
survival of feeder-dependent cells are secreted by either the feeder cells, or the
feeder-dependent cells in response to their paracrine interactions? Similarly, no
proteomic investigation into the paracrine interactions has been conducted with
primary keratinocytes, another feeder-dependent cell type.
In the chapter reported here, I aimed to rectify this situation by undertaking a
comprehensive examination of the keratinocyte in-vitro micro-environment. In
particular, I adopted a proteomic approach to identify the critical factors produced by
the feeder cells that are required for keratinocyte growth. Furthermore, I utilised the
serum-free media developed in Chapter 2, which is fully defined and has minimal
protein content. The minimal protein content of this serum-free media provides a
significant advantage in that it will not “mask” the critical factors secreted by the
feeder cells which may be important for supporting keratinocyte cell growth.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 108
Additionally, serum-containing medium normally requires a pre-processing step
before proteomic analysis, such as the "Multiple Affinity Removal System" (MARS)
(Agilent Technologies). This MARS immuno-depletion technology involves the
removal of high abundant proteins from serum-containing media, which could result
in a loss of candidate factors important for the self renewal of primary keratinocytes.
Similarly, there is no need to grow the cells in serum-free basal media, an approach
routinely adopted in the collection of “conditioned” media. Instead, the media to be
analysed was collected from cells cultured in their normal “growth” media; hence
they were actively growing, rather than nutrient starved and in a stressed state. Taken
together, this provided us with a useful tool to identify the critical factors produced
in the in-vitro keratinocyte culture microenvironment.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 109
4.2 METHODS
4.2.1 Ethics and material collection
Ethics for this project was approved by the Human Research Ethics Committee (ID:
3673H) (Queensland University of Technology) and the St. Andrews and Wesley
Hospitals, Brisbane, Australia. Skin was obtained from informed, consenting patients
undergoing breast reductions and abdominoplasties.
4.2.2 Isolation of primary keratinocytes
Primary keratinocytes were isolated from split thickness skin biopsies obtained from
breast reductions and abdominoplasties as described by Goberdhan et al. (1993).
Briefly, this method involved dissecting the skin biopsy into 0.5 cm2 pieces followed
by a series of antibiotic wash steps. The skin was then incubated in 0.125% trypsin
(Invitrogen, Mulgrave, VIC, Australia) overnight at 4 °C. The epidermis was then
separated from the dermal layer and the keratinocytes isolated. Keratinocyte cells
were then suspended in DMEM (Invitrogen), filtered (100 µm) and pelleted.
4.2.3 VN:GF Culture
Freshly isolated keratinocytes were initially cultured in 75 cm2 flasks at a density of
2 x 106 cells and were then seeded at 2 x 105 cells per 75 cm2 flask for subsequent
passages. Prior to seeding the keratinocytes, a gamma-irradiated (two doses of 25
Gy) (Australian Red Cross Blood Service, Brisbane, QLD, Australia) mouse i3T3
cell feeder cell layer was pre-seeded for four hours at 2 x 106 cells. The feeder cell
layer was then serum-starved for three hours following seeding. The keratinocytes
were propagated in VN:GF medium containing: phenol red-free DMEM/HAMS
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 110
medium (Invitrogen); 0.4 μg/mL hydrocortisone; 0.1 nM cholera toxin; 1.8 x 10-4 M
adenine; 2 x 10-7 M triiodo-l-thyronine; 5 μg/mL transferrin; 2 x 10-3 M glutamine
(Invitrogen); 1000 IU/mL penicillin/1000 μg/mL streptomycin (Invitrogen); 0.6
µg/mL VN (Promega, Annandale, NSW, Australia); 0.6 µg/mL IGFBP-3 (N109D
recombinant mutant) (Auspep, Parkville, VIC, Australia); 0.2 µg/mL IGF-I (GroPep,
Adelaide, SA, Australia); and 0.2 µg/mL EGF (Invitrogen) (VN:GFs). The
keratinocyte cultures were incubated at 37°C in 5% carbon dioxide and re-fed with
VN:GF medium every two days. Morphology and marker expression were used to
ensure that the keratinocytes used in this experiment were phenotypically similar to
those grown using serum. Briefly, this involved probing the cultures with antibodies
against keratins 6 and 14, a marker expressed by undifferentiated keratinocytes,
(refer to Chapter 2, and section 2.2.8).
4.2.4 Two-dimensional proteomics.
Two-dimensional liquid chromatography was used to fractionate conditioned media
samples and employed a BioLogic Duo-flow high performance liquid
chromatography (HPLC) (Bio-Rad, Hercules, California, USA) for the first
dimension separation, while the second stage of the Beckman Coulter’s
ProteomeLab™ PF 2D platform was utilised for the second dimension separation.
Initially, 15 mL of conditioned media was collected from the feeder cell alone or
feeder cell:keratinocyte cultures every 2 days and pre-processed and concentrated
using bulk-phase SPE phenyl-silica sorbant (Alltech- Australia, Dandenong South,
VIC, AUS). Briefly, matrix was prepared in 100% methanol and poured into a 10
cm3 column; the packed column was then equilibrated using ultrapure water
containing 0.1% tri-fluro acetic acid (TFA). Following this, the samples were loaded
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 111
onto the column and the column was then washed in 0.1% TFA. Bound protein was
eluted from the column using 80% acetonitrile in ultrapure water containing 0.1%
TFA and the fraction collected was lyophilised using an eppendorf concentrator
5301 (Eppendorf South Pacific, North Ryde, NSW, AUS) to concentrate the protein.
The protein samples were then reconstituted using 20 mM Tris-HCl and resolved in
the first dimension using a UNO-Q (Bio-Rad) anion-exchange chromatography
column attached to the BioLogic DuoFlow HPLC. Several NaCl gradients were
tested in order to optimise the resolution of the proteins/peptides in the samples. The
first dimension separation involved fractionating the proteins and peptides present in
the conditioned media using a salt gradient (20 mM TRIS-HCL through to 20 mM
TRIS-HCL containing 500 mM NaCl, pH 8.8) and collecting 1 mL fractions at 2 min
intervals using a flow rate of 0.5 mL/min.
These fractions were then further separated using the second dimension platform of
the ProteomeLab PF2D (Beckman Coulter, Gladesville, NSW, AUS) which
employed high performance, reversed-phase liquid chromatography. The second
dimension separation was performed at 50 oC at a flow rate of 0.75 mL/min. Two
hundred microlitres from each first dimension fraction were injected and further
fractionated independently using a 0-100% Acetonitrile/0.1%TFA gradient over 30
min. Two-dimensional images were generated based on protein absorbances
generated by the 2nd dimension separation for both the feeder cell and feeder
cell:keratinocyte conditioned media samples using the ProteoVue software
(Beckman Coulter).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 112
4.2.5 Sample Preparation and LC/MS using LC/ESI/MS and LC-MALDI
Analysis.
To identify proteins present in both the feeder cell and feeder cell:keratinocyte
conditioned media samples, two liquid chromatography/mass spectrometry (LC/MS)
procedures were used, liquid chromatography/electrospray ionization (LC/ESI) and
liquid chromatography/matrix assisted laser desorption ionisation (LC-MALDI).
Initially, the samples were lyophilised using an eppendorf concentrator 5301
(Eppendorf South Pacific, North Ryde, NSW, AUS), then reduced, alkylated and
digested with trypsin. The reduction involved resuspending the lyophilised protein in
100 µL of 0.1 M NH4CO3/20 mM DTT pH 7.9 and incubating the sample at 56°C
for 1 h. Samples were then alkylated using iodoacetamide (Sigma Aldrich) to a final
concentration of 50 mM and incubated at 37°C for 30 minutes in the dark. Finally, a
trypsin digestion using 2.2 µL of (0.5 µg/mL) sequencing grade modified trypsin
(Promega; Madison, WI, USA) was added and by incubated at 37°C for 4 h. The
samples for Liquid Chromatography (LC) were then lyophilised and dissolved in
50/50 solvent A/B (solvent A 0.1% Formic acid) (solvent B 90% acetonitrile in 0.1%
Formic acid). Samples were loaded onto a C18 300A column (150 mm x 0.5 mm x 5
µm particle size) (Vydac, Hesperia, California, USA) with 40/60 solvent A/B at a
flow rate of 300 µL/min. Solvent delivery was achieved by using an Agilent 1100
Binary HPLC system (Agilent, Inc Santa Clara, California, USA).
Column elutes were analysed using the 4000 QTRAP ESI-QqLIT analyser (Applied
Biosystems, Foster City, CA, USA) at the Institute of Molecular Biosciences, at The
University of Queensland (St Lucia, QLD, Australia). Data was analysed using the
Analyst 1.4.1 software. The protein analysis was conducted using the MASCOT
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 113
database GPS Explorer™ software (version 4.0) with the mass/ion peak information
obtained from both the MS and the MS/MS spectra. Alternatively, samples collected
from the LC phase were spotted onto MS plates using 1:1 volume of 5 mg/mL of α-
cyano-4-hydroxycinnamic acid (CHCA): protein sample (Sigma-Aldrich) for LC-
MALDI analysis. Plates were then analysed using the 4700 Proteomics Analyser
(Applied Biosystems) at the Institute for Molecular Bioscience. A plate-wide
calibration for MS and MS/MS data was performed using mass standards contained
in the MS/MS Mass Standards kit (Sigma-Aldrich). Potential protein matches were
then identified from automated searching of the MASCOT database using GPS
Explorer™ protein analysis software (version 4.0) with the mass/ion peak
information obtained from both the MS and the MS/MS spectra.
4.2.6 Sample Preparation and MALDI-TOF-TOF Mass Spectrometry.
Protein peaks for matrix assisted laser desorption ionization-time of flight-time of
flight (MALDI-TOF-TOF) analysis were selected using the ProteoVue software.
Briefly, 400 µL of samples, selected based on their respective protein peaks, were
lyophilised as previously described (section 4.2.5). The lyophilised samples were
then digested as previously described and desalted using Eppendorf C18 PerfectPure
desalting tips (Millipore; Milford, MA, USA) following the manufacturer’s
instructions. De-salted fractions were then spotted onto a MS plate with a 1:1 ratio of
protein:CHCA matrix. Mass spectrometry was performed using the 4700
Proteomics Analyser (Applied Biosystems) at the Institute for Molecular Bioscience.
A plate-wide calibration for MS and MS/MS data was performed using mass
standards contained in the MS/MS Mass Standards kit (Sigma-Aldrich). Potential
protein matches were then identified from automated searching of the MASCOT
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 114
database using GPS Explorer™ protein analysis software (version 4.0) with the
mass/ion peak information obtained from both the MS and the MS/MS spectra.
4.2.7 Database Analysis and Interpretation
The protein score, protein score confidence interval, total ion score (TIS) and total
ion score confidence intervals obtained from MS and MS/MS database analysis were
used to rank proteins from a list of potential matches. Potential proteins for each
spot were firstly ranked by TIS, reflecting how well the proteins were matched to
sequence data obtained from MS/MS analysis, where scores of ≥ 38 were considered
significant (p <0.05 that protein sequence data was matched randomly). However,
select proteins with scores less than 38 are also reported in this chapter due to their
potential as candidate factors for serum-free and feeder-free growth. When MS/MS
data were not able to return total ion scores of ≥ 38, potential matches were ranked
based on protein score. The protein score reflects how well peptide masses matched
those from predicted trypsin cleaved peptide sequences, where scores equal to or
greater than 60 are considered significant (p <0.05 that masses were matched
randomly). Proteins were selected based on the highest TIS and/or the highest
protein score. In this study the TOF-TOF analysis revealed only protein scores of
less than 60. Furthermore, the proteins were identified with their respective
functions using Swiss-Prot (http://au.expasy.org/sprot/), PubMed
(http://www.ncbi.nlm.nih.gov/sites/entrez), and Online Medelian Inheritance in Man
(OMIM) searches (http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 115
4.3 RESULTS
4.3.1 Morphology and expression of cell surface markers present on the passage 2
keratinocytes propagated using VN:GF medium for proteomic analysis.
Morphology and marker expression were used to ensure that the conditioned media
to be analysed was collected from undifferentiated primary keratinocytes. Presently,
there are no definitive assays for determining whether cultured primary keratinocyte
cells have maintained an undifferentiated state. However, keratin markers can be
used to provide useful information regarding the proliferative state of the cell and
whether or not the cell is a basal keratinocyte. Therefore antibodies that recognise
keratin 6 (present in hyper-proliferative keratinocytes), keratin 14 (present in basal
cells), and keratin 1/10/11 (present in more differentiated, supra-basal cells, data not
shown) were used to assess the differentiation status of the cells cultured for the
proteomics study. This analysis revealed that cells propagated using the VN:GF
medium had maintained a normal morphology compared to those grown using serum
(Figure 4.1 B and A, respectively). Additionally, keratinocytes cultured in the
VN:GF medium continued to express keratin 6 and 14 (Figure 4.1 C and D,
respectively), thus suggesting these cells have maintained their undifferentiated
primary keratinocyte morphology.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 116
Figure 4.1: Morphology and expression of cell surface markers on the passage 2
keratinocytes propagated using VN:GF medium for proteomic analysis. Primary
keratinocytes were isolated serum-free and then propagated using: (A) medium
containing serum and a feeder cell layer, or (B) propagated serum-free using the
VN:GF medium in conjunction with a feeder cell layer. Day 4 keratinocytes were
probed with antibodies against (C) keratin 6, and (D) keratin 14 to assess whether the
primary keratinocytes propagated using the VN:GF remained undifferentiated.
Conditioned media was collected from the cultures every two days from three
different patient samples. (Scale bar = 100 µm) (n=3, images are of a representative
culture of one of the 3 separate patients samples analysed).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 117
4.3.2 Two dimensional separation of conditioned media collected from both feeder
cells alone and feeder cell:keratinocyte cultures.
Proteins present in the conditioned media of feeder cells alone and from feeder
cell:keratinocyte co-cultures (Figures 4.2 A and B, respectively) were separated
using a novel form of two-dimensional liquid chromatography separation. This
involved separating proteins via a salt gradient in the first dimension, followed by a
second dimension separation using an acetonitrile gradient. The first dimension of
the standard Beckman Coulter ProteomeLab was replaced with Bio-Rad’s Duo-flow
HPLC due to poor first dimension resolution of the platform. The first dimension
HPLC fractions were then applied to the second dimension of the ProteomeLab and
proteins were visualised based on their absorbance values using the ProteoView
software. Clearly, there is an increase in the number of distinct protein spots
(fractions) expressed in the feeder cell:keratinocyte culture conditioned media
(Figure 4.2 B), above that found with the feeder cell alone conditioned media.
Furthermore, there appear to be observable changes in abundance of
proteins/peptides between the feeder cells alone conditioned media (Figure 4.2 A)
and that obtained from the feeder cell:keratinocyte cultures (Figure 2B).
Subsequently, 187 protein fractions represented in Figure 4.2 A and 238 protein
fractions represented in figure 4.2 B were isolated, digested and analysed using
MALDI TOF-TOF.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 118
Figure 4.2: Two dimensional separation of conditioned media. Media was
collected from (A) feeder cells alone and (B) feeder cell:keratinocyte cultures. First
dimension separation involved injecting 1 mg of protein, concentrated from the
conditioned media, onto a 0 - 500 mM NaCl gradient. Subsequently, fractions were
collected and applied to a second dimension separation which involved using a 0-
100% acetonitrile gradient as per the material and methods section. (Conditioned
medium from 3 separate patient cultures were pooled). The first and second
dimension separation were depicted on the X and Y axes and are represented by
increasing colour intensity (from blue to red). These colour outputs represent protein
fractions and were generated from absorbance readings.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 119
4.3.3 Proteins identified in the feeder cell and the feeder cell:keratinocyte
conditioned media.
Initially, MALDI-TOF-TOF analysis was performed on the protein fractions and did
not reveal significant ion scores for the feeder cell alone or the feeder
cell:keratinocyte conditioned media (CM). Consequently, the CM was analysed
using two liquid chromatography methods; the first involved the QTRAP MS/MS
system (LC/ESI/MS) (conducted on fractions from the first dimension separation),
while the second utilised LC-MALDI (conducted on the concentrated CM sample)
(Table 4.1 and 4.2). The Mascot database was then employed to analyse the proteins
present in the conditioned media. The LC/ESI/MS and LC-MALDI results were
organised into seven major groups; extra-cellular matrix (ECM), membrane, nuclear,
secreted, serum-derived and miscellaneous proteins/factors. Additionally, the
proteins were categorised using accession number, molecular weight, total score and
peptide count. All proteins identified in Tables 4.1 and 4.2 are either identified or
exhibit extensive homology as determined by ion score. The feeder cell alone results
revealed; 12 ECM, 2 growth factors, 17 miscellaneous, 14 membrane, 10 nuclear, 5
secreted, and 3 serum-derived proteins (Table 4.1). The feeder cell:keratinocyte
results revealed; 3 cytoplasmic, 22 ECM, 30 miscellaneous, 21 membrane, 19
nuclear, 9 secreted, and 4 serum-derived proteins. LCMS results were organised by
their total ion score (Table 4.2).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 120
Table 4.1
Protein Accession Number
MW (kDa)
Total Ion Score
(LC/ESI/MS)
Ion Score LC-
MALDI Extra-Cellular Matrix Cartilage intermediate layer protein 1 O75339 135 42 Collagen type 1, alpha-2 P08123 130 40 Collagen type 4, alpha-4 Q9QZR9 166 63 Collagen type 5, alpha-1 P20908 184 50 Collagen type 6, alpha-3 P12111 345 44 Collagen type 7 Q63870 296 52 19 Collagen type 19, alpha-1 Q14993 116 48 Collagen, type 27, alpha-1 Q8IZC6 187 40 Fibronectin precursor P11276 276 31 Laminin subunit alpha-5 Q61001 416 40 18 Stretch-responsive fibronectin protein type 3 Q70X91 399 41 Tenascin-X O18977 454 38 Growth Factors Insulin-like growth factor-I Q13429 15 143 Insulin-like growth factor-II P09535 20 25 Miscellaneous CaM Kinase ID Q8IU85 43 21 Catalase P04040 60 38 Complement C4 [Precursor] AAN72415 193 51 Discs large homolog 5 Q8TDM6 203 43 Fucosyltransferase 8 Q543F5 67 41 Metastasis suppressor protein 1 Q8R1S4 74 28 Myosin-9 P35579 146 44 Neuronal apoptosis inhibitory protein 5 Q8BG68 162 23 Neutral alpha-glucosidase C type 3 Q8TET4 105 28 Peroxiredoxin 1 Q9BGI4 22 42 Plectin-1 Q9QXS1 535 40 Poly [ADP-ribose] polymerase 14 Q460N5 172 48 Transglutaminase y Q6YCI4 80 40 Tuberin CAA56563 276 41 Tyrosine-protein phosphatase non-receptor type 13
Q64727 117 38
Uncharacterised progenitor cells protein Q9NZ47 9 25 Vinculin Q64727 117 38 Membrane Activin receptor type-2B Q13705 58 39 EGF-like domain-containing protein 4 Q7Z7M0 265 38 Fat3 Q8R508 505 41 Hepatocyte growth factor receptor Q9QW10 30 21 Insulin-like growth factor 1 receptor Q60751 158 20 Integrin alpha-7 Q13683 130 47 Intercellular adhesion molecule 1 Q95132 60 41 Chondroitin sulfate proteoglycan 4 Q6UVK1 251 40 Mucin-4 Q8JZM8 367 44 Neurexin-2-alpha Q9P2S2 180 38 Protein patched homolog 2 O35595 130 24 Serine/threonine-protein kinase MARK2 O08679 81 48 Tumor-associated hydroquinone oxidase Q16206 71 48 Ubiquitin thioesterase T30850 293 49
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 121
Nuclear Antigen KI-67 P46013 321 55 34 PPAR-binding protein Q925J9 105 40 Scapinin Q8BYK5 63 38 Sentrin-specific protease 2 Q91ZX6 67 22 SON protein P18583 260 41 STAT5a Q3UZ79 32 19 Telomerase-binding protein EST1A P61406 162 38 Tra1 homolog Q80YV3 294 48 Zinc finger protein HRX P55200 425 46 Zinc finger protein spalt-3 [Fragment] Q9EPW7 136 40 Secreted Alpha-fetoprotein P49066 68 78 Insulin P01317 11 22 Kininogen P01044 69 61 Latent-transforming growth factor beta-binding protein 2
Q14767 204 39
Transferrin
P02787 79 64
Serum-Derived Bovine Serum Albumin AAN17824 71 198 524 Fetuin S22394 39 147 124 Hemiferrin Q64599 25 91
Table 4.1: Proteins identified from feeder cell conditioned media using
LC/ESI/MS system and LC-MALDI. Conditioned media was collected every two
days, pooled concentrated, isolated and separated in the first dimension as per the
material and methods section. Fractions collected from the first dimension separation
were processed and applied to the LC/ESI/MS. Data was analysed using the Analyst
1.4.1 software and proteins were later identified using the Mascot database search
engine. Individual ions scores > 37 indicate identity or extensive homology (p<0.05).
Alternatively, LCMS-MALDI was conducted on protein samples as a secondary
analysis. Potential proteins matches were then identified from automated searching
of the MASCOT database using GPS Explorer™ protein analysis software (version
4.0) with the mass/ion peak information obtained from both the MS and the MS/MS
spectra.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 122
Table 4.2
Protein Accession Number
MW (kDa)
Total Ion Score
(LC/ESI/MS)
Ion Score LC-
MALDI Extra-Cellular Matrix Cartilage intermediate layer protein 1 O75339 135 42 Collagen type 1, alpha-2 P08123 130 40 Collagen type 2 alpha-1 P02458 142 40 Collagen type 4, alpha-1 Q9QZR9 166 63 Collagen type 4, alpha-3 Q9QZS0 163 39 Collagen type 7 P12111 345 44 Collagen type 7, alpha-1 Q63870 295 56 Collagen type 11, alpha-2 P13942 172 54 Collagen type 12, alpha-1 Q99715 334 55 Collagen, type 27, alpha-1 Q8IZC6 187 40 25 Fibronectin 1 Q3UHL6 260 22 Hypothetical fibronectin type III Q8BKM5 82 38 Lamb3 protein Q91V90 132 41 Laminin subunit alpha-1 CAA41418 297 69 Laminin subunit alpha-2 Q59H37 204 27 Laminin subunit alpha-5 Q61001 416 40 Laminin alpha 3b chain Q76E14 376 61 Laminin subunit beta-2 [Precursor] Q61292 203 43 Laminin subunit gamma-3 [Precursor] Q9Y6N6 177 39 Laminin 5 WO0066731 132 37 Stretch-responsive fibronectin protein type 3 Q70X91 399 41 Tenascin-X O18977 454 38 Cytoplasm Liprin-alpha-2 Q8BSS9 143 63 Liprin-alpha-3 O75145 133 40 Serine/threonine-protein kinase TAO1 Q7L7X3 116 42 Growth Factors
Transforming growth factor alpha P01135 18 31 Miscellaneous Actin alpha 2 P62736 42 81 Actin, beta [Fragment] Q96HG5 41 78 Ankyrin-3 Q12955 482 37 Carbamoyl-phosphate synthetase I P31327 165 38 Catalase P04040 60 38 CDNA FLJ11753 fis, clone HEMBA1005583 Q9HAE5 32 37 Complement C4 [Precursor] AAN72415 193 51 Discs large homolog 5 Q8TDM6 203 43 Dystrophin P11531 427 48 Exostosin-1 Q16394 87 48 Fucosyltransferase 8 Q543F5 67 41 Granulocyte inhibitory protein II homolog Q9UD48 2 31 Hypothetical protein Q8C7W2 55 40 Kinesin-like protein KIF13A Q9H1H9 200 46 Myosin-9 P35579 146 44 myosin-IXb Q14788 230 45 Myosin-XVIIIa Q9JMH9 117 42 Neuron navigator 3 Q8NFW7 245 58 Peroxiredoxin 1 Q9BGI4 22 42 Plectin-1 Q9QXS1 535 40
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 123
Poly [ADP-ribose] polymerase 14 Q460N5 172 48 Protein diaphanous homolog 2 O70566 125 46 Protein disulfide-isomerase P04785 30 37 Protein piccolo Q9Y6V0 568 59 Sacsin Q9NZJ4 441 39 Serine protease inhibitor EIC Q8K3Y1 42 41 Transglutaminase y Q6YCI4 80 40 Tuberin CAA56563 276 41 Tyrosine-protein phosphatase non-receptor type 13
Q64727 117 38
Ubiquitin specific protease 1 Q8BJQ2 88 58 Membrane Acetyl-CoA carboxylase 2 O00763 281 39 Cadherin EGF LAG seven-pass G-type receptor 3
Q91ZI0 363 40
Cation-independent mannose-6-phosphate receptor
P11717 281 41
Chondroitin sulfate proteoglycan 4 Q6UVK1 251 40 Cytokeratin-1 P04264 66 68 Cytokeratin-9 P35527 62 127 EGF-like domain-containing protein 4 Q7Z7M0 265 38 EMR1 hormone receptor Q14246 101 40 Fat3 Q8R508 505 41 Integrin beta-4 P16144 211 43 Integrin alpha-7 Q13683 130 47 Intercellular adhesion molecule 1 Q95132 60 41 Mucin-4 Q8JZM8 367 44 Mucin-16 Q8WXI7 747 49 Neurexin-2-alpha Q9P2S2 180 38 RIM ABC transporter P78363 258 58 Serine/threonine-protein kinase MARK2 O08679 81 48 Talin-1 Q9Y490 273 43 Talin-2 Q9Y4G6 274 40 Tumor-associated hydroquinone oxidase Q16206 71 48 Ubiquitin thioesterase T30850 293 49 Nuclear DNA-binding protein SMUBP-2 Q60560 109 43 Antigen KI-67 CAA46520 321 42 Lipin-3 Q7TNN8 95 38 Nesprin-2 AAL33548 801 53 Nef-associated factor 1 Q15025 35 46 NFX1-type zinc finger-containing protein 1 Q9P2E3 225 46 Periaxin AAK19279 155 52 PPAR-binding protein Q925J9 105 40 Putative rRNA methyltransferase 3 Q9DBE9 95 48 Scapinin Q8BYK5 63 38 SET-binding factor 1 O95248 210 41 SON protein P18583 233 42 Telomerase-binding protein EST1A P61406 161 49 Tra1 homolog Q80YV3 294 48 Transcription factor 7-like 2 Q924A0 52 34 TTF-I-interacting protein 5 Q9UIF9 210 57 Zinc finger protein HRX P55200 425 46 Zinc finger protein spalt-3 [Fragment] Q9EPW7 136 40 Zinc finger protein 40 P15822 299 57 Secreted Apolipoprotein A-II P81644 8 56
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 124
Follistatin-related protein 5 Q8BFR2 95 27 Latent-transforming growth factor beta-binding prot-2
Q28019 208 38
Matrix-remodeling-associated protein 5 Q9NR99 314 39 Nidogen P10493 139 26 Platelet glycoprotein V Q9QZU3 64 39 Proteoglycan-4 [Precursor] Q9JM99 117 37 SCO-spondin [Precursor] P98167 575 38 Transferrin P02787 79 64 Serum-Derived Bovine Serum Albumin AAN17824 71 198 335 Fetuin S22394 39 147 126 Hemiferrin A39684 24 50 Human Serum Albumin CAA23753 71 64
Table 4.2: Proteins identified from feeder cell:keratinocyte conditioned media
using LC/ESI/MS and LC-MALDI. Conditioned media was collected every two
days, from cell cultures derived from skin isolated from 3 different patients. The
conditioned media was pooled, concentrated, isolated and separated in the first
dimension as per the material and methods section. Fractions collected from the first
dimension separation were processed and applied to the QTRAP MS/MS system.
Data was analysed using the Analyst 1.4.1 software and proteins were later identified
using the Mascot database search engine. Individual ions scores > 37 indicate
identity or extensive homology (p<0.05). Alternatively, LCMS-MALDI was
conducted on the protein samples as a secondary analysis. Potential proteins matches
were then identified from automated searching of the MASCOT database using GPS
Explorer™ protein analysis software (version 4.0) with the mass/ion peak
information obtained from both the MS and the MS/MS spectra.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 125
4.3.4 Differences in abundance of protein species found in the feeder cell and the
feeder cell:keratinocyte conditioned media.
Relevant proteins and protein differences for the culture of keratinocyte cells were
tabulated from the LC-ESI, LC-MALDI (Table 4.1 and 4.2) and MALDI-TOF-TOF
(Table AI.1 & 2) analysis. These candidate proteins were then separated into their
respective categories including; Extra-cellular Matrix, Growth Factors and
Cytokines, Secreted and Intracellular proteins. There was overlap between proteins
in both treatments including: Collagens I, IV and VII; fibronectin I; Laminin V;
TGFs alpha and beta; VEGF; Interleukins 1, 10 and 15; Telomerase-binding protein
EST1A; and Tra1 homolog. However, unique proteins were also observed in the
feeder cell alone treatment including: Collagens V and VI; Bone Morphogenic
protein 1 (BMP 1); bFGF; human growth hormone (hGH); FGF 3; Insulin; IGF-I and
-II; Interleukin-8; Leukemia inhibitory factor and Megakaryocyte-CSF. Furthermore,
unique proteins were also observed in the feeder cell:keratinocyte treatment
including: Fibronectin III; Laminin I and III; nerve growth factor (NGF); PC cell-
derived growth factor; platelet-derived growth factor beta (PDGF); Interleukin 4 and
6; PDGF-inducible JE glycoprotein; Follistatin-related protein 5; growth inhibitory
factor; Growth differentiation factor 9 and telomerase reverse transcriptase.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 126
Table 4.3
Feeder Cell Alone Score Ion (I) Protein
(P)
Feeder Cell:Keratinocyte Score Ion (I) Protein
(P) Extra-cellular Matrix Extra-cellular Matrix Collagen I I-40 Collagen I I-40 Collagen IV I-63 Collagen IV I-63 Collagen V I-50 Collagen VII I-44 Collagen VI I-44 Fibronectin I I-22 Collagen VII I-52 Fibronectin III I-38 Fibronectin I I-31 Laminin I I-69 Laminin V I-40 Laminin III I-61 Laminin V I-37 Growth Factors and Cytokines BMP 1 P-25 Growth Factors and Cytokines bFGF P-32 FGF-2 associated protein 3 P-36 FGF homologous factor 3 P-20 NGF homolog 1 P-40 Growth hormone P-34 PC cell-derived growth factor P-36 Insulin I-22 PDGF bb P-16 Insulin-like growth factor 1 I-143 TGF alpha I-31 Insulin-like growth factor 2 I-25 TGF beta I P-18 TGF alpha P-14 VEGF P-20 TGF beta 2 P-34 Interleukin 1 alpha P-21 VEGF P-20 Interleukin 4 P-20 Interleukin 1 beta P-39 Interleukin 10 P-21 interleukin-8 P-32 Interleukin-6 P-37 Interleukin 10 P-32 Shorter isoform of interleukin 15 P-19 Isoform of interleukin 15 P-25 PDGF-inducible JE glycoprotein P-43 Leukemia inhibitory factor P-33 Secreted Secreted Follistatin-related protein 5 I-27 Megakaryocyte- CSF P-22 growth inhibitory factor P-15 Growth differentiation factor 9 P-31 Intracellular Telomerase-binding protein EST1A I-38 Intracellular Tra1 homolog I-48 Telomerase reverse transcriptase P-31 Telomerase-binding protein
EST1A I-49
Tra1 homolog I-48
Table 4.3: Differences in abundance of protein species found in the feeder cell
and the feeder cell:keratinocyte conditioned media. Mass spectrometry analysis
was performed on the liquid fractions obtained from the feeder cell alone or the
feeder cell:keratinocyte conditioned media (CM) and candidate and or proteins of
interest were categorised by functional class of the protein and ion score (I) or
protein score (P).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 127
4.4 DISCUSSION
Many novel technologies involving primary keratinocytes are being developed for
the therapeutics industry to aid in the regeneration and healing of skin defects
(Harkin et al. 2006; Sun et al. 2007). However, technologies used to propagate these
cells ex-vivo still require undefined components, such as serum and/or feeder cells,
and generally utilise a poorly defined culture system. As outlined in Chapter 2, I
have developed a fully defined serum-free technology (VN:GF) that can support the
isolation, establishment and serial propagation of undifferentiated keratinocytes.
Whilst this discovery was a step forward, the culture approach still required the use
of an irradiated i3T3 feeder cell layer for successful serial propagation and in-vitro
expansion.
It has been demonstrated that irradiated i3T3 feeder cells secrete large quantities of
IGFs and ECM proteins (Barreca et al. 1992), as well as a variety of other proteins.
Moreover, keratinocytes have also been demonstrated to express the receptors for
many growth factors and ECM proteins (Adams. and Watt 1991; Haase et al. 2003;
Rodeck et al. 1997; Stoll, Garner, and Elder 1997; Watt and Jones 1993; Watt et al.
1993). Indeed, other laboratories have investigated the use of these proteins for the
culture of keratinocytes. For example, Dawson et al. (1996) demonstrated that
keratinocytes can attach and proliferate in response to VN-coated surfaces.
Nevertheless, the most robust culture systems for keratinocytes still require the use
of a feeder cell layer (Huang et al. 2006). This requirement for a feeder cell layer
highlights the importance that the feeder cells have in the culture system. More
recently, other groups have demonstrated that other cell types, such as human
embryonic stem cells, can be propagated feeder-free using ECM proteins when the
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 128
culture system is supplemented with conditioned media obtained from MEFs, thus
suggesting that the critical component provided by the feeder cells is a soluble factor
secreted by the feeder cell layer (Lebkowski et al. 2001; Xu et al. 2001) .
Therefore, I hypothesised that novel proteins in conditioned media may be able to be
identified using proteomic techniques and that these proteins could potentially be
used in conjunction with the VN:GF medium to support serum-free and feeder cell-
free propagation of keratinocytes. Furthermore, given that the VN:GF media does
not contain serum or high abundance proteins such as albumin i.e. it is a low protein
content media, I was in a unique position to identify critical factors important to
keratinocyte survival. These factors may normally be masked by the high abundant
proteins traditionally incorporated into serum-containing or high protein content
media.
To date, most proteomic analysis in this area and related fields, has been conducted
on the feeder cell layer alone (Prowse et al. 2005; Boraldi et al. 2003; Wee Eng Lim
and Bodnar 2002), providing insight into what fibroblasts secrete into the media.
However, my research takes this one step further by establishing a system in which
secretions triggered by paracrine interactions of the feeder cells with the
keratinocytes could also be analysed. To examine this hypothesis I examined what
the feeder cell alone and feeder cell:keratinocyte cultures were secreting into the
media. The study of both of these treatments provides a more complete picture of the
secreted factors in response to not only the autocrine interactions, but also the
paracrine interactions, and gives a greater insight into the optimal in-vitro micro-
environment for keratinocytes. In an ideal situation, I would have also examined a
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 129
keratinocyte alone treatment and realise that this is a shortcoming of my approach,
however, the VN:GF medium would not allow the serial propagation of
keratinocytes feeder-free. Indeed, this is what prompted me to conduct the proteomic
analysis reported here. Serum- and feeder-free mediums do exist for the propagation
of keratinocytes and could have been employed for my studies, however, using one
of these media would have altered the proteomic profiles due to the fact that these
media are undefined and contain many compounds purified from animal and human
sources.
In the scope of this study I observed 187 protein spots from the feeder cell alone
conditioned medium (CM) represented in Figure 4.2 A and 238 protein fractions
from the feeder cell:keratinocyte CM represented in figure 4.2 B. Following the mass
spectrometry analyses 63 proteins from the feeder cell alone CM and 108 proteins
from the feeder cell:keratinocyte CM were further prioritised with respect to their
potential use in generating a serum-free feeder-free culture system for primary
keratinocytes (Table 4.3). The higher number of proteins identified in the feeder
cell:keratinocyte CM (Table 4.2) was expected and is likely to arise from the fact
that there were two cell types present within this culture system. However, of the
proteins reported in Table 4.3 only 25 proteins in the feeder cell alone CM and 27
proteins in the feeder cell:keratinocyte CM were observed as having a possible
relevance for future studies. Briefly, these proteins were prioritised based on the
functional class of the protein, previous characterisation in the published literature,
reagents available for testing. Interestingly, many of the candidate proteins were
present in the two CM treatments, with the major exceptions being: Collagens V and
VI, Bone Morphogenic protein 1 (BMP 1), bFGF, human growth hormone (HGH),
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 130
FGF 3, Insulin, IGF-I and -II, Interleukin-8, Leukemia inhibitory factor and
Megakaryocyte-CSF in the feeder cell alone CM; and Fibronectin III; Laminin I and
III; nerve growth factor (NGF); PC cell-derived growth factor; platelet-derived
growth factor beta (PDGF); Interleukin 4 and 6; PDGF-inducible JE glycoprotein;
Follistatin-related protein 5; growth inhibitory factor; Growth differentiation factor 9
and telomerase reverse transcriptase in the feeder cell:keratinocyte CM (Table 4.3).
Whilst the system employed here utilised the serum-free VN:GF medium described
in Chapter 2, several bovine and human serum-derived proteins were identified in
the feeder cell alone and feeder cell:keratinocyte treatments; namely, bovine and
human serum albumin, fetuin, and members of the transferrin family. This was not
unexpected as the fibroblast cells were cultivated in, and exposed to bovine serum-
containing medium prior to transferring cells to VN:GF medium. Likewise, the
human serum-derived proteins were carried over from the donor patient’s skin
during the keratinocyte isolation, despite the fact that the keratinocytes themselves
were isolated and cultured entirely serum-free. Additionally, high abundant serum
proteins, such as albumin are often adhesive and associate with extra-cellular
surfaces and culture vessels, thus making them difficult to completely remove
through washing steps alone. Indeed, this serum carry over is commonly observed
when conducting proteomic studies and indeed Prowse et al. (2005) and Lim and
Bondar (2002) also observed these serum-derived proteins even though they
employed a series of wash steps and an incubation of the cells in serum-free
medium. Nevertheless, it is clear that the series of washes and serum-starvation steps
employed in both their study and ours, prior to transfer to serum-free conditions
significantly reduced the presence of these serum-derived components in the CM.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 131
Therefore, these serum-derived proteins did not markedly interfere with the
resolution of the proteomic profiles (Figure 4.2 A & B). Future studies will involve
developing a serum-free media for the propagation of fibroblast feeder cells. This
will aid in the removal of the foetal bovine serum-derived proteins that are
commonly carried over with the serum-cultivated fibroblast cells.
Several intra-cellular proteins were observed within both CM treatments of this
study. The presence of these proteins is most likely due to the cells lysing, hence
leaking their intracellular contents into the culture system. Whilst these intracellular
proteins were not the prime focus of this study, some of the proteins identified
warrant further investigation such as telomerase reverse transcriptase, telomerase
binding protein, c-myc, and Tra1. It is also important to note here that several
proteins were omitted from tables 4.1 and 4.2 due to the fact that they could not be
identified; that is, they are classified on the database as being i.e. hypothetical
proteins, unknown proteins, and proteins with no known function. While these may
well provide to be critical factors, the discussion that follows focuses on proteins
whose functions and characteristics are known, at least to some extent.
The analysis of the feeder cell alone conditioned medium (Figure 4.2A, Table 4.1
and Table AI.1) and the feeder cell:keratinocyte culture conditioned medium (Figure
4.2B, Table 4.2 and Table AI.2), revealed several proteins important for the survival
of primary keratinocytes. Several ECM proteins were identified and include;
Collagen I, IV, V, VI, and VII, Fibronectin 1 and 3, Lamb3, Laminin alpha 1, 3, 5,
and Tenascin X (Tables 4.1 and 4.2). Indeed, many of these ECM proteins were also
identified in the studies conducted by Prowse et al. (2005) and Lim and Bondar
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 132
(2002). The ECM proteins generally exist associated with cellular surfaces rather
than as secreted products, however, they may have been present in the CM due to the
cells lysing and the presences of proteases in the conditioned medium. All the same,
these ECM proteins are found in-vivo in the extra-cellular matrix of the epidermis
and dermis (Marionnet et al. 2006). Furthermore, these proteins are commonly
involved in the attachment, migration and or proliferation of keratinocytes and have
also been proposed to have roles in wound healing (Rho et al. 2006; Schneider et al.
2006; Spichkina et al. 2006; Hartwig et al. 2007).
Research groups involved in the development of serum-free and feeder cell-free
culture methods for hES cells have recently commenced exploring the use of ECM
proteins, such as those mentioned, in their culture systems. For example, laminin was
demonstrated to replace the need for a feeder cell layer when grown in the presence
of mouse embryonic fibroblast (MEF) conditioned medium (Xu et al. 2001) or with
knock-out serum replacement (KSR) + Activin-A (Beattie et al. 2005). Moreover,
Amit et al. (2004) discovered a method to propagate these cells using a fibronectin
matrix in conjunction with a range of growth factors including, transforming growth
factor β1 (TGF β1), leukaemia inhibitory factor (LIF) and basic fibroblast growth
factor (bFGF). Due to the fact that the culture of primary keratinocytes is analogous
to hES cell culture, it is therefore likely that these ECM protein-based technologies
can be translated to the culture of keratinocytes. Interestingly, all the ECM
technologies developed for the propagation of keratinocyte and hES cells thus far,
also involve the use of some form of mitogen.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 133
The results reported herein demonstrated that several growth factors and mitogens
were present in the conditioned medium including IGF-I, IGF-II, insulin,
transforming growth factors (TGF) α and β, platelet-derived growth factor (PDGF)
and bFGF, all of these being present in the conditioned media of the two treatments
(Tables 4.1, 4.2 and Appendix I). Interestingly, neither Prowse et al. (2005) or Lim
and Bondar (2002) identified any of these growth factors in their studies examining
at the proteomic profiles of fibroblast cells. I believe this is due to the previously
described advantages that I gained through using a minimal protein content medium.
Alternatively, the secretion of these growth factors may have been induced via the
use of the serum-free medium.
One of the growth factors identified, insulin is a critical component in many
mammalian cell culture media and has been incorporated into the culture of
keratinocytes for some time now. Usually insulin is present in these keratinocyte
culture media at high concentrations, however, we recently demonstrated that low
concentrations of IGF-I can replace the need for insulin (Hollier et al. 2005; Hyde et
al. 2004). Indeed, it has been reported that when insulin is present at high
concentrations its growth stimulating effects are in fact mediated by the IGF-I
receptor (Dupont and leRoith 2001), hence the ability to replace insulin with IGF-I in
media used to culture keratinocytes is not surprising. Similarly, studies conducted in
my own honours project revealed that IGF-I and IGF-II when used in conjunction
with VN caused mitogenic effects in hES cells. Moreover, bFGF, TGF-beta and
PDGF, are heparin binding growth factors that have been demonstrated to enhance
the proliferation and self renewal of feeder cell dependent hES cells (Wang et al.
2005; Liu et al. 2006; James et al., 2005; Pebay et al., 2005). Furthermore, the TGF
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 134
proteins have been demonstrated to enhance migration (Li et al. 2006) and
proliferation of epidermal and keratinocyte cells (Fortunel et al. 2003; Sawamura et
al. 2004) and thus have been proposed as potentially being effective in mediating
wound healing events (Sun et al. 2004b). Interestingly, these heparin-binding growth
factors appear to be able to bind to VN through its heparin binding domain (Hollier
et al. 2005; Schoppet et al. 2002). Thus, the growth factors identified in this
proteomic analysis all have roles related to keratinocyte growth and may well prove
to be useful in conjunction with the VN:GF medium in providing a serum-free,
feeder-free media for the in-vitro expansion of transplantable cells for use in clinical
therapies.
In addition to the proteins discussed above, telomerase reverse transcriptase (TERT)
telomerase-binding protein (EST1A), Follistatin-like 5, and tumor rejection antigen1
(Tra1) homolog, were also expressed in the conditioned media of both treatments
(Tables 4.1, 4.2 and Appendix I). The telomerase-binding protein is involved in
telomere replication in-vitro via human telomerase reverse transcriptase.
Interestingly, a down regulation in hTERT or telomerase abundance is linked to
embryonic stem cell differentiation (Wang et al. 2007). Therefore, if this protein can
be induced, directly or indirectly, in the culture of keratinocytes, it may facilitate the
long term propagation of primary keratinocytes. Another nuclear protein that is of
interest is the Tra1 homolog which has a central role in c-Myc transcription
activation, and also participates in cell transformation. Furthermore, c-Myc has been
demonstrated to be important in the activation and regulation of hTERT (Chen et al.
2006). The secreted protein, follistatin-like 5, was also present in the conditioned
media examined. Notably, the follistatin-like domain present in this protein has been
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 135
implicated in the inactivation of activin-A and TGF-β (Schneyer et al. 2003;
Schneyer et al. 2004), two proteins which have been demonstrated to be important
for the self renewal of human embryonic stem cells (James et al. 2005). Taken
together, these data suggests that these proteins may also play an important role in
maintaining the undifferentiated status of other primitive cells, such as primary
keratinocytes.
In summary, the proteomic study reported here has revealed the abundance of many
proteins from both the feeder cells alone and the feeder cell:keratinocyte culture
treatments. In light of the paracrine relationship which exists between the dermal
fibroblasts and keratinocytes (Maas-Szabowskiet al. 1999; Werner and Smola 2001),
the study here identified not only what the feeder cells are secreting in isolation, but
what they and the keratinocytes secrete due to their paracrine interactions. Ideally, it
would have been of great benefit to also examine media conditioned by keratinocytes
alone to determine what these cells secrete when cultivated without feeder cells.
However, this highlights the key point of this investigation, i.e. keratinocyte cells
grow poorly in the absence of a feeder cell layer.
While this chapter reports a preliminary investigation into the feeder
cell:keratinocyte paracrine interaction, future studies will also adopt a more
quantitative approach and will also compare and contrast the differences in
abundance between similar proteins expressed in both the culture conditions. This
will provide insights into not only which candidate proteins/factors warrant further
investigation, but also provide information into the concentrations of candidate
proteins to add in conjunction with the VN:GF medium. Indeed, the most obvious
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 136
candidates to apply to the VN:GF medium would be the ECM proteins and HSA as
these have been demonstrated to be promising candidate factors in the feeder- and
serum-free culture of hES cells (Ludwig et al. 2006). More specifically, the VN:GF
medium will initially be examined in keratinocytes in conjunction with a laminin
bed, HSA and bFGF as these have all been shown to provide an appropriate micro-
environment for hES cells. Additionally, leukaemia inhibitory factor, which has been
demonstrated to support the self renewal of mouse embryonic stem but not human
stem cells, may also provide a keratinocyte culture environment free from fibroblast
feeder cells.
Nevertheless, whilst extensive validation and testing of these candidates is still
required, the data reported in this chapter has provided intriguing preliminary
insights into the in-vitro micro-environment of primary keratinocytes and has
provided useful initial information on candidate proteins that may hold potential if
used in conjunction with the serum-free medium. The proteins reported in Table
4.3.4 may provide an important first step towards developing the first fully defined,
synthetic culture system for primary keratinocyte cells, and may ultimately provide
researchers and clinicians with a realistic culture approach to generate
therapeutically viable tissue source for transplantation.
.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 137
CHAPTER 5
DISCUSSION AND
CONCLUSION
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 138
5.0 GENERAL DISCUSSION
Tissue engineering is the construction of tissues, such as skin, bone, and cartilage, in
an in-vitro micro-environment. Currently, the tissue engineering market is worth an
estimated $US120 billion worldwide (Urban 2005) and carries great promise for the
treatment of cell, tissue and organ damage, through the generation of transplantable
material. However, the in-vitro culture of cells relies heavily on the use of undefined
foreign components for their successful cultivation. Examples of these foreign
components include fibroblasts and serum, sourced from allogeneic or xenogeneic
origins. These two components have been demonstrated to support the cells of
interest, such as keratinocytes and hES cells, by providing them with a suitable
microenvironment that promotes their self renewal. Particularly important to the
growth of cells are ECM proteins and growth factors, which aid in their attachment,
migration and proliferation. Indeed, irradiated 3T3 (i3T3) feeder cells are known to
secrete large quantities of IGFs and ECM proteins (Barreca et al. 1992), suggesting
that this could be a key role of feeder cells in tissue culture systems. Furthermore,
serum has also been demonstrated to contain large quantities of ECM proteins e.g.
VN (Schvartz, et al. 1999), fibronectin, albumin, as well as various other growth
promoting components such as growth factors.
5.1 Serum-free propagation of primary human keratinocytes.
Human keratinocytes are a cell type which demonstrates the most immediate
potential in the cell-based therapeutics industry (Green 1991; Meana et al. 1998;
Wright et al. 1998). The first successful propagation of these cells was in 1975
(Rheinwald and Green 1975). However, this cultivation method required both serum
and fibroblasts for their undifferentiated growth, thus exposing potentially
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 139
transplantable material to diseases and pathogens that could be present within either
the serum or feeder cell layer. In view of this there has been a concerted effort by
scientists world-wide to develop ways to reduce the risk of contamination from the
culture system, and in particular by developing methods that allow the removal of
serum and/or the feeder cell layer.
Castro-Munozledo et al. (1997) first hypothesised that they could replace foetal
bovine serum with purified bovine serum albumin. Whilst this method did prove
successful in the propagation of keratinocytes, it did not remove the risk of potential
contamination of the cells by the bovine serum-derived albumin, nor did it result in a
fully defined media, as the BSA, which acts as a carrier protein, was purified from
serum, thus other serum-derived proteins could be transferred with it into the media.
More recently, Sun et al. (2004a) developed a technique whereby normal human
keratinocytes, pre-established on fibroblasts using serum-containing media, could be
propagated under xenobiotic-free conditions. They demonstrated that a non-
irradiated human skin-derived feeder cell layer, used at the appropriate density,
would support the serum-free propagation of human keratinocytes. However, whilst
this proved successful for the propagation of keratinocytes, this technology could not
be used for the isolation and the initial establishment of primary keratinocytes from
skin, as serum was still required for these steps. Indeed, all primary keratinocyte cell
lines isolated and established have been reported to use either allogeneic or
xenogeneic serum for these initial steps, which once again carries the risk of
contaminating the cells that are ultimately to be used for transplantation.
Additionally, Bullock et al. (2006) reported a method to substitute xenogeic feeder
cell layers for human-derived feeder cell layers sourced from the fibroblast cells of
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 140
the dermis. They demonstrated successful propagation and subsequent re-
epithelisation of cells using the human feeder cell layer under serum-free conditions.
Nevertheless, this methodology still required the use of serum for the initial isolation
of the keratinocytes and for trypsin neutralistion, thus resulting in the potential carry
over of serum components to the serum-free culture conditions subsequently used.
As described in this thesis, I have demonstrated that primary keratinocytes can be
isolated and serially propagated long term, in a fully defined serum-free medium.
Furthermore these cells expressed markers demonstrating that they remained in the
undifferentiated state and were able to re-epithelialise 3D dermal skin equivalent
models (Figures 2.3, 2.4, 2.5, 2.6 Chapter 2). The successful propagation of primary
keratinocytes using the VN:GF serum-free medium is supported to some extent by
the fact that human keratinocytes express the receptors for these proteins (Adams
and Watt 1991; Haase et al. 2003; Rodeck et al. 1997; Stoll and Elder 1997; Watt and
Jones 1993; Watt et al. 1993). However, while this new serum-free media represents
an important step forward, the culture approach still relies on the presence of a
feeder cell layer for the undifferentiated propagation of keratinocytes. Nevertheless,
its potential as a fully defined serum-free alternative has now caught the attention of
biotechnology companies, and the media is currently being externally tested as a
potential product for keratinocyte culture by Invitrogen Corporation.
5.2 Serum-free propagation of primary human embryonic stem cells.
Human embryonic stem cells on the other hand were successfully passaged in-vitro
for the first time by using donated embryos that were discarded from in-vitro
fertilisation (IVF) programs (Thomson et al. 1998). These cells demonstrated a
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 141
unique pluripotent state when propagated on a MEF feeder cell layer in media
containing foetal bovine serum (FBS) (Thomson et al. 1998; Reubinoff et al. 2000).
This pluripotency allows hES cells to transform into all the cell types within the
body, thereby underpinning the potential of hES cells in the regenerative medicine
therapeutics industry (Docherty 2001; Guan et al. 2001; Boheler et al. 2002).
However, like their keratinocyte counterparts, hES cells rely on undefined and
xenogeneic culture components, and carry the same risks of introducing pathogens
and immunogenic agents (e.g. N-glycolylneuraminic acid, Neu5Ac) (Martin et al.
2005; Heiskanen et al. 2007). Thus, there is a global move towards creating a fully
defined synthetic medium for the undifferentiated growth of these cells.
To this end, many investigators have attempted to replace xeno-derived feeder cells
with human-derived feeder cell layers (Amit et al. 2000; Richards et al. 2002; Cheng
et al. 2003). However, this is still not an ideal situation as hES cells could just as
easily be infected from pathogens within the human-derived feeder cell layer. Due to
the feeder cell layer’s support role as a source of ECM proteins and growth factors,
Xu et al. (2001) hypothesised that an ECM bed, such as laminin or matrigel, could
replace the need for a feeder cell layer. However, this technology was only
successful with the addition of MEF conditioned medium, and hence any benefit
obtained through the removal of the MEF feeder cell layer was abrogated. More
recently, Ludwig et al. (2006) demonstrated a methodology which allowed hES cells
to be propagated both feeder-free and serum-free. This technology involved the use
of large quantities of purified human serum albumin, as well as a range of other
growth factors and proteins. Through this innovation they were able to serially
passage hES cells for several months. However, chromosomal aberrations ultimately
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 142
appeared in their cell lines, suggesting that while this was a significant step forward,
it was still not the answer. Thus, with the project reported herein, I sought to
determine whether a fully defined serum-free VN:GF medium could be developed
for hES cells. Similar to the media developed in Chapter 2 for keratinocytes, the
VN:GF medium for hES cells included; VN, IGF-I and IGFBP-3, with, bFGF being
used instead of EGF. Using this media, karyotypically normal hES cells could be
serially propagated long term, whilst still maintaining markers for their
undifferentiated state (Figures 1-5 Chapter 3).
Having demonstrated that two independent hES cell lines could be serially
propagated in a fully defined serum-free culture system (Chapter 3), I then decided
to explore whether the feeder-free technology developed by Beattie et al. (2005)
could be combined with the VN:GF media. The technology developed by Beattie et
al. (2005) removed the need for a MEF feeder cell layer and involved the use of
activin-A, keratinocyte growth factor and nicotinamide (ANK). Beattie’s studies
demonstrated that hES cells can be serially propagated feeder-free long term, whilst
still maintaining an undifferentiated state. However, their protocol still required
KSR, a serum-replacement component which is undefined and uncharacterised.
Therefore, I conducted studies at the Whittier Institute (La Jolla, CA, USA), in
conjunction with Beattie et al. (2005) examining whether ANK could be used in
conjunction with the VN:GF medium. As reported in this thesis, the HUES-7 cell
line could be grown in an undifferentiated state using ANK and the VN:GF medium
(Figures 6 D and 7D Chapter 3). However, hES cells cultured in these conditions
were not optimal as determined by the morphology of the hES colonies. Moreover,
only short-term studies exploring this approach were conducted, so clearly further
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 143
investigation is required to determine unequivocally whether hES cells can be
established and propagated long term using the ANK/VN:GF medium.
As with the primary keratinocytes, the VN:GF medium I developed for hES cells
still requires the MEF feeder cell layer for their successful propagation. Therefore
proteomic studies into the hES cell in-vitro micro-environment are required to
investigate what factors may better recapitulate a favourable culture system for the
ex vivo expansion of these cells. Whilst the technology I developed still requires a
MEF feeder cell layer for successful propagation of hES cells, the potential of
VN:GF medium has been recognised by many biotechnology companies in the
sector. Indeed, Invitrogen Corporation, recently independently validated the
technology I developed and have now acquired an exclusive international license to
sell and distribute the VN:GF media for stem cells. This new media will be launched
at the upcoming International Society for Stem Cell Research meeting in Cairns in
June 2007. The media to be distributed by Invitrogen will contain recombinant
vitronectin and growth factors, manufactured to GMP standards by Tissue Therapies
Limited, a biotechnology company spun out of QUT to commercialise the VN:GF
technology. Thus, this media will be the first fully defined, synthetic GMP-grade
media for the culture of hES cells.
5.3 Proteomics of Keratinocyte Conditioned Media
Since a paracrine relationship exists in-vivo between dermal fibroblasts and
keratinocytes (Maas-Szabowski 1999; Werner and Smola 2001), I proposed that
proteomic approaches may shed insights into this relationship. Furthermore, I
hypothesised that novel compounds important for the self-renewal of cells may be
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 144
identified through this approach and thus may be able to be used in conjunction with
the VN:GF medium to generate a fully defined synthetic culture system for primary
keratinocytes. Moreover, these studies may also reveal potential candidates/factors
which may be of use to generate a similar system for hES cells. To date most
proteomic analyses in this field have been conducted on the feeder cell layer
(fibroblasts) alone (Boraldi et al. 2003; Prowse et al. 2005; Lim and Bodnar 2002),
providing insight therefore into only what the fibroblasts secrete. However, this is a
very limited method of analysis due to the fact that this type of study does not take
into account the paracrine relationship that exists between fibroblasts and
keratinocytes. Thus factors secreted by either cell type when they are co-cultured
would not be revealed.
I therefore decided to develop a two pronged proteomic approach in which firstly, I
identified what the fibroblasts secrete into the conditioned media, and secondly, I
analysed the conditioned media of co-cultured fibroblasts and primary keratinocytes.
The conditioned media was studied, rather than cell-surface associated proteins,
based on previous reports demonstrating that hES cells could be propagated using
media conditioned by mouse embryonic fibroblast cells, thus suggesting that the
critical component for feeder-free growth was a soluble factor secreted by the
fibroblast feeder cell layer (Lebkowski et al. 2001; Xu et al. 2001). Furthermore, my
strategy also involved the use of the VN:GF media instead of serum. The importance
of this is that this media has minimal protein content, thus will not suffer from the
“masking” effect of highly abundant proteins commonly seen when conducting
proteomics on samples that have been grown using serum. An additional benefit of
using this serum-free media approach was that no immuno-depletion step to remove
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 145
highly-abundant serum-proteins from media was required, which in turn reduces the
chances of important or novel protein species being inadvertently lost through this
processing step.
The studies reported in Chapter 4 of this thesis revealed several proteins which may
be important for the survival of primary keratinocytes (Tables 1, 2 and Appendix I).
The most obvious candidate proteins for future studies included: the ECM proteins,
collagen (Rho et al. 2006), fibronectin (Spichkina et al. 2006) and laminin
(Schneider et al. 2006); the growth factors, IGF-I (Hollier et al. 2005; Chapter 2),
IGF-II, insulin (Ludwig et al. 2006), TGF α and β (Li et al. 2006; Fortunel et al.
2003; Sawamura et al. 2004), PDGF (Pebay et al. 2005), and bFGF (Liu et al. 2006;
Wang 2005). Additionally, other secreted proteins of interest observed in this study
were cytokines, particularly; interleukin 6 and LIF both of which have been
demonstrated to maintain feeder-dependent cells in a self renewing state (Hernandez-
Quintero et al. 2006; Hao et el. 2006). Interestingly, I supervised a concurrent
investigation into the hES cell in-vitro micro-environment conducted by the QUT
honours student, Luke Cormack. This study revealed a similar proteomic profile to
that herein. Thus, there was significant similarity in the proteins identified as being
secreted into the conditioned media by both the primary keratinocyte cells and hES
cells (refer to Appendix II) (Cormack et al. 2007). The results of both studies have
highlighted the above mentioned proteins as potential candidates and clearly warrant
future investigations in both the keratinocyte and hES culture systems. These future
studies will analyse the individual effects of these candidate proteins, and will also
analyse their effects when added in conjunction with the serum-free VN:GF medium.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 146
Many other potentially interesting proteins were also identified in the feeder cell
alone and feeder cell:keratinocyte cultures. For example, Telomerase reverse
transcriptase (TERT), Telomerase-binding protein EST1A, Tra1 homolog and
follistatin-like 5. Significantly, the abundance of Telomerase-binding protein EST1A
and telomerase reverse transcriptase has been linked to cells that are in a state of
self-renewal (Wang et al. 2007). This may suggest that the feeder cell layer is
secreting or directly interacting with the keratinocytes to trigger the expression of
this protein. Surprisingly, neither the Telomerase reverse transcriptase (TERT) nor
Telomerase-binding proteins (EST1A), two proteins commonly expressed in hES
cells, were discovered in the studies examining the hES cell in-vitro micro-
environment (refer to Appendix II).
Interestingly, both Tra1 homolog and follistatin-like 5 have roles in the regulation of
human telomerase reverse transcriptase (hTERT) and thus stem self-renewal. Tra1
homolog appears to elicit this function through regulating c-myc (Chen et al. 2006),
while follistatin-like 5 achieves this through its inactivation of TGF-β (Schneyer et
al. 2003; Schneyer et al. 2004), which has been demonstrated to suppresses human
telomerase reverse transcriptase activity (Li et al. 2006). Conversely, the
activin/TGF-β/nodal branch has been demonstrated to induce hES cell self-renewal
(James et al. 2005). The above studies suggest that while TGF-β inhibits hTERT,
thereby inducing differentiation, it also acts in conjunction with activin to promote
pluripotency in stem cells. Together this data highlights the interconnectedness and
tight regulation of these pathways. This also suggests that future proteomic studies
examining the intricate signaling pathways involved in the self-renewal of cells may
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 147
reveal a component/s that will replace the need for a feeder cell layer in the
keratinocyte culture system.
Whilst this proteomic approach revealed interesting insights, this study was a
preliminary investigation into the in-vitro micro-environment of primary
keratinocytes and clearly further research is required. For example, studies
examining cell surface, cytoplasmic and nuclear proteins are also required to provide
a better understanding of the in-vitro micro-environment of the primary keratinocyte.
Whilst important components maybe secreted into the media, cell surface,
cytoplasmic, and nuclear proteins may also provide us with methods with which to
create a xeno-free culture environment for these cells. For example, these studies
may highlight relevant pathways for self renewal which we can activate by adding
exogenous factors to the culture system.
5.4 Conclusion
Clearly, research examining the ex vivo recapitulation of the in vivo
microenvironment is in its infancy and many questions remain to be answered.
However, there is a pressing need to eliminate animal products from the culture of
these cells and to develop a fully defined system. Synthetic alternatives, such as the
VN:GF medium I developed, are required and represent a major advance, as has
been tangibly recognised by the uptake of this technology by Invitrogen Corporation.
The research that I document in this thesis has comprehensively demonstrated that
both primary keratinocytes and hES cells can attach, expand and survive in an
undifferentiated state when using the VN:GF medium as a serum-free media.
Furthermore, the preliminary studies reported here, together with future proteomic
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 148
and validation studies, may reveal important components that can be added in
conjunction with the VN:GF media to create a fully defined, synthetic culture system
that will facilitate the safe culture of transplantable cells and tissues. This may have a
profound impact on the translation and realisation of diverse regenerative medicine
therapies.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 150
Adams, J. C. and F. M. Watt (1991). "Expression of beta 1, beta 3, beta 4, and beta 5
integrins by human epidermal keratinocytes and non-differentiating keratinocytes." J
Cell Biol 115(3): 829-41.
Ainscough, S. L., Z. Barnard, Z. Upton and D. G. Harkin (2006). "Vitronectin
supports migratory responses of corneal epithelial cells to substrate bound IGF-I and
HGF, and facilitates serum-free cultivation." Exp Eye Res 83(6): 1505-14.
Amit, M., M. K. Carpenter, M. S. Inokuma, C. P. Chiu, C. P. Harris, M. A. Waknitz,
J. Itskovitz-Eldor and J. A. Thomson (2000). "Clonally derived human embryonic
stem cell lines maintain pluripotency and proliferative potential for prolonged
periods of culture." Dev Biol 227(2): 271-8.
Amit, M., C. Shariki, V. Margulets and J. Itskovitz-Eldor (2004). "Feeder cell layer-
free and serum-free culture of human embryonic stem cells." Biol Reprod 70(3):
837-45.
Bagutti, C., A. M. Wobus, R. Fassler and F. M. Watt (1996). "Differentiation of
embryonal stem cells into keratinocytes: comparison of wild-type and beta 1
integrin-deficient cells." Dev Biol 179(1): 184-96.
Barreca, A., M. De Luca, P. Del Monte, S. Bondanza, G. Damonte, G. Cariola, E. Di
Marco, G. Giordano, R. Cancedda and F. Minuto (1992). "In vitro paracrine
regulation of human keratinocyte growth by fibroblast-derived insulin-like growth
factors." J Cell Physiol 151(2): 262-8.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 151
Beattie, G. M., A. D. Lopez, N. Bucay, A. Hinton, M. T. Firpo, C. C. King and A.
Hayek (2005). "Activin A maintains pluripotency of human embryonic stem cells in
the absence of feeder layers." Stem Cells 23(4): 489-95.
Boheler, K. R., J. Czyz, D. Tweedie, H. T. Yang, S. V. Anisimov and A. M. Wobus
(2002). "Differentiation of pluripotent embryonic stem cells into cardiomyocytes."
Circ Res 91(3): 189-201.
Bongso, A., C. Y. Fong, S. C. Ng and S. Ratnam (1994). "Isolation and culture of
inner cell mass cells from human blastocysts." Hum Reprod 9(11): 2110-7.
Boraldi, F., L. Bini, S. Liberatori, A. Armini, V. Pallini, R. Tiozzo, I. Pasquali-
Ronchetti and D. Quaglino (2003). "Proteome analysis of dermal fibroblasts cultured
in vitro from human healthy subjects of different ages." Proteomics 3(6): 917-29.
Bradshaw, A. D., K. M. McNagny, D. B. Gervin, G. M. Cann, T. Graf and D. O.
Clegg (1995). "Integrin alpha 2 beta 1 mediates interactions between developing
embryonic retinal cells and collagen." Development 121(11): 3593-602.
Bullock, A. J., M. C. Higham and S. MacNeil (2006). "Use of human fibroblasts in
the development of a xenobiotic-free culture and delivery system for human
keratinocytes." Tissue Eng 12(2): 245-55.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 152
Burger, H., K. Nooter, G. J. Zaman, P. Sonneveld, K. E. van Wingerden, R. G.
Oostrum and G. Stoter (1994). "Expression of the multidrug resistance-associated
protein (MRP) in acute and chronic leukemias." Leukemia 8(6): 990-7.
Carpenter, M. K., E. S. Rosler, G. J. Fisk, R. Brandenberger, X. Ares, T. Miura, M.
Lucero and M. S. Rao (2004). "Properties of four human embryonic stem cell lines
maintained in a feeder-free culture system." Dev Dyn 229(2): 243-58.
Castro-Munozledo, F., M. Hernandez-Quintero, M. Marsch-Moreno and W. Kuri-
Harcuch (1997). "Cultivation, serial transfer, and differentiation of epidermal
keratinocytes in serum-free medium." Biochem Biophys Res Commun 236(1): 167-
72.
Chang, M. C. (1959). "Fertilization of rabbit ova in vitro." Nature 184(Suppl 7):
466-7.
Chen, Z., Z. Wu, X. Guo and M. Jiang (2006). "[Expression of telomerase reverse
transcriptase and its relationship with expression of c-myc in laryngeal squamous
cell carcinomas]." Lin Chuang Er Bi Yan Hou Ke Za Zhi 20(21): 963-6.
Cheng, L., H. Hammond, Z. Ye, X. Zhan and G. Dravid (2003). "Human adult
marrow cells support prolonged expansion of human embryonic stem cells in
culture." Stem Cells 21(2): 131-42.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 153
Clemmons, D. R. (1998). "Role of insulin-like growth factor binding proteins in
controlling IGF actions." Mol Cell Endocrinol 140(1-2): 19-24.
Cole, S. P., K. E. Sparks, K. Fraser, D. W. Loe, C. E. Grant, G. M. Wilson and R. G.
Deeley (1994). "Pharmacological characterization of multidrug resistant MRP-
transfected human tumor cells." Cancer Res 54(22): 5902-10.
Cormack, L., S. Richards, D. Leavesley and Z. Upton (2007). Analysis of the Human
Embryonic Stem Cell In-vitro Micro-Environment. School of Life Sciences.
Brisbane, Queensland University of Technology: 47.
Cowan, C. A., I. Klimanskaya, J. McMahon, J. Atienza, J. Witmyer, J. P. Zucker, S.
Wang, C. C. Morton, A. P. McMahon, D. Powers and D. A. Melton (2004).
"Derivation of embryonic stem-cell lines from human blastocysts." N Engl J Med
350(13): 1353-6.
Dawson, R. A., N. J. Goberdhan, E. Freedlander and S. MacNeil (1996). "Influence
of extracellular matrix proteins on human keratinocyte attachment, proliferation and
transfer to a dermal wound model." Burns 22(2): 93-100.
Dawson, R. A., Z. Upton, J. Malda and D. G. Harkin (2006). "Preparation of
cultured skin for transplantation using insulin-like growth factor I in conjunction
with insulin-like growth factor binding protein 5, epidermal growth factor, and
vitronectin." Transplantation 81(12): 1668-76.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 154
Dietrich, J., M. Cella, M. Seiffert, H. J. Buhring and M. Colonna (2000). "Cutting
edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor
expressed in myeloid cells." J Immunol 164(1): 9-12.
Dinsmore, J., J. Ratliff, D. Jacoby, M. Wunderlich and C. Lindberg (1998).
"Embryonic stem cells as a model for studying regulation of cellular differentiation."
Theriogenology 49(1): 145-51.
Docherty, K. (2001). "Growth and development of the islets of Langerhans:
implications for the treatment of diabetes mellitus." Curr Opin Pharmacol 1(6): 641-
50.
Draper, J. S., C. Pigott, J. A. Thomson and P. W. Andrews (2002). "Surface antigens
of human embryonic stem cells: changes upon differentiation in culture." J Anat
200(Pt 3): 249-58.
Dupont, J. and D. LeRoith (2001). "Insulin and insulin-like growth factor I receptors:
similarities and differences in signal transduction." Horm Res 55 Suppl 2: 22-6.
Ealey, P. A., M. E. Yateman, S. J. Holt and N. J. Marshall (1988). "ESTA: a
bioassay system for the determination of the potencies of hormones and antibodies
which mimic their action." J Mol Endocrinol 1(2): R1-4.
Edwards, R. G., B. D. Bavister and P. C. Steptoe (1969). "Early stages of
fertilization in vitro of human oocytes matured in vitro." Nature 221(5181): 632-5.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 155
Eiges, R., M. Schuldiner, M. Drukker, O. Yanuka, J. Itskovitz-Eldor and N.
Benvenisty (2001). "Establishment of human embryonic stem cell-transfected clones
carrying a marker for undifferentiated cells." Curr Biol 11(7): 514-8.
Evans, M. J. and M. H. Kaufman (1981). "Establishment in culture of pluripotential
cells from mouse embryos." Nature 292(5819): 154-6.
Fortunel, N. O., J. A. Hatzfeld, P. A. Rosemary, C. Ferraris, M. N. Monier, V.
Haydont, J. Longuet, B. Brethon, B. Lim, I. Castiel, R. Schmidt and A. Hatzfeld
(2003). "Long-term expansion of human functional epidermal precursor cells:
promotion of extensive amplification by low TGF-beta1 concentrations." J Cell Sci
116(Pt 19): 4043-52.
Geijsen, N., M. Horoschak, K. Kim, J. Gribnau, K. Eggan and G. Q. Daley (2004).
"Derivation of embryonic germ cells and male gametes from embryonic stem cells."
Nature 427(6970): 148-54.
Goberdhan, N. J., R. A. Dawson, E. Freedlander and S. Mac Neil (1993). "A
calmodulin-like protein as an extracellular mitogen for the keratinocyte." Br J
Dermatol 129(6): 678-88.
Green, H. (1991). "Cultured cells for the treatment of disease." Sci Am 265(5): 96-
102.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 156
Guan, K., H. Chang, A. Rolletschek and A. M. Wobus (2001). "Embryonic stem
cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal
cells." Cell Tissue Res 305(2): 171-6.
Haase, I., R. Evans, R. Pofahl and F. M. Watt (2003). "Regulation of keratinocyte
shape, migration and wound epithelialization by IGF-1- and EGF-dependent
signalling pathways." J Cell Sci 116(Pt 15): 3227-38.
Harkin, D. G., R. A. Dawson and Z. Upton (2006). "Optimized delivery of skin
keratinocytes by aerosolization and suspension in fibrin tissue adhesive." Wound
Repair Regen 14(3): 354-63.
Hartwig, B., B. Borm, H. Schneider, M. J. Arin, G. Kirfel and V. Herzog (2007).
"Laminin-5-deficient human keratinocytes: defective adhesion results in a saltatory
and inefficient mode of migration." Exp Cell Res 313(8): 1575-87.
Heiskanen, A., T. Satomaa, S. Tiitinen, A. Laitinen, S. Mannelin, U. Impola, M.
Mikkola, C. Olsson, H. Miller-Podraza, M. Blomqvist, A. Olonen, H. Salo, P.
Lehenkari, T. Tuuri, T. Otonkoski, J. Natunen, J. Saarinen and J. Laine (2007). "N-
glycolylneuraminic acid xenoantigen contamination of human embryonic and
mesenchymal stem cells is substantially reversible." Stem Cells 25(1): 197-202.
Henderson, J. K., J. S. Draper, H. S. Baillie, S. Fishel, J. A. Thomson, H. Moore and
P. W. Andrews (2002). "Preimplantation human embryos and embryonic stem cells
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 157
show comparable expression of stage-specific embryonic antigens." Stem Cells
20(4): 329-37.
Hollier, B., D. G. Harkin, D. Leavesley and Z. Upton (2005). "Responses of
keratinocytes to substrate-bound vitronectin: growth factor complexes." Exp Cell
Res 305(1): 221-32.
Huang, Y. C., T. W. Wang, J. S. Sun and F. H. Lin (2006). "Investigation of
mitomycin-C-treated fibroblasts in 3-D collagen gel and conditioned medium for
keratinocyte proliferation." Artif Organs 30(3): 150-9.
Hyde, C., B. Hollier, A. Anderson, D. Harkin and Z. Upton (2004). "Insulin-like
growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance
keratinocyte protein synthesis and migration." J Invest Dermatol 122(5): 1198-206.
Iacovitti, L., N. D. Stull and H. Jin (2001). "Differentiation of human dopamine
neurons from an embryonic carcinomal stem cell line." Brain Res 912(1): 99-104.
James, D., A. J. Levine, D. Besser and A. Hemmati-Brivanlou (2005).
"TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in
human embryonic stem cells." Development 132(6): 1273-82.
Jiang, F., T. J. Frederick and T. L. Wood (2001). "IGF-I synergizes with FGF-2 to
stimulate oligodendrocyte progenitor entry into the cell cycle." Dev Biol 232(2):
414-23.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 158
Kaur, P., A. Li, R. Redvers and I. Bertoncello (2004). "Keratinocyte stem cell
assays: an evolving science." J Investig Dermatol Symp Proc 9(3): 238-47.
Kitagaki-Ogawa, H., T. Yatohgo, M. Izumi, M. Hayashi, H. Kashiwagi, I.
Matsumoto and N. Seno (1990). "Diversities in animal vitronectins. Differences in
molecular weight, immunoreactivity and carbohydrate chains." Biochim Biophys
Acta 1033(1): 49-56.
Krane, J. F., D. P. Murphy, D. M. Carter and J. G. Krueger (1991). "Synergistic
effects of epidermal growth factor (EGF) and insulin-like growth factor
I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I
transmodulation of the EGF receptor." J Invest Dermatol 96(4): 419-24.
Kricker, J. A., C. L. Towne, S. M. Firth, A. C. Herington and Z. Upton (2003).
"Structural and functional evidence for the interaction of insulin-like growth factors
(IGFs) and IGF binding proteins with vitronectin." Endocrinology 144(7): 2807-15.
Kunugiza, Y., N. Tomita, Y. Taniyama, T. Tomita, M. K. Osako, K. Tamai, T.
Tanabe, Y. Kaneda, H. Yoshikawa and R. Morishita (2006). "Acceleration of wound
healing by combined gene transfer of hepatocyte growth factor and prostacyclin
synthase with Shima Jet." Gene Ther 13(15): 1143-52.
Lanzendorf, S. E., C. A. Boyd, D. L. Wright, S. Muasher, S. Oehninger and G. D.
Hodgen (2001). "Use of human gametes obtained from anonymous donors for the
production of human embryonic stem cell lines." Fertil Steril 76(1): 132-7.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 159
Leary, T., P. L. Jones, M. Appleby, A. Blight, K. Parkinson and M. Stanley (1992).
"Epidermal keratinocyte self-renewal is dependent upon dermal integrity." J Invest
Dermatol 99(4): 422-30.
Lebkowski, J. S., J. Gold, C. Xu, W. Funk, C. P. Chiu and M. K. Carpenter (2001).
"Human embryonic stem cells: culture, differentiation, and genetic modification for
regenerative medicine applications." Cancer J 7 Suppl 2: S83-93.
Li, A. and P. Kaur (2005). "FACS enrichment of human keratinocyte stem cells."
Methods Mol Biol 289: 87-96.
Li, A., N. Pouliot, R. Redvers and P. Kaur (2004). "Extensive tissue-regenerative
capacity of neonatal human keratinocyte stem cells and their progeny." J Clin Invest
113(3): 390-400.
Li, H., D. Xu, J. Li, M. C. Berndt and J. P. Liu (2006). "Transforming growth factor
beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3
interactions with c-Myc and the hTERT gene." J Biol Chem 281(35): 25588-600.
Li, Y., J. Fan, M. Chen, W. Li and D. T. Woodley (2006). "Transforming growth
factor-alpha: a major human serum factor that promotes human keratinocyte
migration." J Invest Dermatol 126(9): 2096-105.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 160
Lim, J. W. and A. Bodnar (2002). "Proteome analysis of conditioned medium from
mouse embryonic fibroblast feeder layers which support the growth of human
embryonic stem cells." Proteomics 2(9): 1187-203.
Liu, Y., Z. Song, Y. Zhao, H. Qin, J. Cai, H. Zhang, T. Yu, S. Jiang, G. Wang, M.
Ding and H. Deng (2006). "A novel chemical-defined medium with bFGF and
N2B27 supplements supports undifferentiated growth in human embryonic stem
cells." Biochem Biophys Res Commun 346(1): 131-9.
Lu, J., R. Hou, C. J. Booth, S. H. Yang and M. Snyder (2006). "Defined culture
conditions of human embryonic stem cells." Proc Natl Acad Sci U S A 103(15):
5688-93.
Ludwig, T. E., M. E. Levenstein, J. M. Jones, W. T. Berggren, E. R. Mitchen, J. L.
Frane, L. J. Crandall, C. A. Daigh, K. R. Conard, M. S. Piekarczyk, R. A. Llanas and
J. A. Thomson (2006). "Derivation of human embryonic stem cells in defined
conditions." Nat Biotechnol 24(2): 185-7.
Ludwig, T. E. (2007). Long-term stability and differentiation potential of human
embryonic stem cells cultured in defined medium. 5th ISSCR Annual Meeting,
Cairns Convention Centre, Cairns, Queensland, Australia.
Lumelsky, N., O. Blondel, P. Laeng, I. Velasco, R. Ravin and R. McKay (2001).
"Differentiation of embryonic stem cells to insulin-secreting structures similar to
pancreatic islets." Science 292(5520): 1389-94.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 161
Maas-Szabowski, N., A. Shimotoyodome and N. E. Fusenig (1999). "Keratinocyte
growth regulation in fibroblast cocultures via a double paracrine mechanism." J Cell
Sci 112 ( Pt 12): 1843-53.
Marinaro, J. A., E. C. Hendrich, K. S. Leeding and L. A. Bach (1999). "HaCaT
human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with
activity against IGFBP-6." Am J Physiol 276(3 Pt 1): E536-42.
Marionnet, C., C. Pierrard, C. Vioux-Chagnoleau, J. Sok, D. Asselineau and F.
Bernerd (2006). "Interactions between fibroblasts and keratinocytes in
morphogenesis of dermal epidermal junction in a model of reconstructed skin." J
Invest Dermatol 126(5): 971-9.
Martin, M. J., A. Muotri, F. Gage and A. Varki (2005). "Human embryonic stem
cells express an immunogenic nonhuman sialic acid." Nat Med 11(2): 228-32.
McLaren, A. (2002). "Human embryonic stem cell lines: socio-legal concerns and
therapeutic promise." C R Biol 325(10): 1009-12.
Meana, A., J. Iglesias, M. Del Rio, F. Larcher, B. Madrigal, M. F. Fresno, C. Martin,
F. San Roman and F. Tevar (1998). "Large surface of cultured human epithelium
obtained on a dermal matrix based on live fibroblast-containing fibrin gels." Burns
24(7): 621-30.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 162
Morris, C. A., P. A. Underwood, P. A. Bean, M. Sheehan and J. A. Charlesworth
(1994). "Relative topography of biologically active domains of human vitronectin.
Evidence from monoclonal antibody epitope and denaturation studies." J Biol Chem
269(38): 23845-52.
Nam, T., A. Moralez and D. Clemmons (2002). "Vitronectin binding to IGF binding
protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions." Endocrinology
143(1): 30-6.
Newman-Smith, E. D. and Z. Werb (1995). "Stem cell defects in parthenogenetic
peri-implantation embryos." Development 121(7): 2069-77.
Noble, A., C. Towne, L. Chopin, D. Leavesley and Z. Upton (2003). "Insulin-like
growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration."
Endocrinology 144(6): 2417-24.
Nonoshita, L. D., N. C. Wathen, B. A. Dsupin, T. Chard and L. C. Giudice (1994).
"Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed
IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance
to maternal-embryonic and fetal interactions." J Clin Endocrinol Metab 79(5): 1249-
55.
Pebay, A., R. C. Wong, S. M. Pitson, E. J. Wolvetang, G. S. Peh, A. Filipczyk, K. L.
Koh, I. Tellis, L. T. Nguyen and M. F. Pera (2005). "Essential roles of sphingosine-
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 163
1-phosphate and platelet-derived growth factor in the maintenance of human
embryonic stem cells." Stem Cells 23(10): 1541-8.
Pei, Y., J. Ma, X. Zhang and W. Ji (2003). "Serum-free culture of rhesus monkey
embryonic stem cells." Arch Androl 49(5): 331-42.
Pera, M. F., B. Reubinoff and A. Trounson (2000). "Human embryonic stem cells." J
Cell Sci 113 ( Pt 1): 5-10.
Pons, S. and E. Marti (2000). "Sonic hedgehog synergizes with the extracellular
matrix protein vitronectin to induce spinal motor neuron differentiation."
Development 127(2): 333-42.
Pouliot, N., N. A. Saunders and P. Kaur (2002). "Laminin 10/11: an alternative
adhesive ligand for epidermal keratinocytes with a functional role in promoting
proliferation and migration." Exp Dermatol 11(5): 387-97.
Prowse, A. B., L. R. McQuade, K. J. Bryant, D. D. Van Dyk, B. E. Tuch and P. P.
Gray (2005). "A proteome analysis of conditioned media from human neonatal
fibroblasts used in the maintenance of human embryonic stem cells." Proteomics
5(4): 978-89.
Rees, C. and D. R. Clemmons (1998). "Inhibition of IGFBP-5 binding to
extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of
IGFBP-5." J Cell Biochem 71(3): 375-81.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 164
Reubinoff, B. E., M. F. Pera, C. Y. Fong, A. Trounson and A. Bongso (2000).
"Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro."
Nat Biotechnol 18(4): 399-404.
Reubinoff, B. E., M. F. Pera, G. Vajta and A. O. Trounson (2001). "Effective
cryopreservation of human embryonic stem cells by the open pulled straw
vitrification method." Hum Reprod 16(10): 2187-94.
Reya, T. and H. Clevers (2005). "Wnt signalling in stem cells and cancer." Nature
434(7035): 843-50.
Rheinwald, J. G. and H. Green (1975). "Serial cultivation of strains of human
epidermal keratinocytes: the formation of keratinizing colonies from single cells."
Cell 6(3): 331-43.
Rho, K. S., L. Jeong, G. Lee, B. M. Seo, Y. J. Park, S. D. Hong, S. Roh, J. J. Cho,
W. H. Park and B. M. Min (2006). "Electrospinning of collagen nanofibers: effects
on the behavior of normal human keratinocytes and early-stage wound healing."
Biomaterials 27(8): 1452-61.
Richards, M., C. Y. Fong, W. K. Chan, P. C. Wong and A. Bongso (2002). "Human
feeders support prolonged undifferentiated growth of human inner cell masses and
embryonic stem cells." Nat Biotechnol 20(9): 933-6.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 165
Rideout, W. M., 3rd, K. Hochedlinger, M. Kyba, G. Q. Daley and R. Jaenisch
(2002). "Correction of a genetic defect by nuclear transplantation and combined cell
and gene therapy." Cell 109(1): 17-27.
Rodeck, U., M. Jost, J. DuHadaway, C. Kari, P. J. Jensen, B. Risse and D. L. Ewert
(1997). "Regulation of Bcl-xL expression in human keratinocytes by cell-substratum
adhesion and the epidermal growth factor receptor." Proc Natl Acad Sci U S A
94(10): 5067-72.
Rohwedel, J., K. Guan, C. Hegert and A. M. Wobus (2001). "Embryonic stem cells
as an in vitro model for mutagenicity, cytotoxicity and embryotoxicity studies:
present state and future prospects." Toxicol In Vitro 15(6): 741-53.
Rolleston, W. B. (1999). "Bovine serum: reducing the variables through the use of
donor herds." Dev Biol Stand 99: 79-86.
Sato, N., L. Meijer, L. Skaltsounis, P. Greengard and A. H. Brivanlou (2004).
"Maintenance of pluripotency in human and mouse embryonic stem cells through
activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor." Nat
Med 10(1): 55-63.
Sawamura, D., S. Ina, M. Goto, M. Akiyama and H. Shimizu (2004). "In vivo
transfer of TGF-alpha and beta genes to keratinocytes." J Dermatol Sci 34(3): 234-6.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 166
Schick, B. P., H. C. Ho, K. C. Brodbeck, C. W. Wrigley and J. Klimas (2003).
"Serglycin proteoglycan expression and synthesis in embryonic stem cells." Biochim
Biophys Acta 1593(2-3): 259-67.
Schneider, H., C. Muhle and F. Pacho (2006). "Biological function of laminin-5 and
pathogenic impact of its deficiency." Eur J Cell Biol.
Schneyer, A., A. Schoen, A. Quigg and Y. Sidis (2003). "Differential binding and
neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-
3/FSRP/FLRG)." Endocrinology 144(5): 1671-4.
Schneyer, A., Y. Sidis, Y. Xia, S. Saito, E. del Re, H. Y. Lin and H. Keutmann
(2004). "Differential actions of follistatin and follistatin-like 3." Mol Cell Endocrinol
225(1-2): 25-8.
Schoppet, M., T. Chavakis, N. Al-Fakhri, S. M. Kanse and K. T. Preissner (2002).
"Molecular interactions and functional interference between vitronectin and
transforming growth factor-beta." Lab Invest 82(1): 37-46.
Schrock, E., S. du Manoir, T. Veldman, B. Schoell, J. Wienberg, M. A. Ferguson-
Smith, Y. Ning, D. H. Ledbetter, I. Bar-Am, D. Soenksen, Y. Garini and T. Ried
(1996). "Multicolor spectral karyotyping of human chromosomes." Science
273(5274): 494-7.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 167
Schuldiner, M., O. Yanuka, J. Itskovitz-Eldor, D. A. Melton and N. Benvenisty
(2000). "Effects of eight growth factors on the differentiation of cells derived from
human embryonic stem cells." Proc Natl Acad Sci U S A 97(21): 11307-12.
Schvartz, I., D. Seger and S. Shaltiel (1999). "Vitronectin." Int J Biochem Cell Biol
31(5): 539-44.
Schwarzenbach, H. (2002). "Expression of MDR1/P-glycoprotein, the multidrug
resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma."
Med Oncol 19(2): 87-104.
Seiffert, D. (1997). "The glycosaminoglycan binding site governs ligand binding to
the somatomedin B domain of vitronectin." J Biol Chem 272(15): 9971-8.
Seiffert, D. and J. W. Smith (1997). "The cell adhesion domain in plasma vitronectin
is cryptic." J Biol Chem 272(21): 13705-10.
Spichkina, O. G., N. V. Kalmykova, L. V. Kukhareva, I. V. Voronkina, M. I.
Blinova and G. P. Pinaev (2006). "[Isolation of human basal keratinocytes by
selective adhesion to extracellular matrix proteins]." Tsitologiia 48(10): 841-7.
Stoll, S., W. Garner and J. Elder (1997). "Heparin-binding ligands mediate autocrine
epidermal growth factor receptor activation In skin organ culture." J Clin Invest
100(5): 1271-81.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 168
Sun, T., J. Haycock and S. Macneil (2006). "In situ image analysis of interactions
between normal human keratinocytes and fibroblasts cultured in three-dimensional
fibrin gels." Biomaterials 27(18): 3459-65.
Sun, T., M. Higham, C. Layton, J. Haycock, R. Short and S. MacNeil (2004a).
"Developments in xenobiotic-free culture of human keratinocytes for clinical use."
Wound Repair Regen 12(6): 626-34.
Sun, T., D. Norton, A. J. Ryan, S. MacNeil and J. W. Haycock (2007). "Investigation
of fibroblast and keratinocyte cell-scaffold interactions using a novel 3D cell culture
system." J Mater Sci Mater Med 18(2): 321-8.
Sun, X. Q., X. B. Fu, W. Chen and T. Z. Sun (2004b). "[Effects of fibroblast growth
factor-10 on the secretions of transforming growth factor-alpha, platelet-derived
growth factor-AB and vascular endothelial growth factor by normal adult human
keratinocytes in culture]." Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16(1): 13-8.
Tanghetti, E., R. Ria, P. Dell'Era, C. Urbinati, M. Rusnati, M. G. Ennas and M.
Presta (2002). "Biological activity of substrate-bound basic fibroblast growth factor
(FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts."
Oncogene 21(24): 3889-97.
Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V.
S. Marshall and J. M. Jones (1998). "Embryonic stem cell lines derived from human
blastocysts." Science 282(5391): 1145-7.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 169
Trojan, J., T. R. Johnson, S. D. Rudin, B. K. Blossey, K. M. Kelley, A. Shevelev, F.
W. Abdul-Karim, D. D. Anthony, M. L. Tykocinski, J. Ilan and et al. (1994). "Gene
therapy of murine teratocarcinoma: separate functions for insulin-like growth factors
I and II in immunogenicity and differentiation." Proc Natl Acad Sci U S A 91(13):
6088-92.
Trounson, A.O., Gardner, D.K., Baker, G., Barnes, F.L., Bongso, A., Bourne, H.,
Calderon, I., Cohen, J., Dawson, K., Eldar-Geve, T., Gardner, D.K., Graves, G.,
Healy, D., Lane, M., Leese, H.J., Leeton, J., Levron, J., Liu, D.Y., MacLachlan, V.,
Munné, S., Oranratnachai, A., Rogers, P., Rombauts, L., Sakkas, D., Sathananthan,
A.H., Schimmel, T., Shaw, J., Trounson, A.O., Van Steirteghem, A., Willadsen, S.,
and Wood, C. (2000b). Handbook of in vitro fertilization, (Boca Raton, London,
New York, Washington, D.C.: CRC Press).
Trounson, A. (1982). "Current perspectives of in vitro fertilization and embryo
transfer." Clin Reprod Fertil 1(1): 55-65.
Upton, Z. and J. A. Kricker (2002). International Patent. WO 02/24219 A1.
Upton, Z., H. Webb, K. Hale, C. A. Yandell, J. P. McMurtry, G. L. Francis and F. J.
Ballard (1999). "Identification of vitronectin as a novel insulin-like growth factor-II
binding protein." Endocrinology 140(6): 2928-31.
Urban, R. (2005). Tissue, when they all fall down. The Age, Fairfax Digital.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 170
Valve, E., P. Martikainen, J. Seppanen, S. Oksjoki, S. Hinkka, L. Anttila, S.
Grenman, P. Klemi and P. Harkonen (2000). "Expression of fibroblast growth factor
(FGF)-8 isoforms and FGF receptors in human ovarian tumors." Int J Cancer 88(5):
718-25.
Vardy, D. A., C. Kari, G. S. Lazarus, P. J. Jensen, A. Zilberstein, G. D. Plowman and
U. Rodeck (1995). "Induction of autocrine epidermal growth factor receptor ligands
in human keratinocytes by insulin/insulin-like growth factor-1." J Cell Physiol
163(2): 257-65.
Wang, G., H. Zhang, Y. Zhao, J. Li, J. Cai, P. Wang, S. Meng, J. Feng, C. Miao, M.
Ding, D. Li and H. Deng (2005). "Noggin and bFGF cooperate to maintain the
pluripotency of human embryonic stem cells in the absence of feeder layers."
Biochem Biophys Res Commun 330(3): 934-42.
Wang, S., C. Hu and J. Zhu (2007). "Transcriptional silencing of a novel hTERT
reporter locus during in vitro differentiation of mouse embryonic stem cells." Mol
Biol Cell 18(2): 669-77.
Watt, F. M. (1998). "Epidermal stem cells: markers, patterning and the control of
stem cell fate." Philos Trans R Soc Lond B Biol Sci 353(1370): 831-7.
Watt, F. M. and P. H. Jones (1993). "Expression and function of the keratinocyte
integrins." Dev Suppl: 185-92.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 171
Watt, F. M., M. D. Kubler, N. A. Hotchin, L. J. Nicholson and J. C. Adams (1993).
"Regulation of keratinocyte terminal differentiation by integrin-extracellular matrix
interactions." J Cell Sci 106 ( Pt 1): 175-82.
Werner, S. and H. Smola (2001). "Paracrine regulation of keratinocyte proliferation
and differentiation." Trends Cell Biol 11(4): 143-6.
Wilder, P. J., D. Kelly, K. Brigman, C. L. Peterson, T. Nowling, Q. S. Gao, R. D.
McComb, M. R. Capecchi and A. Rizzino (1997). "Inactivation of the FGF-4 gene in
embryonic stem cells alters the growth and/or the survival of their early
differentiated progeny." Dev Biol 192(2): 614-29.
Wright, K. A., K. B. Nadire, P. Busto, R. Tubo, J. M. McPherson and B. M.
Wentworth (1998). "Alternative delivery of keratinocytes using a polyurethane
membrane and the implications for its use in the treatment of full-thickness burn
injury." Burns 24(1): 7-17.
Xu, C., M. S. Inokuma, J. Denham, K. Golds, P. Kundu, J. D. Gold and M. K.
Carpenter (2001). "Feeder-free growth of undifferentiated human embryonic stem
cells." Nat Biotechnol 19(10): 971-4.
Zhuang, P., M. N. Blackburn and C. B. Peterson (1996). "Characterization of the
denaturation and renaturation of human plasma vitronectin. I. Biophysical
characterization of protein unfolding and multimerization." J Biol Chem 271(24):
14323-32.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 172
Zhuang, P., H. Li, J. G. Williams, N. V. Wagner, D. Seiffert and C. B. Peterson
(1996). "Characterization of the denaturation and renaturation of human plasma
vitronectin. II. Investigation into the mechanism of formation of multimers." J Biol
Chem 271(24): 14333-43.
zur Nieden, N. I., L. J. Ruf, G. Kempka, H. Hildebrand and H. J. Ahr (2001).
"Molecular markers in embryonic stem cells." Toxicol In Vitro 15(4-5): 455-61.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 173
APPENDIX I
RESULTS
Proteins identified from feeder cell and feeder cell:keratinocyte culture
conditioned media.
MALDI TOF-TOF analysis was conducted on the protein spots transferred from the
second dimension separation as described in section 4.2.4. Several proteins were
observed in this study; however, these results were reduced to a few potential
candidate proteins that may be relevant for the culture of keratinocytes. Results were
organised into: cytokines, growth factors, secreted, and intracellular for the feeder
treatment; and, cytokines, growth factors, hormones, secreted, and intracellular for
the feeder:keratinocyte treatment. Moreover, proteins were categorised based on,
accession number, molecular weight, and protein score. The results for Table A.1
revealed; 5 cytokines, 7 growth factors, 2 secreted and 1 nuclear. Additionally, the
results for Table A.2 revealed; 6 cytokines, 8 growth factors, 2 hormones, 5 secreted
and 4 nuclear proteins.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 174
Table AI.1 MALDI-TOF-TOF Feeder Cell Conditioned Medium.
Protein Accession Number
Molecular Weight
Protein Score
Cytokines Interleukin 1 beta (Fragment) Q6PUJ4 7928.9 39 interleukin-8 precursor [similarity] S42496 11575 32 Interleukin 10 (Fragment) Q4VHD7 8081 32 Shorter isoform of interleukin 15 (IL-15A precursor) Q9Z0G5 1501.7 25 Leukemia inhibitory factor Q8SPP1 8695 33 Growth Factors Growth hormone (Fragment) O19033 6253 34 Transforming growth factor alpha (Fragment) Q9UQ91 9882.9 14 Fibroblast growth factor homologous factor 3 BQ9JLA7 1869 20 bFGF (Human) E969488 16918 32 Vascular endothelial growth factor Q91ZE2 2836 20 Transforming growth factor beta 2 (Fragment) Q19KA8 5972 34 bone morphogenetic protein 1 C58788 4339 25 Secreted Megakaryocyte colony-stimulating factor P40225 33957 22 Secreted frizzled-related sequence protein 1 Q505A2 36317 20 Intracellular Stat4 Q3U098 54189 23
Table AI.2 MALDI-TOF-TOF Feeder Cell:Keratinocyte Conditioned Medium.
Protein Accession Number
Molecular Weight
Protein Score
Cytokines Shorter isoform of interleukin 15 (precursor) Q9Z0G5 1501.7 19 Interleukin 1 alpha (Fragment).- Ovis aries Q9TU76 1518.7 21 Interleukin 4 (Fragment).- Capra hircus Q1WD38 2230.2 20 Interleukin 10 (Fragment).- Homo sapiens Q9BXR7 1616.8 21 Interleukin-6.- Sus scrofa (Pig). Q8MKE5 24034.9 37 Interleukin-1 alpha (Fragment).- Q71VD0 1841.9 19 PDGF-inducible JE glycoprotein precursor A30209 16543.6 43 Growth Factors FGF-2 activity-associated protein 3 Q96PS2 5633.9 36 PC cell-derived growth factor, PCDGF=EPITHELIN
Q9QWB4 5755.7 36
nerve growth factor homolog 1 - rat A49023 28150.9 40 Platelet-derived growth factor bb, chain B, fragment 2 - human
1PDGB2 7685 16
Platelet-derived growth factor bb, chain C, fragment 2 - human
1PDGC2 8032.1 15
Platelet-derived growth factor bb, chain A, fragment 2 - human
1PDGA2 8174.2 15
TGFBI (Fragment).- Mus musculus Q19PV3 4892.6 18 VEGF (Fragment).- Homo sapiens (Human). CAC60171 1356.8 20 Hormones OVINE GROWTH HORMONE AA 122-138.- Ovis aries
E963408 1911 18
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 175
PREPROPARATHYROID hormone (Fragment).- Q9UD38 3505 18 Secreted growth inhibitory factor - mouse I67866 8144.1 15 Growth differentiation factor 9 (Fragment).- Q38G65 39567.1 31 secreted frizzled-related 1 Q6ZSL4 20923.1 23 Wnt-12 O00744 13581.7 30 Intracellular Telomerase reverse transcriptase Q5I1Y3 8126.1 31 insulin gene enhancer protein isl-1 - rat 1BW5 7985.2 35 Janus kinase 1 (Fragment).- Macaca Q4G3Y7 21692.7 26 STAT- 2 type a S63681 7419.7 35 SUMO-2 P61956 10920 28
Table AI.1 & AI.2: Proteins identified from feeder and feeder:keratinocyte cell
conditioned media using MALDI-TOF-TOF. Conditioned media was collected
every two days, from 3 different patients’ samples, concentrated, isolated, and
separated in two dimensions as per section (4.2.4). Spots from the 2nd dimension
were then lyophilised and tryptically digested as per section (4.2.5). Data was
analysed using the MASCOT database using GPS Explorer™ protein analysis
software (version 4.0) with the mass/ion peak information obtained from both the
MS and the MS/MS spectra refer to section (4.2.6).
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 176
APPENDIX II
This work was submitted by Luke Cormack for his honours thesis at the
Faculty of Science - School of Life Sciences.
Queensland University of Technology, June 2007.
Analysis of the Human Embryonic Stem Cell In-vitro Micro-Environment
Mr Luke Cormack, Mr Sean Richards, Dr David Leavesley and Prof Zee Upton
Running Title: Analysis of the stem cell micro-environment
Key Words: human embryonic stem cells, mouse embryonic fibroblasts, serum-free,
undifferentiated, proteomic analysis, conditioned media.
Luke Cormack (n5021928)
Tissue Regeneration and Repair Program
School of Life Science
Institute of Health and Biomedical Innovation
60 Musk Ave
Kelvin Grove, QLD, 4059
Australia
Tel. +61-7-38657656
Fax. +61-7-38641534
Email: [email protected]
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 177
Results
Identified Proteins from the MEF Cells Alone and the MEF:hES Cell Conditioned
Media. Proteins in the MEF CM and the MEF:hES cell CM was analysed using three
methods, MALDI-TOF-TOF, LC/ESI/MS and LC-MALDI. The Mascot database
was employed to analyse proteins present within the CM and the results were
organised into seven protein species; ECM, membrane, nuclear, secreted,
differentiation and growth factors, and serum-derived. Additionally, the proteins
were categorised using accession number, molecular weight, protein score and ion
score. The MALDI-TOF-TOF results were related to the protein score. The MALDI-
TOF-TOF results for the MEF CM media revealed 3 ECM, 3 membrane, 3 nuclear, 1
cytoplasmic, 4 secreted and 7 differentiation and growth factor proteins (Table 1).
Furthermore, the MALDI-TOF-TOF results for the MEF:hES cells CM revealed 4
membrane, 4 nuclear, and 6 secreted proteins (Table 2). All MALDI-TOF-TOF
results, except for the nuclear protein heterogeneous nuclear ribonucleoprotein M
(Table 2), were unconfirmed as determined by their protein scores. The LC/ESI/MS
results are related to the ion scores. The LC/ESI/MS results for the MEF CM
revealed 11 ECM, 4 membrane, 5 nuclear, 1 cytoplasmic, 3 secreted, and 3 serum-
derived proteins (Table 1). Additionally, the LC/ESI/MS results for the MEF:hES
cell CM revealed 12 ECM, 4 membrane, 6 nuclear, 6 cytoplasmic, 1 secreted, and 2
serum-derived proteins (Table 2). The LC-MALDI results are also related to the ion
score. The LC-MALDI results for the MEF CM revealed 1 ECM, 1 membrane, 2
cytoplasmic and 1 secreted protein (Table 1). Furthermore, the LC-MALDI results
for the MEF:hES cell CM revealed 1 cytoplasmic and 2 secreted proteins (Table 2).
All proteins revealed via the LC/ESI/MS analysis were either confirmed or exhibit
extensive homology as determined by their ion scores. All three analyses described
above were conducted in order to increase the legitimacy of the returned results.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 178
Table AII.1 Feeder Cell Conditioned Medium. Protein Accession Number MW
(kDa) MALDI-
TOF-TOF Protein score
LC/ESI/MS Ion
score
LC-MALDI Ion
score Extra Cellular Matrix Collagen alpha-1(I) chain Q63079 138 64 Collagen alpha-1(V) chain BAA14323 184 41 Collagen alpha-3(VI) chain CAB60731 549 52 Collagen alpha-1(VII) chain AAA58965 293 59 Collagen alpha-1(XII) chain AAC51244 334 52 Fibronectin S14428 275 44 Laminin alpha-1 chain MMMSA 347 40 Laminin alpha-4 chain LMA4_HUMAN 204 52 Laminin alpha-5 chain LMA5_MOUSE Laminin, gamma 1 Q5VYE7_HUMAN 30 Laminin, gamma-3 AAD36991 177 38 Laminin M I54245 16 43 Proteoglycan link protein A29165 11 35 Tenascin-X T42629 454 41 Thrombospondin 1 Q80YQ1 133 39 Vitronectin Q2Y097_9CARN 7 32 Membrane FGF receptor C44775 3 24 IGF-II mRNA-binding protein 2 AAD31596 66 34 IGF-II receptor Q95MI9 263 41 32 JAK1 protein AAA36527 133 40 JAK2 protein Q7TQD0 132 49 Mast/stem cell growth factor receptor AAA37420 2 43 Membrane-type matrix metalloproteinase-1
Q9XSP0 66 41
Nuclear Cell proliferation antigen Ki-67 T30249 325 40 p53 tetramerization domain 1AIE 3 41 MAP kinase kinase 7 Q8BSP1 47 40 MAPK/ERK kinase kinase 4 T03022 183 47 Protein inhibitor of activated STAT2 AAF12825 64 40 T-box transcription factor TBX20 CAC04520 33 25 Tra1 homolog TRAP_MOUSE 294 39 Ubiquitin carboxyl-terminal hydrolase 43
Q8N2C5 69 59
Probable E3 ubiquitin-protein ligase MYCBP2
O75592 518 49
Cytoplasmic Growth factor receptor-bound protein 14
AAH53559 60 23
Peroxiredoxin-1 BAB27120 22 39 Phospholipase C-epsilon Q8K4S1 258 42 Casein kinase I (isoform alpha) Q5U46 37 25 Secreted Follistatin-related protein 1 S38251 35 64 Interleukin-1 receptor antagonist [Precursor]
AAO24703 20 37
Interleukin-8 Q6LAA1_CANFA 7 37 Matrix-remodelling-associated protein 5
Q9NR99 314 39 23
Protein Wnt-2b AAC25397 45 41 Secreted frizzled-related protein 2 Q9BG86_RABIT 33 36 Suppression of Tumorigenicity 5 Q924W7 TGF-beta-induced protein ig-h3 AAB88697 4 22
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 179
Serum Derived Alpha-2-HS-glycoprotein S22394 39 72 Serotransferrin] AAA96735 79 55 Serum albumin AAN17824 71 452 Differentiation and growth factor Bone morphogenetic protein 15 Q8MII6_BOVIN 12 37 Hepatocyte growth factor BAA01065 84 45 IGF-1 CAA01955 13 59 IGF-II protein CAA04657 8 34 Platelet-derived growth factor B chain
AAH53430 27 47
Pro-epidermal growth factor CAA24116 4 22 TGF beta 2 Q9MYZ1_CAPHI 10 32
Table AII.1: Proteins identified from the MEF conditioned media using
MALDI-TOF-TOF, LC/ESI/MS and LC-MALDI. Media conditioned by the MEF
cells alone was collected daily, concentrated, isolated, and separated in the first
dimension and second dimension as per the materials and methods. This was
repeated for three separate experiments. Fractions collected from the second
dimension were processed and applied to MALDI-TOF-TOF mass spectrometry.
Database searching of non-interpreted TOF-MS and TOF-TOF MS/MS data was
carried out using the GPS Explorer™ automated interrogation of the MASCOT
database using protein score, protein score confidence interval, total ion score and
total ion score confidence interval. Alternatively, LC/ESI/MS was conducted on
protein fractions as a secondary analysis. Fractions collected from the first dimension
separation were processed and applied to the LC/ESI/MS system. Data was analysed
using the Analyst 1.4.1 software and proteins were later identified using the
MASCOT database search engine. The probability Mowse score was used to
determine homology. Briefly, this score is -10*Log(P), where P is the probability
that the observed match is a random event. Individual ions scores > 38 indicate
identity or extensive homology (p<0.05). Further analysis was conducted on
processed “raw” CM samples using LC-MALDI. Potential protein matches were
then identified from automated searching of the MASCOT database using GPS
Explorer™ protein analysis software (version 4.0) with the mass/ion peak
information obtained from both the MS and the MS/MS spectra.
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 180
Table AII.2 Feeder Cell:hES Cell Conditioned Medium. Protein Accession
Number MW
(kDa) MALDI-
TOF-TOF Protein score
LC/ESI/MS Ion
score
LC-MALDI Ion
score Extra Cellular Matrix Collagen alpha-2(I) chain AAC64485 129 50 Collagen alpha 1(IV) chain CGHU4B 161 38 Collagen alpha-6(IV) chain BAA04809 163 41 Collagen alpha-1(V) chain BAA14323 184 41 Collagen alpha-2(V) chain Q7TMS0 145 41 Collagen alpha-1(XI) chain BAA07367 181 63 Collagen alpha-1(XII) chain AAC51244 334 42 Collagen alpha-1(XV) chain Q9EQD9 140 38 Laminin alpha-2 chain S53868 351 42 Laminin subunit alpha-5 LMA5_MOUSE 416 43 Tenascin X T09070 442 39 Versican core protein T42389 371 43 Membrane Cadherin-20 AAG23739 89 39 Collagen alpha-2(VI) chain AAB20836 33 44 Catenin alpha-2 I49499 101 39 Insulin receptor AAB61414 1 20 Myelin-oligodendrocyte glycoprotein
Q29ZP9_CALJA 5 17
Tensin-1 Q9HBL0 186 41 Tumor-associated calcium signal transducer 1
CAA32870 35 26
Zeta-sarcoglycan AAK21962 33 55 Nuclear Cell proliferation antigen Ki-67 T30249 325 42 E3 SUMO AAC41758 362 65 Fos-related antigen 2 CAA58804 3 20 Myc-binding protein 2 O75592 518 43 Mitogen-activated protein kinase 14 AAC50329 34 44 Progesterone receptor Q9GLW0 99 50 T-box transcription factor TBX3 BAC34999 79 46 TGF-beta-inducible nuclear protein 1 BAB31689 6 49 Transcription factor Dp-2 TDP2_HUMAN 49 38 E3 ubiquitin-protein ligase UHRF1 O7TPK1 94 39 Cytoplasm Casein kinase I isoform alpha Q9GLY1 37 43 Dishevelled DVL3_HUMAN 78 40 MAP kinase kinase kinase 4 T03022 183 42 23 Peroxiredoxin AAH68135 147 49 Protein deltex-4 AAH58647 67 48 Triple functional domain protein AAC34245 326 40 Secreted Collagenase 3 AAC24596 45 22 Follistatin-related protein 1 S38251 35 47 Galanin-like peptide AAF19724 12 44 Interleukin-2 CAA42722 15 47 Interleukin-4 CAA28874 3 38 Interleukin-13 Q4VB53 9 40 Metalloproteinase-disintegrin domain containing protein
Q71U12_MOUSE 74 48
Prostaglandin-H2 D-isomerase BAA21769 21 23 Suppression of tumorigenicity 5 AAH36655 127 44 Serum Derived Serotransferrin AAA96735 79 94 Serum albumin AAN17824 71 452
SEAN RICHARDS
TOWARDS FEEDER-FREE AND SERUM-FREE GROWTH OF CELLS 181
Table 2: Proteins identified from the MEF:hES cells conditioned media using
MALDI-TOF-TOF, LC/ESI/MS and LC-MALDI. Media conditioned by the
MEF: hES cells was collected daily, concentrated, isolated, and separated in the first
dimension and second dimension as per the material and methods. This was repeated
for three separate experiments. Fractions collected from the second dimension were
processed and applied to MALDI-TOF-TOF mass spectrometry. Database searching
of non-interpreted TOF-MS and TOF-TOF MS/MS data was undertaken using the
GPS Explorer™ automated interrogation of the MASCOT database using protein
score, protein score confidence interval, total ion score and total ion score confidence
interval. Alternatively, LC/ESI/MS was conducted on protein fractions as a
secondary analysis. Fractions collected from peaks in the first dimension separation
were processed and applied to the LC/ESI/MS system. Data was analysed using the
Analyst 1.4.1 software and proteins were later identified using the MASCOT
database search engine. The probability Mowse score was used to determine
homology. Briefly, score is -10*Log(P) where P is the probability that the observed
match is a random event. Individual ions scores > 38 indicate identity or extensive
homology (p<0.05). Further analysis was conducted on processed “raw” CM
samples using LC-MALDI. Potential protein matches were then identified from
automated searching of the MASCOT database using GPS Explorer™ protein
analysis software (version 4.0) with the mass/ion peak information obtained from
both the MS and the MS/MS spectra.